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ABSTRACT 
The role for protein dynamics in the transition states (TS) of enzyme reactions has 
been debated over decades. Dihydrofolate reductase (DHFR) catalyses the NADPH-
dependent reduction of dihydrofolate to tetrahydrofolate and has long been 
considered a paradigm of enzymology. Numerous studies on DHFR have provided 
strong evidence that there is no coupling between the long-range motions on 
nanosecond to millisecond timescales to the chemical coordinate. However, the 
role of femtosecond (fs) bond vibrations in the TS has not been fully investigated. 
This investigation focused on understanding how these fast protein vibrations 
affect enzyme catalysis. A thermophilic DHFR from Geobacillus stearothermophilus 
(BsDHFR) was investigated kinetically by complete enzyme isotope substitution. Our 
studies indicated that, whilst protein vibrations do couple to the reaction 
coordinate, they do not affect the height or width of barrier crossing. Instead, 
dynamic coupling enhances the frequency of dynamic recrossing. In line with the 
other DHFR investigations by enzyme isotope substitution, efficient enzymes tend 
to reduce dynamic coupling as a mean to maximise enzyme catalytic efficiency. The 
transition state in DHFR was also characterised by α-secondary hydrogen and heavy 
atom kinetic isotope effects (KIEs). Secondary KIEs were measured for DHFR 
isolated from Escherichia coli, Moritella profunda and G. stearothermophilus. The 
high resemblance in the magnitude and temperature dependence of the measured 
α-secondary KIE implied that the reaction ready configuration is essentially the 
same among these enzymes. Carbon isotope effect measurements were measured 
for EcDHFR. The reacting carbon in NADPH showed a profound isotope effect at low 
temperature. Further analysis by measuring hydride KIE indicated the hypothetical 
"promoting" motion is unlikely to act via the C4 atom of NADPH. The carbon 
isotope effect likely reports on the recrossing events or the reorganisation effect 
that occur along the transition state dividing surface. 
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1.1 Enzymes - nature's catalysts 
Enzymes are capable of enhancing the reaction rate of biological processes by many 
orders of magnitude (Figure 1.1A). Orotidine monophosphate (OMP) decarboxylase 
is able to increase the rate of reaction by a factor of 1017 compared to the rate of 
spontaneous OMP decarboxylation (1). Like all catalysts, enzymes lower the 
activation energy of the reaction (Figure 1.1B) in this case through the formation of 
the enzyme-substrate (ES) complex. One of the earliest theories to explain this 
extraordinary activity was proposed by Fischer in 1894, who published the "lock 
and key" theory in which enzyme active sites are specifically designed to tightly 
bind the substrate (2). Later, Eyring developed transition state theory (TST), a key 
component of which is the existence of an activated ES complex (ES‡). This was 
modified by Pauling soon after, who proposed the preferential binding of the 
transition state as a mechanism for enzyme activity (3, 4).  
The increasing experimental results that could not be explained by the "lock and 
key" model, including examples of non-competitive inhibition, led to Koshland 
proposing the "induced fit" mechanism (5, 6). This theory suggested that upon 
binding the substrate(s), the enzyme undergoes conformational changes, forming 
an ES complex that is closer in structure to the transition state. This is thought to 
reduce the activation energy by three main methods, including bringing the 
reacting groups of the substrates closer together, weakening bonds that need to be 
broken and/or stabilising the transition state itself. Finally, Warshel has shown that 
enzymes can form a favourable polar environment, termed "electrostatic 
preorganisation", and this contributes to the increased catalytic power (7). 
Subsequent studies, including allosteric control of enzymes and protein NMR 
investigations, provided evidence that enzymes could adopt different 
conformations, often with wide ranging catalytic properties (8, 9). However, the 
intrinsic catalytic power of enzymes is still not well understood. This is highlighted 
by results from research into the design of artificial enzymes. Despite numerous 
efforts, the ability to mimic nature and produce synthetic enzymes that are not only 
able to catalyse reactions, but do so under typical physiological conditions (water, 
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pH 7, ambient temperature) is still incredibly challenging, with few cases reported 
to date (see recent reviews for more information (10-13)). 
 
 
Figure 1.1 A) Comparison of the rate of a typical enzyme catalysed reaction with 
uncatalysed spontaneous reaction rates. Figure taken from Wolfenden, R., (2003) 
Thermodynamic and extrathermodynamic requirements of enzyme catalysis, Biophysical 
Chemistry, 105, 559-572. B) Reaction pathway of an uncatalysed reaction (black) and a 
simple enzyme-catalysed reaction (red). Formation of the activated enzyme-substrate 
complex (ES‡) from the ES requires less energy than formation of the uncatalysed 
activated substrate (S‡). 
 
1.1.1 Enzyme dynamics 
Evidence of proteins being able to adopt multiple conformations led to the idea 
that they were dynamic entities, and it is thought that understanding this 
phenomenon will shed light on the incredible efficiency of enzymes. Enzyme 
motions span a wide range of time scales: bond vibrations (femtoseconds), rotation 
of side-chains at a protein's surface (picoseconds), hinge-bending at the interface 
between domains (pico-nanoseconds), rotation of side-chains buried in the interior 
Image removed due to copyright 
reasons. See legend for reference. 
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of a protein (micro-milliseconds) and allosteric transitions (micro-milliseconds) (14-
16). Whilst most large scale conformational changes, such as allosteric control, are 
widely accepted, the contribution of faster motions, typically those that occur after 
formation of the ES complex, have proved much more controversial (17-19). 
Motions are implicit in chemical reactions, with vibrations on an atomistic scale 
affecting bond lengths, angles and charge distributions, all of which enable 
(enzymatic) reactions to occur. The term "enzyme dynamics" is used specifically to 
refer to non-statistical motions. Statistical motions are those in thermal equilibrium 
with the surrounding environment and encompass the vast majority of enzyme 
motions. On the other hand, non-statistical motions or enzyme dynamics are not in 
equilibrium with the surrounding thermal environment. Controversy arises when 
enzyme dynamics (encompassing a wide range of timescales) are claimed to couple 
directly to enzyme catalysis, enhancing the rate of reaction. A typical TS exists for 
50-100 fs (18), and it is how this short-lived intermediate is affected by motions on 
a similar timescale (i.e. bond vibrations), and those on a much longer time scale 
(e.g. ms loop movements), that has sparked numerous debates in the literature. 
Recent enzymology studies, both theoretical and experimental, have focused on 
determining how enzyme dynamics contribute to enhancing reaction rates. The 
large number of enzymatic reactions that involve hydrogen transfer (H+, H- or H•) 
have provided an excellent framework for these investigations (20-25). Numerous 
catalytic models have been proposed to explain the results from these 
investigations, and will be explained below. 
 
1.1.2 Transition state theory and isotope effects 
Transition state theory (TST) is often used as a simple, but nonetheless effective, 
model to explain enzyme catalysis (26). TST relies on two basic assumptions: 1) that 
the reaction follows a reaction coordinate and must pass through a maximum 
point, known as the transition state (TS), and 2) that the concentration of the TS is 
in equilibrium with the substrate(s) of the reaction. The concentration of the TS is 
governed by the law of thermodynamics and leads to the equation: 
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where A and B are the substrates, and K‡ is the psuedo-equilibrium constant of the 
formation of the TS given by: 
     
    
   
where ΔG‡ is the Gibbs free energy of formation of the TS. The concentration of the 
TS is thus: 
             
    
          
   
  
    
    
As TST assumes that the TS is in equilibrium with the substrates, the rate of reaction 
is governed by the concentration of the TS and the frequency with which the TS 
decomposes to form the products. It is assumed that the frequency of the 
decomposition of the transition state is proportional to the vibrational frequency of 
relevance (v) and the transmission coefficient (Γ): 
        
  
         
where v is equal to kBT/h where kB and h are the Boltzmann constant and Planck's 
constant respectively. The transmission coefficient is defined as the factor that 
includes all effects not incorporated in the TST constant (27). In most reactions Γ is 
assumed to be unity (see below for corrections to this theory). This leads to the 
Eyring equation: 
    
   
 
  
   
  
    
   
One of the most effective tools for studying enzyme reactions is the use of kinetic 
isotope effects (KIE), defined as: 
    
  
  
 
where kL is the rate constant of the reaction involving the light isotope and kH is the 
rate constant of the reaction involving the heavier isotope. In regards to enzyme 
Introduction 
 
6 
 
studies the most common isotope effects measured are primary isotope effects 
involving the isotopes of hydrogen – deuterium and tritium. A primary isotope 
effect occurs when the isotope is part of the bond being broken during the reaction 
(28).  
In semi-classical TST, KIEs are due solely to the difference in zero point energy (ZPE) 
between the bonds to light and heavy isotope (Figure 1.2). Each bond has many 
different energy levels, and these levels are expressed as: 
      
 
 
       n = 0,1,2... 
therefore when n = 0, 
    
 
 
     
where v' is the frequency of the stretching vibration of a bond: 
   
 
  
 
  
 
 
where k' is the force constant of the bond and μ is the reduced mass: 
  
    
     
 
The presence of the heavier isotope results in a smaller stretching frequency of the 
bond due to the greater reduced mass. This causes a lower ZPE, hence heavier 
isotopes have a larger ΔH‡ to reach the TS compared to the light isotope. At 25 °C 
the difference in ZPE between a C-H and a C-D bond is 4.8 kJ mol-1, and following 
substitution into the Eyring equation, results in a kH/kD value of 6.9: 
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Figure 1.2 Reaction profile showing the difference in ZPE between a C-H and C-D bond 
(red and blue respectively) and the resulting differences in ΔH‡. 
 
The Arrhenius law can also be used to relate the rate of reaction to the energy 
barrier that has to be overcome during the reaction: 
     
   
   
where A is the pre-exponential factor and Ea is the activation energy. Similarly to 
the Eyring equation, the difference in ZPE between the light and heavy isotope 
causes the perceived KIE: 
  
  
 
  
  
  
 
        
 
      
where AH and AD are pre-exponential factors for hydrogen and deuterium transfer 
and 1/2 hvH and 1/2hvD are the ZPE of a C-H and C-D bond respectively. In semi-
classical theory the AH/AD ratio is 1, i.e. at infinite temperature the difference in 
activation energy disappears and so there is no difference between kH and kD. 
Early KIE theories focused on explaining how smaller than expected values could be 
obtained. Eyring's theory assumes sole importance of the stretching vibrational 
frequency becoming translational frequency, a characteristic of the TS. This 
simplification ignores contributions from bending vibrational frequencies, 
vibrational modes of all other atoms in the molecule, and new vibrational 
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frequencies introduced at the TS (29). It was found that these other vibrational 
modes at the TS could reduce the difference between the ZPE at the GS and TS, 
resulting in lower KIEs (29). This led to the theory that the magnitude of the KIE 
would reflect the position of the TS. A symmetric TS results in a maximum KIE value, 
i.e. ~7, whereas a TS resembling either the reactants or products would result in a 
lower KIE (29). However, with the discovery that hydrogen tunnelling may play a 
significant role in enzyme catalysis, it was found that models incorporating 
quantum mechanics were required to explain the observed results. 
 
1.1.3 The Bell tunnelling correction 
As stated, the semi-classical models surrounding the Eyring and Arrhenius 
equations fail to explain larger than expected KIEs, thought to be attributed to 
tunnelling. Bell proposed a modification of semi-classical theory to incorporate the 
uncertainty of a particle's position as it passed through the reaction coordinate, 
allowing the molecule to "tunnel" through the reaction barrier (Figure 1.3) (30). Bell 
used the theory, first proposed by de Broglie, that a particle's uncertainty of 
position is due to its wavelength (λ): 
        
where m is the mass and E is the energy of the molecule. As can be seen, the lighter 
the molecule the greater the de Broglie wavelength and therefore the greater level 
of uncertainty of a particle's position. This is particularly relevant to the isotopes of 
hydrogen as the relatively large differences in mass mean significant differences in 
the respective de Broglie wavelengths (Table 1.1). As a typical reaction coordinate is 
approximately 1 Å or less, these de Broglie wavelengths signify a high probability of 
tunnelling occurring through the reaction barrier. 
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Figure 1.3 Reaction coordinate highlighting the barrier width at which H and D tunnelling 
can occur. 
 
Table 1.1 Comparison of the de Broglie wavelengths of H, D T and carbon (assuming an 
energy of 20 kJ mol-1). 
 H D T C 
Mass (amu) 1 2 3 12 
λ (Å) 0.63 0.45 0.36 0.18 
 
Bell's theory focuses on a minor adaption to the Arrhenius equation by the 
correction factor, Q (30): 
     
   
   
where Q is: 
  
 
  
  
  
  
  
   
   
   
  
  
     
and β is: 
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where a is the width of the barrier, m the mass of the tunnelling particle, and Ea the 
barrier height. The mass of the particle has a large effect on Q due to the 
exponential involving β. The large difference in mass between hydrogen and 
deuterium/tritium can therefore result in large KIEs.  
 
 
Figure removed due to copyright reasons. 
See legend for reference 
 
 
Figure 1.4 Arrhenius plot of hydrogen transfer (above) and KIE (below) consistent with 
the Bell tunnelling correction. Figure taken from Stojković, V. and Kohen, A. (2009), 
Enzymatic H Transfers: Quantum Tunneling and Coupled Motion from Kinetic Isotope 
Effect Studies. Isr. J. Chem., 49: 163–173.  
 
The temperature dependence of the KIE and the AH/AD ratio has also been used to 
infer a contribution from tunnelling during the reaction (30). TST with a Bell 
correction predicts that at high temperatures i.e. with excess thermal energy, the 
reaction will proceed over the barrier with very little contribution from tunnelling. 
This will result in a temperature dependent KIE and AH/AD ≈ 1 (region I, Figure 1.4). 
At low temperatures, tunnelling becomes the main contribution to the reaction 
rate, resulting in temperature independent KIEs and an AH/AD > 1 (region III, Figure 
1.4). However, these are the extremes of the scale, with enzyme catalysis typically 
studied in a narrow temperature range between the two (5 - 80 °C). Over this scale 
hydrogen is more sensitive to tunnelling than deuterium and this can result in 
strong temperature dependence of the KIE and AH/AD<< 1 (region II, Figure 1.4) 
(30).  
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1.1.4 Recent tunnelling models of enzyme catalysis 
Although the Bell tunnelling correction went some way towards explaining results 
that did not fit the semi-classical TST model, it is widely accepted that this model 
has a number of flaws with regards to enzyme catalysis. The Bell tunnelling model 
treats the reaction barrier as static and focuses on the reaction coordinate of the 
hydrogen atom (or deuterium), ignoring any contribution that heavy atom motions 
might play in the reaction. A number of experimental results from a range of 
enzymes couldn't be explained by TST with a simple tunnelling correction (25, 31-
35). These violations include large KIEs (> 80) and a greater than unity AL/AH ratio, 
both with temperature dependent and temperature independent KIEs (17, 36). This 
led to the development of a number of models based on Marcus theory of electron 
transfer.  
Marcus theory of electron transfer states that when electrons transfer between 
two orbitals, the donor and acceptor, they do not change energy. Therefore, for this 
transfer to occur both orbitals must assume the same energy level. This requires 
energy to be put into the system in order to distort the reactant-solvent and/or 
product-solvent ensembles to achieve this equal energy level (37). In Marcus 
theory, this energy is termed reorganisation energy (λ, Figure 1.5). Marcus-like 
models applied to hydrogen tunnelling replace the transferring electron with a 
hydrogen atom. It is reorganisation of the heavy nuclei of the reactant and product 
to equal energy levels that causes the barrier to tunnelling, rather than the 
stretching of the C-H bond in simpler models discussed above (17). 
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Figure 1.5 Reaction coordinate of electron transfer using Marcus theory. An electron is 
transferred from the donor orbital (blue) to the acceptor orbital (red). The proposed 
reorganisation energy is shown by λ. 
 
Marcus-like models can be described using the general equation: 
     
        
           
      
       
  
  
 
where C is an isotope independent pre-exponential value, the first exponential is 
the Marcus term that relates the reorganisation energy (λ) to the driving force of 
the reaction ΔGo, the second exponential is the Franck-Condon term (F(m)) and the 
final exponential includes a distance sampling term (-EF(m)) (36). The Marcus term 
causes the rate of reaction to be dependent on the reorganisation energy and 
driving force as these will affect the transfer of the particle through the reaction 
barrier. This term is temperature dependent but whilst this term is also mass 
dependent the effect of isotopic change is thought to be minimal in relation to the 
size of primary isotope effects influenced by the second exponential (36). The 
Franck-Condon term is temperature independent but, as stated, is greatly affected 
by the mass of the transferring particle. The third exponential, known as the 
distance sampling term, accounts for the sensitivity of tunnelling to the donor-
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acceptor distance (DAD), and this term is both temperature and isotope sensitive. 
The Franck-Condon term and the distance sampling term are integrated for all the 
conformations sampled by the DAD (36). 
These Marcus-like models include rate-promoting vibrations (38, 39), vibrationally 
enhanced tunnelling (25, 40) and environmentally coupled tunnelling (41, 42). Rate 
promoting vibrations, proposed by Schwartz and coworkers, states that a network 
of long range motions is coupled to hydrogen tunnelling by modulating the DAD 
(38, 39). The opposite view is taken by Scrutton et al., who argued that long-range 
motions are not coupled to the reaction coordinate. They proposed that short-
range vibrations promote hydrogen tunnelling by reducing the barrier width i.e. 
vibrationally enhanced tunnelling (25, 40). Klinman's model, environmentally 
coupled tunnelling, predicts that two sets of motions are linked to enzyme catalysis. 
The first set of motions, known as preorganisation, allow the enzyme to adopt a 
reaction ready conformation. The second set of motions then modulate the DAD, 
known as reorganisation (not to be confused with reorganisation energy in relation 
to Marcus theory discussed above), and directly couple to the barrier width and 
thus couple to tunnelling (41, 42). 
Truhlar and coworkers also presented a model for enzyme catalysis based on a 
generalised TST equation. In this case the correcting factor, Γ(T), is split into the 
different factors affecting the rate of reaction (27): 
          
   
 
 
    
   
where (C0) is the standard-state concentration and Γ(T) comprises γ(T) which 
accounts for dynamic recrossing of the barrier, κ(T) which accounts for the 
tunnelling contribution in the reaction and g(T) which accounts for deviations in the 
equilibrium distribution (27). Recrossing refers to reaction trajectories that, having 
crossed the transition state dividing surface from reactants to products, return 
across the dividing surface to the reactant side (43). This equation has been used as 
the basis for ensemble averaged-variational TST and multidimensional tunnelling 
(EA-VTST/MT) model (43, 44). VTST assumes a simple reaction will have a transition 
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state that has a significant rate of recrossing, and thus the position of the transition 
state can be chosen to minimise this rate. EA-VTST/MT takes into account the 
complexity of enzyme systems, in that the reaction may proceed by numerous 
reaction paths, each of which has a transition state that can be chosen to give the 
lowest rate of recrossing, and thus takes an average of the overall ensemble (45, 
46). The multi-dimensional tunnelling calculations take into consideration that 
tunnelling can occur through multiple pathways, rather than the one-dimensional 
pathway assumed by the simple tunnelling models discussed earlier (43). EA-
VTST/MT couples enzyme motions to the reaction coordinate, with the reasoning 
that any differences between the enzyme reaction and the non-enzyme catalysed 
reaction must occur from the added complexity of the environment surrounding 
the reaction coordinate. This theory has been applied to a number of enzymes (see 
reviews for more detail (27, 43, 47)) and has shown that TST can still be used to 
explain the non-classical results observed in numerous enzymes. 
The Marcus-like models focus on the theory that enzyme motions (whether long-
range or short-range) are directly coupled to the reaction coordinate or promote 
hydrogen tunnelling. By comparison EA-VTST/MT theory developed by Truhlar does 
not give a general trend to the role of enzyme motions. It is worth noting though 
that any coupling of long-range motions or multiple conformations of enzymes are 
incorporated into the EA-VTST part of the calculations, and DAD fluctuations are 
incorporated into the MT part of the calculations (44, 46, 48). As a result the 
coupling of enzyme dynamics to the reaction coordinate are often used to explain 
the results from EA-VTST/MT calculations. 
However, the idea that enzyme dynamics and hydrogen tunnelling play a significant 
role in the chemical step of enzyme catalysis is strongly disputed by Warshel (49-
52). This view is also taken by Mulholland and coworkers, who showed that a 
simple model involving multiple enzyme conformations could explain many of the 
non-classical findings without involving enzyme dynamics (53, 54). However, whilst 
Mulholland and coworkers have fitted data from numerous enzymes to their 
model, no direct evidence of multiple conformations has been reported in these 
enzymes. Calculations performed by Warshel and coworkers have shown that 
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electrostatic effects have the greatest effect on enzyme catalysis. The active site of 
the enzyme was found to act as a much more efficient "solvent" for the reaction 
coordinate than the comparable reaction in aqueous solution. This was due to the 
reorganisation energy of water molecules being much higher, as most of the 
reorganisation of the enzyme active site towards stabilising the TS‡ is performed 
during protein folding (49). Warshel and coworkers have also shown that mutations 
to enzymes that cause decreases in reaction rates and are then used as evidence to 
suggest promoting motions are actually due to preorganisation effects. It was 
shown that mutations to enzymes actually change the conformational sampling of 
an enzyme due to the change in potential energy surface, rather than providing 
evidence of coupled motions (50, 51). Further evidence that non-statistical motions 
do not play a key part in enzyme catalysis of the chemical step is the similarity 
between the transmission coefficients of the catalysed and uncatalysed reaction, as 
well as the similarity in vibrational modes between the enzyme reaction and the 
equivalent reaction in solution (55). It is perhaps worth noting that Truhlar, through 
the use of EA-VTST, stated that the effects contained in the transmission coefficient 
were very small compared to the overall rate enhancement of enzymes from 
reducing the free energy of activation (typically 1 or 2 orders of magnitude from the 
transmission coefficient compared to rate enhancements up to 17 orders of 
magnitude for OMP decarboxylase) (43).  
Overall, enzyme dynamics and the role they play in catalysis is a topic that is hotly 
debated, with many contrasting viewpoints. More evidence on the role that 
enzyme motions play in enzyme catalysis is therefore needed to allow a consensus 
model to be adopted. As explained above, enzymes involved in hydride transfer are 
ideal targets for investigating this possible relationship between enzyme dynamics 
and catalysis. Studies involving alcohol dehydrogenase (20, 21), soybean 
lipoxygenase (22), methylamine dehydrogenase (25) and dihydrofolate reductase 
(23, 24) have contributed significantly (amongst others), both in support and 
against, to the proposed tunnelling models. In particular, dihydrofolate reductase 
has been the focus of a large number of experimental and computational 
investigations, the specific findings of which will be discussed in more detail below. 
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1.2 Dihydrofolate reductase 
Dihydrofolate reductase (DHFR) catalyses the reduction of 7,8-dihydrofolate (DHF) 
to 5,6,7,8-tetrahydrofolate (THF), via the oxidation of NADPH (56). The HRe hydride 
is transferred from the C4 position of NADPH to the C6 position of DHF, and a 
proton is transferred to the N5 position (Scheme 1.1)(57, 58).  
 
 
Scheme 1.1 Reaction catalysed by DHFR 
 
The product of this reaction, THF, is involved in a number of reactions within cells 
due to its capability as a carrier of one-carbon units at the N5, N10 or both positions 
(Scheme 1.2) (59). These cofactors are used for amino acid biosynthesis including 
serine, glycine and methionine, cofactor biosynthesis including S-adenosyl 
methionine and both purine and pyrimidine nucleotides. The majority of these 
reactions result in the recycling of THF or its derivatives, however, the biosynthesis 
of thymidine monophosphate (dTMP) produces DHF as a product. THF is converted 
to 5,10-methylene-THF via serine hydroxymethyl transferase and utilised by 
thymidylate synthase in the production of dTMP, resulting in the production of 
DHF. DHF is then recycled via DHFR, allowing the levels of THF in the cell to be 
maintained (60). The importance of DHFR results in this enzyme being found in 
almost every organism, although a bifunctional DHFR-thymidylate synthase is found 
in some primitive protozoa (61). Some bacterial species have evolved without the 
chromosomal gene encoding DHFR (folA) (62-64). Many of these species have 
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evolved a different thymidylate synthase that utilises FADH2, producing 
tetrahydrofolate rather than dihydrofolate as the product of the reaction (62, 63).  
 
 
 
Scheme 1.2 Formation of one-carbon carrier units from tetrahydrofolate 
 
As stated, DHFR is used as a model system for studying the relationship between 
dynamics, catalysis and hydrogen tunnelling. Escherichia coli DHFR (EcDHFR) is one 
of the most studied DHFRs, but more recently thermophilic DHFRs from 
Thermotoga maritima (TmDHFR) and Geobacillus stearothermophilus (BsDHFR) 
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have also been used to investigate enzyme dynamics in this family of enzymes (see 
below). 
 
1.2.1 Escherichia coli DHFR (EcDHFR) 
1.2.1.1 Structure of EcDHFR 
EcDHFR is a monomeric enzyme with a mass of 18000, consisting of 159 amino 
acids that make up four α-helices (αB, αC, αE and αF) and an eight stranded β-sheet 
(βA-βH) (Figure 1.6) (65-69). The strands that make up the β-sheet are named 
sequentially: βA (residues 1-8), βB (39-43), βC (89-95), βD (73-75), βE (89-95), βF 
(108-116), βG (132-141) and βH (150-159) (65). The β-strands are all parallel with 
the exception of the anti-parallel βH at the C-terminal of the protein. The α-helices 
are named by their proximity to the β-sheets with two helices each side of the β-
sheet: αB (residues 24-35), αC (43-50), αE (77-86) and αF (96-104) (65).  
 
 
Figure 1.6 Cartoon representation of EcDHFR (1RX2 (69)) in two different orientations. 
The α-helices (red) and β-strands (yellow) are labelled. 
 
The tertiary structure of EcDHFR was originally split into two main subdomains: the 
adenosine binding domain (ABD, residues 36-106) and the loop domain (LD, 1-35 
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and 107-159) (67, 69) (Figure 1.7). The ABD consists of β-strands B-E and α-helices C, 
E and F. This subdomain is rigid, and as the name suggests, binds the adenine part 
of the cofactor NADPH. The remaining part of the tertiary structure is deemed the 
LD due to 45% being made of three important loops: M20 (residues 10-24), FG 
(116-132) and GH (141-150) (Figure 1.7). The gap between the two subdomains, 
caused by the hydrogen bonding pattern between αA and αE, allows the 
nicotinamide ring to span this gap coplanar to the β-sheet. The pteridine ring of 
DHF occupies the cleft between αB and αC, and the reaction centre, i.e. C4 of 
NADPH and C6 of DHF, are held within sub van der Waals contact. This cleft forms 
the active site of EcDHFR and is shielded by the M20 loop. The binding of the 
nicotinamide-ribose moiety of NADPH is stabilised by the presence of the pteridine 
ring of substrate and it was found that only 75% of the nicotinamide-ribose moiety 
bound in the absence of substrate (69). More recently, the substrate binding 
domain (SBD) has been used to describe the areas that bind DHF, primarily 
consisting of αB (70, 71). 
 
Figure 1.7 Cartoon representation of EcDHFR (1RX2 (69)) showing A) the three 
subdomains: ABD (red), LD (green) and SBD (cyan) and B) the M20, FG and GH loops 
(purple, red and yellow respectively). NADP+ and folate are shown in blue and orange 
respectively. 
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The substrate binds to the active site through hydrogen bonds to Asp27, Trp22, 
Thr113 and two water molecules (Figure 1.8) (68, 69, 72). Asp27 forms two 
hydrogen bonds with the C2-amino group and the N3 of the pterin ring. Thr113 also 
forms a hydrogen bond via one of the water molecules to the C2-amino group and 
Trp22 forms a hydrogen bond through the second water molecule to the carbonyl 
group of the pterin ring. This hydrogen bonding network between the three 
residues has been shown through site directed mutagenesis (SDM) studies to 
contribute to EcDHFR activity, and a decrease in catalytic activity is observed if one 
of the hydrogen bonds cannot form (73-75). The substrate was found to have 
hydrophobic interactions along the molecule between a number of residues in the 
SBD, in particular the conserved Leu28, Phe31, Ile50 and Leu54 residues. A 
hydrogen bond between Arg57 and the glutamate moiety is also present (68). A 
number of active site residues have been identified with regards to cofactor 
binding. The cofactor was found to hydrogen bond with Ser49 via a water molecule, 
as well as having hydrophobic interactions with Ile14 and Tyr100. Once again, SDM 
studies showed reduced reaction rates when these residues were substituted (76, 
77).  
 
Figure 1.8 Active site of EcDHFR (1RX2 (69)) showing hydrogen bonds (dashed lines) 
between folate (orange) and the three key residues (cyan). The two water molecules are 
shown as red spheres. 
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1.2.1.2 Protonation of DHF 
The protonation step is thought to be the route of the pH dependence of the 
EcDHFR reaction (with an approximate pKa of 6.5). Asp27 is the only ionisable 
residue in the active site and, as it is highly conserved between other DHFRs (78), 
was predicted to be the proton source. However, the large distance between this 
residue and N5 atom of DHF makes direct protonation impossible. A proposed keto-
enol tautomerisation of the substrate following binding (Figure 1.9) was suggested 
to stabilise a water molecule in the active site, hence allowing protonation of the 
N5 position (77, 79). However, it was shown by Shrimpton and Allemann that the 
bond angles and position of the water molecules were not conducive towards this 
proposed mechanism (80).  
Significant evidence now suggests that the proton comes directly from the solvent. 
Crystal structures have shown a water molecule coordinated between Asp27, Trp22 
and the carbonyl at C4 position in the pterin ring and this has been designated site 
A in the literature (Figure 1.9). Despite this position being too far away from the 
protonation site at N5, Shrimpton and Allemann calculated that only minor changes 
were needed in the active site conformation to move water molecules within 
hydrogen bonding distance of the reaction centre (site B, Figure 1.9 (80). The 
results from the modelling also showed an increase in the likelihood of water being 
found in site B as the reaction time progressed to 1 ns (80). Recent data suggests 
the first evidence of a bound water molecule at the N5 position has been witnessed 
(S. Benkovic, private communication). Additionally, an isotopic Raman shift was 
previously seen from the N5=C6 stretch in the Michaelis complex with D2O as the 
solvent (81). The presence of a water molecule at site B was also seen by NMR 
spectroscopy, although in this case it was in human DHFR (82). Modelling has 
shown that as the reaction progresses the active site becomes more accessible to 
water, implying that after hydride transfer the conformation of the active site 
changes to allow protonation via the solvent (72, 80, 83). 
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Figure 1.9 A) Proposed enol-keto tautomerisation mechanism of N5 protonation. B) 
Position of the water molecules in site A and site B of the active site of EcDHFR. Hydrogen 
bonds in both diagrams are shown by dashed lines. 
 
1.2.1.3 Catalytic cycle of EcDHFR 
Early kinetic studies on EcDHFR determined the pH dependence of the catalytic 
cycle and showed that hydride transfer was not rate limiting at physiological pH (75, 
84, 85). However, the complete kinetic cycle of EcDHFR was determined by 
Benkovic and coworkers in 1987 (86). It was found that EcDHFR cycles through five 
key intermediates during the kinetic cycle: the holoenzyme (E:NADPH), the 
Michaelis complex (E:NADPH:DHF), the product ternary complex (E:NADP+:THF), 
the product binary complex (E:THF) and the product release complex 
(E:NADPH:THF). Rate constants and dissociation constants were determined for all 
steps in the cycle (Figure 1.10). Proceeding from the holoenzyme, the first step in 
the cycle is binding of DHF to form the Michaelis complex. The chemical step from 
the Michaelis complex to the product ternary complex is pH dependent, as stated 
earlier, with a pKa of 6.5 and the maximum rate of 950 s
-1 was determined at pH 5. 
At pH 7, the rate of hydride transfer drops to 220 s-1 but is still 18 fold faster than 
the rate limiting step. Following the chemical step the oxidised cofactor is released, 
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NADPH rebound, and the final step is product release to reform the holoenzyme. 
The rate limiting step at pH 7 is this release of THF to reform the holoenzyme 
complex (12 s-1). At high pH (> 9) the chemical step becomes rate limiting due to the 
lack of protons available to protonate at the N5 position of DHF. Free EcDHFR is not 
formed at any stage of the preferred cycle (86). KIE studies have also been 
performed at pH 7 by Allemann and coworkers using transient state kinetics, and at 
pH 9 using steady state kinetics by Kohen and coworkers (87, 88). Although the 
measurements at pH 9 allow the intrinsic KIE to be determined, the pH 7 
measurements provide physiologically relevant data. Recently, an investigation has 
claimed to have measured the intrinsic kH/kT value at pH 7 (89). However, very little 
description of how this was performed is given, and it is unclear how the inherent 
problems of performing this measurement at pH 7 were overcome, and in fact the 
authors rely on pre-steady state measurements for analysis of results in the same 
study (89). At high pH the KIE is temperature independent with a AH/AD value of 4.0 
± 1.5 which is above the semi-classical limit (88). At pH 7 the KIE becomes 
temperature dependent with an inverse AH/AD value (0.108 ± 0.04) (87). Both the 
intrinsic KIE at pH 9 and the observed KIE at pH 7 are unable to be explained by 
semi-classical theory and infer that hydrogen tunnelling is involved in the EcDHFR 
reaction. 
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Image removed due to copyright reasons. 
See legend for reference. 
 
 
Figure 1.10 Kinetic scheme of EcDHFR at 25 °C, pH 7. E = enzyme, NH = NADPH, N = 
NADP+, DHF = dihydrofolate and THF = tetrahydrofolate. Adapted from Fierke, C. A., 
Kohnson, K. A. and Benkovic, S. J., (1987), Construction and evaluation of the kinetic 
scheme associated with dihydrofolate reductase from Escherichia coli, J. Am. Chem. Soc., 
26, 4085-4092. 
 
Following on from the kinetic characterisation by Benkovic and coworkers, the 
structures of the five key intermediate complexes were determined by Sawaya and 
Kraut (69). Crystal structures were obtained of the holoenzyme (E:NADPH), 
Michaelis complex mimic (E:NADP+:Folate), product ternary complex (E:ATP-
ribose:dideazaTHF), product binary complex (E:ddTHF) and product release complex 
(E:NADPH:ddTHF). An E:NADPH:methotrexate complex was also obtained, 
proposed to be a transition state analogue. The M20 loop, which shields the active 
site in the Michaelis complex, was seen to adopt three different conformations: 
closed, occluded and open. The closed and occluded conformations are adopted 
during the main catalytic cycle of EcDHFR (Figure 1.11). The findings by Sawaya and 
Kraut have since been verified via NMR spectroscopy, with conformational 
differences witnessed in solution by Wright and coworkers, inferring the presence 
of the open and occluded conformations (70, 90-92). 
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Figure removed due to copyright reasons. 
See legend for reference 
 
Figure 1.11 Main catalytic cycle of EcDHFR showing the closed (C) and occluded (O) 
conformations adopted at each stage. E = enzyme, NH = NADPH, N = NADP+, DHF = 
dihydrofolate and THF = tetrahydrofolate. Figure adapted from Venkitakrishnan, R.P., 
Zaborowski, E., McElheny, D., Benkovic, S.J., Dyson, H.J., and Wright, P.E., (2004), 
Conformational changes in the active site loops of dihydrofolate reductase during the 
catalytic cycle, Biochemistry, 43, 16046-16055. 
 
The closed conformation is adopted in both the holoenzyme and the Michaelis 
complex. In this state the M20 shields the active site by forming a short anti-parallel 
sheet (residues 16-19) and hairpin turn. This effectively seals the active site by 
placing Asn18, part of the hairpin, in a position to form a hydrogen bond with a 
histidine residue in αC (His45). The M20 loop also forms a hydrogen bond with the 
amide group of the nicotinamide ring through Ile14. This conformation is stabilised 
through a pair of hydrogen bonds that form between Asp122 of the FG loop and 
Gly15 and Glu17 on the M20 loop (Figure 1.12) (69). The remaining three complexes 
(with the product bound) all form the occluded conformation. In this conformation 
the M20 loop "occludes" the active site and prevents the coenzyme binding in the 
active site. This is caused by a 180° rotation around the ψ bond of Ile14, resulting in 
the N-terminal end of the loop blocking the nicotinamide binding pocket. The 
central part of the M20 loop forms a helix in this conformation, instead of the sheet 
and hairpin seen in the closed conformation. The rotation at Ile14 also disrupts the 
hydrogen bonds with FG that stabilised the closed conformation. As a result the 
occluded conformation is stabilised by a pair of hydrogen bonds between Asn23 in 
the M20 loop and Ser148 in the GH loop (Figure 1.12) (69). The open conformation 
shows a mixture of characteristics between the closed and occluded forms (69).  
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Figure 1.12 A) Overlay of the closed and occluded structures of EcDHFR (pink, 1RX2 and 
blue, 1RX6 respectively (69)). B) The M20, FG and GH loops in the closed and occluded 
conformations (red and blue). The hydrogen bonds that stabilise each structure are 
shown (dashed lines). 
 
1.2.2 EcDHFR catalysis and the role of dynamics 
It is generally accepted that the physical steps of catalysis in EcDHFR are controlled 
by the large loop movements and conformational changes described above. 
However, this has led to numerous studies and proposals on the coupling of these 
motions to the hydride transfer step in EcDHFR. This proposed coupling has been 
debated by a number of groups both experimentally and theoretically, and will be 
discussed here. 
 
1.2.2.1 Dynamic nature of EcDHFR 
Early evidence that suggested the coupling of motions to catalysis in EcDHFR was 
the effect that mutations distal to the active site had on hydride transfer rate. 
Model-free 15N relaxation measurements were performed on the binary product 
complex (E:Fol) by Wright and Benkovic (93). They found a number of residues in 
the FG loop, M20 loop and ABD that showed dynamic fluctuations on the ps-ns 
timescale. It was predicted that these residues could potentially be coupled to the 
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conformational changes or catalysis of EcDHFR (93). One of the residues identified 
was Gly121 positioned in the FG loop over 12 Å from the reaction centre (C4 of 
NADPH). Benkovic and coworkers found that the G121V mutant exhibited a drop in 
hydride transfer rate by around 160 fold (94). Other distal mutants have also been 
investigated that affect the early stages of the catalytic cycle by a factor of 6 or 
more, including mutations to Met42, Arg44, His45, Thr46, Leu54, Asp122 and 
Phe125 (95-101). 
Radkiewicz and Brooks performed molecular modelling on the Michaelis complex 
(E:NADPH:DHF), the product ternary complex (E:NADP+:THF) and the product 
release complex (E:NADPH:THF) (102). Simulations were performed over 10 ns for 
each complex in order to capture slow motions, and it was found that there were 
strong correlated and anti-correlated motions in the Michaelis complex of EcDHFR 
(Figure 1.13). A high level of correlation was seen between the FG, M20 and αC 
regions in the Michaelis complex (yellow regions in Figure 1.13). These motions were 
not present in the product complexes leading to the presumption that these 
motions are necessary/involved in the chemical step of EcDHFR. It was also seen 
that many of the mutations that were reported to affect the catalytic rate show 
anti-correlated motions with other parts of the enzyme (102). Following on from 
this investigation, Wright and Benkovic repeated model-free 15N relaxation NMR 
studies, this time on the Michaelis complex (E:NADP+:Fol), the product ternary 
complex/product release complex (E:DHNADPH:Fol) and the product binary 
complex (E:Fol) (90). The NMR investigation also found a difference in the dynamics 
seen in the Michaelis complex and the two product complexes that supported the 
findings from the modelling. The product complexes showed large motions in the 
M20, FG loop and ABD (as seen in the previous investigation on the E:Fol complex 
only). The Michaelis complex showed perturbation in the M20 and FG loop 
movements but increased flexibility in the ABD. These findings supported the 
theory that long distance coupling is involved in EcDHFR catalysis (90).  
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Image removed due to copyright reasons. 
See legend for reference. 
 
 
Figure 1.13 Residue-residue map of correlated and anti-correlated motions (red and blue 
respectively). Letters on the top and bottom edge show residues that have been shown 
to affect catalysis when mutated. Reprinted with permission from Radkiewicz, J.L. and 
Brooks, C.L., (2000), Protein dynamics in enzymatic catalysis: Exploration of dihydrofolate 
reductase. J. Am. Chem. Soc., 122, 225-231. 
 
Benkovic and Hammes-Schiffer provided a more complete picture of this dynamic 
network proposed in EcDHFR (103). Genomic analysis highlighted conserved 
residues that are found in different DHFRs, and kinetic analysis of mutants of these 
residues showed detrimental effect on catalysis. In addition, mixed 
quantum/classical molecular dynamics were performed on the hydride transfer 
step of the reaction. It was suggested that the DAD decreased during the course of 
the reaction from 3.4 Å in the reactants to 2.7 Å, and the authors insinuated that a 
number of distal and proximal residues contributed to this change in the reaction 
coordinate as a network of residues e.g. Asp122 and Gly15 (Figure 1.14). Finally, 
analysis of specific mutants suggested that vibrations occurring over a time scale of 
femtoseconds to picoseconds were also present during the hydride transfer 
reaction. It was found that this network of proposed coupled promoting motions 
was present through to the transition state. However, significantly, it was noted 
that the study was unable to differentiate motions that play an active role in 
catalysis and those that occur as a result of it (103). 
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Image removed due to copyright reasons. 
See legend for reference. 
 
 
Figure 1.14 Network of coupled promoting motions that occur during the hydride transfer 
reaction in EcDHFR. Figure taken from Agarwal, P.K., Billeter, S.R., Rajagopalan, P.T.R., 
Benkovic, S.J., and Hammes-Schiffer, S., (2002), Network of coupled promoting motions 
in enzyme catalysis. Proc. Nat. Acad. Sci. U.S.A., 99, 2794-2799. 
 
These findings all suggested that the EcDHFR catalytic cycle involves a large 
contribution from enzyme dynamics. However, none of the experimental or 
theoretical studies showed direct evidence of the dynamics being intrinsically 
coupled to the hydride transfer step. It is perhaps worth noting that the high level 
of structural interlinking in EcDHFR, through the many hydrogen bonds between 
loops and with the substrate, would naturally result in correlated motions whether 
the distal region is involved in catalysis or not. 
 
1.2.2.2 Role of dynamics in EcDHFR 
Whilst the dynamic nature of EcDHFR is clear, and not unexpected from the large 
number of interactions within the protein itself and with the cofactor/substrate, 
the potential coupling of slow, large-scale motions to the chemical step, itself 
several orders of magnitude faster, has been the subject of much discussion. At pH 
9 the primary KIE was found to be temperature independent, have a larger than 
zero ΔEa and AH/AD ratio greater than unity (88). A temperature independent KIE 
would be expected when the main contribution is from tunnelling and does not 
require thermal activation, hence, an ΔEa greater than zero in EcDHFR requires 
further explanation. It was proposed that a Marcus-like model with a temperature 
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dependent, isotope independent rearrangement and an isotope dependent, 
temperature independent tunnelling step explained the results obtained at pH 9 
(88).  
 
However, pH dependence measurements of the hydride transfer showed that the 
temperature independent regime of the KIE appears between pH 7.5 and 8, with a 
temperature dependent regime below this (104). This implied that it was most 
likely a conformational change or electrostatic effect that caused the temperature 
dependence in EcDHFR, ruling out a role for environmentally coupled tunnelling. 
Furthermore, the effect of numerous solvents on hydride transfer was measured 
with the hypothesis that any long range coupling should be affected by the viscosity 
of the solvent. It was found that whilst electrostatic properties of the solvents had 
an effect on the hydride transfer step there was no correlation with the viscosity of 
the solvent (105). Whilst these findings provide evidence against long-range 
coupling, further claims were published, again relying on assumptions that coupling 
was the reason behind observed results. 
One EcDHFR mutant in particular, N23PP/S148A, has been at the centre of 
numerous statements surrounding the existence of large-scale motions coupled to 
EcDHFR catalysis (106). This mutant is catalytically compromised, with a much 
reduced hydride transfer rate supposedly due to a loss of ms motions between the 
WT and mutant enzyme (106). However, investigations have highlighted the 
dangers of comparing results from WT enzymes and their mutants without taking 
into account the specific effect that the mutation has on the potential energy 
surface (107-109). Atomistic simulations (51) and stopped-flow analysis (110) have 
shown that a different potential energy surface and subsequent preorganisation of 
the active site does indeed account for the observed reduction in rate, thus ruling 
out a role for long-range coupled motions. Perhaps most tellingly, the original 
authors behind the assumption that coupling exists in EcDHFR-N23PP/S148A have 
both reversed their opinions. Benkovic states that although ms motions do exist in 
EcDHFR, a fact that was widely accepted previously, coupled motions do not (111). 
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Similarly, Wright claims increased conformational sampling of non-productive 
conformations is the inherent cause behind the slower rates in EcDHFR-
N23PP/S148A, rather than the loss of assumed coupled motions (112).  
The evidence that long-range motions do not play a role in the chemical step of 
EcDHFR significantly outweighs the somewhat circumstantial evidence to suggest 
coupling ever existed. Instead, the ability of the enzyme to undergo conformational 
sampling and preorganisation of the reaction coordinate are suggested as the main 
factors for the observed effects in EcDHFR catalysis (51, 110, 113). However, the 
role of short-range, vibrational motions on the fs timescale, coupled to the 
chemical step, cannot be ruled out in the experimental investigations above. 
Recently, isotopically labelled enzymes have been employed as tools to study this 
problem. Electrons have a mass roughly 1/2000 of that of a proton, the lightest 
component of the nucleus. This huge mass difference led to the Born-Oppenheimer 
approximation, which states that at any given point in time nuclei are stationary 
with regards to the much lighter, fast-moving electrons. Therefore isotopes of the 
same element have identical potential-energy surfaces (28). This means that any 
differences in reaction rates arising from isotopic substitution are due to mass-
dependent motions rather than any electrostatic properties being altered. These 
mass-dependent motions can refer to large conformational changes on a 
millisecond time scale as well as the ultrafast, short-range bond vibrations that 
occur on the fs time scale.  
"Heavy enzymes", labelled with the stable isotopes 13C, 15N and 2H, have been used 
to investigate HIV protease, purine nucleoside phosphorylase (PNP), alanine 
racemase (deuterated only) and pentaerythritol tetranitrate reductase (PETNR) (19, 
114-116). These studies all found a measurable effect on reaction rates upon 
isotopic labelling, implying that fs vibrations play a role in catalysis. Additionally, 
two investigations on isotopically labelled EcDHFR and the isotopically labelled 
EcDHFR-N23PP/S148A have determined the specific effect that these ultrafast, 
mass-dependent motions have on catalysis (117, 118). The fs motions were shown 
to couple to the reaction coordinate, as seen in other heavy enzyme studies, but 
additional calculations enabled the specific role that these vibrations play on barrier 
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crossing, in particular the role that they play in both tunnelling and recrossing, to be 
elucidated (117). In EcDHFR, mass-dependent vibrations had no effect on barrier 
height or tunnelling probability during the reaction, instead reporting on the 
frequency of re-crossing events during the reaction (117). This showed that the 
mass-dependent vibrations do not directly modulate the DAD, but that the protein 
environment as a whole couples to the reaction coordinate. The heavy EcDHFR 
mutant investigation found direct coupling of these fs vibrations to the reaction 
coordinate actually decreases the catalytic efficiency (118), further confirming early 
conclusions that a reduction in coupled motions was not the cause of the 
compromised activity. Possibly one of the strongest arguments against the role of 
enzyme dynamics being coupled to hydride transfer/hydrogen tunnelling in EcDHFR 
is the fact that at physiological pH the chemical step is approximately 20 fold faster 
than the rate limiting step. Without selective pressure, therefore, it seems unlikely 
that the enzyme structure would be optimised with regard to dynamic motions in 
this way, as a more efficient chemical step offers no evolutionary advantage. 
Overall it can be seen that the role of enzyme dynamics in EcDHFR (and enzyme 
catalysis in general) is still an area of scientific interest. Whilst both long-range and 
short-range dynamics that influence the catalysis in EcDHFR have seemingly been 
ruled out, there are still disagreements in the literature. As well as this, although 
EcDHFR has been used as a paradigm for studying enzyme dynamics, the study of 
other DHFR homologues might enable a general theory to be postulated. 
 
1.2.3 Extremophilic DHFRs 
In the last few years extremophilic DHFRs have also started to be used as model 
systems to investigate enzyme dynamics. Whilst the information on these DHFRs is 
limited compared to the volume of information surrounding EcDHFR, they are still 
potentially useful models. 
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1.2.3.1 Thermotoga maritima DHFR (TmDHFR) 
Thermotoga maritima is a hyperthermophilic bacterium that inhabits hot springs 
and hydrothermal vents. The optimum environmental temperature for this 
bacterium is 80 °C (119). TmDHFR is therefore a hyperthermophilic enzyme with a 
melting point of 82 °C, considerably higher than other DHFRs (120). TmDHFR is also 
unique in the fact that it is the only chromosomally encoded DHFR that forms a 
dimer quaternary structure (Figure 1.15). The dimer consists of two monomer units 
that are very similar in tertiary structure to monomeric DHFRs (121). Each 
monomer consists of the same four α-helices and eight β-strands as seen in EcDHFR 
but also contains a ninth anti-parallel β-strand. The monomer units dimerise 
through a hydrophobic core formed through the extra β-strand from each 
monomer, as well as two salt bridges between Lys129 from one monomer and 
Glu128 and Glu136 from the other. This hydrophobic core and salt bridges are 
believed to be the route of the intrinsic thermostability seen in this protein (121-
123). The dimerisation region also includes the M20, FG and GH loops, preventing 
the significant movements that are observed in EcDHFR. As a consequence, the 
M20 loop of TmDHFR is fixed in an open conformation resulting in the active site 
being accessible to the solvent. This causes a different electrostatic structure of the 
active site compared to monomeric DHFRs (124). 
 
Figure 1.15 Cartoon representation of TmDHFR (1D1G (121)) showing the two monomer 
units that make up the dimer structure bound to NADPH and MTX (blue and orange 
respectively). 
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The catalytic turnover of TmDHFR is much lower than that seen in EcDHFR with kH 
values 1000 fold lower (0.14 s-1 at 25 °C) and steady state turnover 50 fold slower 
(0.2 s-1 at 25 °C) at pH 7 (120). Unlike in EcDHFR, the hydride transfer is partially 
rate limiting at all temperatures at pH 7 in TmDHFR. KIE measurements on hydride 
transfer showed a breakpoint in the primary KIE at 25 °C. Above 25 °C the KIE is 
temperature independent with AH/AD value of 1.56. Below 25 °C the KIE becomes 
strongly temperature dependent and the AH/AD becomes << 1 (0.002). A 
computational study showed that the reaction in TmDHFR has a significant 
contribution from hydrogen tunnelling (125). Subsequent work involving numerous 
co-solvents found that the viscosity of the solvent had no effect on the hydride 
transfer, ruling out long range motions (or the lack of) as a reason for the 
breakpoint seen (126). It was suggested that the breakpoint was due to the enzyme 
being unable to adopt a conformation conducive to hydride transfer at low 
temperature. An investigation on the V11D mutant, which is able to switch to a 
monomer in the presence of non-denaturing detergents, found that the kcat rate 
decreased suggesting the catalytic loops of TmDHFR are unable to function in the 
same manner as those in EcDHFR (127). More recently a mutant hybrid of EcDHFR 
and TmDHFR found that whilst the physical steps of catalysis require the loops of 
EcDHFR to be flexible this is not the case in TmDHFR catalysis (128). This finding 
shows that the results seen in the dimeric TmDHFR are not always comparable to 
other monomeric DHFRs. 
 
1.2.3.2 Geobacillus stearothermophilus DHFR (BsDHFR) 
Geobacillus stearothermophilus (formerly Bacillus stearothermophilus) is a 
moderate thermophile that occupies a wide range of ecological niches (129, 130). 
The optimal temperature for this organism is 60 °C, although it is able to survive 
between 30 and 75 °C. BsDHFR (this term is used in previous literature) has a 
melting temperature of 67 °C, showing moderate thermophilicity (131). As with 
other monomeric DHFRs the tertiary structure is highly conserved with that seen in 
EcDHFR. Once again the structure is made up of an eight stranded β-sheet with four 
α-helices, two either side. It can be seen from the structural overlay with EcDHFR 
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that there is a difference in the αE region of the ABD, with a 20° tilt seen in BsDHFR 
compared to the mesophilic enzyme (132). Interestingly for a thermophilic enzyme 
it was found that BsDHFR is more flexible than EcDHFR over the majority of the 
enzyme. Neutron scattering and hydrogen/deuterium exchange mass spectroscopy 
showed that whilst the inner core of the protein is more rigid than EcDHFR, the 
remaining structure including the loop regions are more flexible in BsDHFR (133, 
134). Unlike EcDHFR, which adopts the closed and occluded conformation during 
the catalytic cycle, there has been no evidence to date of the occluded 
conformation playing a role in BsDHFR catalysis (132). 
 
 
Figure 1.16 Cartoon representation of BsDHFR (yellow, 1ZDR (132)) overlaying EcDHFR 
(pink, 1RX2 (69)). αE is labelled highlighting the difference between the two enzymes. 
 
The steady state characteristics of BsDHFR were found to be very similar to EcDHFR 
although the full kinetic cycle, and thus the rate-determining step at pH 7, has not 
been determined (132, 135). At pH 7, BsDHFR shows a slightly increased rate of 
turnover compared to the mesophilic enzyme, with a kcat of 21.6 ± 1.6 at 25 °C 
(136). As with EcDHFR, the hydride transfer step becomes rate limiting at high pH, 
and KIE measurements at pH 9 showed a weakly temperature dependent KIE and 
Introduction 
 
36 
 
AH/AD value of 0.57 (132). These values are just outside the semi-classical region, 
therefore suggesting a role for hydride tunnelling. Unlike in EcDHFR, Klinman and 
coworkers argue that the M20, FG and GH loops are only involved in 
preorganisation in BsDHFR. Moreover, they argue that temperature dependent 
motions in the βA and αF regions of BsDHFR contribute to the reorganisation 
process and thus hydride transfer (131). However, previous work involving 
cosolvents showed similar findings to that of EcDHFR and TmDHFR (105, 137). It 
was found that BsDHFR was affected by the dielectric properties but not by the 
viscosity of the solvent (138), giving a strong indication against long-range coupling 
to the chemical step in this system. 
 
1.2.3.3 Moritella profunda DHFR (MpDHFR) 
Moritella profunda is a psychrophilic bacteria that is found in the oceans. At 0.1 
MPa the optimal growth temperature is 2 °C, with no growth seen above 12 °C 
(139). MpDHFR has a lower melting temperature compared to EcDHFR at 37.5 °C, as 
would be expected for a psychrophilic enzyme (135). The tertiary structure of 
MpDHFR follows the same trend as the other DHFR enzymes with an eight stranded 
β-sheet and four α-helices (Figure 1.17) (140). Unlike many other DHFRs, the 
conserved Asp27 residue (EcDHFR numbering) has been replaced by a glutamate in 
the active site of MpDHFR (140). This difference has also been found in numerous 
trimethoprim resistant DHFRs (141, 142), and was thought to be the cause of the 
lower binding affinity observed in MpDHFR (143). However, investigations of the 
mutant MpDHFR-E28D have shown that this single mutation is not the cause of the 
decrease in the binding affinity of trimethoprim (144, 145). M. profunda is able to 
grow at high pressure in deep ocean environment, however, an investigation found 
that MpDHFR showed no obvious signs of pressure adaptation (140). The kinetic 
properties of MpDHFR are similar to other DHFRs, in that at pH 7 the rate limiting 
step is much slower than hydride transfer, and is thought to be product release 
(146). At pH 9, the hydride transfer becomes the rate limiting step. The kcat at 25 °C, 
pH 7 is 18.7 ± 0.8, significantly faster than EcDHFR (12 s-1) (135). Similarly the kH is 
faster in MpDHFR, with a rate constant of 527 compared to 220 s-1 in EcDHFR (113). 
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KIE measurements at pH 7 found a very similar trend to EcDHFR, with a 
temperature dependent KIE. The magnitude of the observed KIE is slightly lower 
than seen in EcDHFR (1.9 compared to 2.7 at 25 °C) (113). MpDHFR has been found 
to be more flexible, as shown by hydrogen/deuterium exchange measurements 
using NMR spectroscopy. As with BsDHFR (see above) there is no evidence that the 
occluded conformation plays a part in the catalytic cycle of MpDHFR. Large-scale 
dynamics have been ruled out in MpDHFR through analysis of hydride transfer with 
cosolvents (113), although the role of short-range motions has not been 
investigated to date in this enzyme. 
 
Figure 1.17 Cartoon representation of MpDHFR (green, 3IA4 (140)) overlaying EcDHFR 
(pink, 1RX2 (69)). 
 
1.3 Secondary KIEs, heavy atom KIEs and TS analogues 
Although the use of primary hydrogen KIEs has proved invaluable in the study of 
enzyme catalysis, many other isotope effects can be measured that elucidate key 
information regarding reaction mechanisms (147). Isotope labelling of hydrogen 
atoms that do not directly take part in the reaction allow secondary (2°) KIEs to be 
measured (28). If the isotope position is bonded to the reaction centre but does not 
take part in the reaction an α-2° KIE is measured. Any other hydrogen position that 
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is labelled results in a β-2° KIE (28). Isotope effects involving atoms other than 
hydrogen are termed heavy atom KIEs (147). Once again, these can be primary or 
secondary depending on atom position, and are normally restricted to 15N, 18O, 13C 
and 14C KIEs.  
 
 
 
Figure 1.18 A) The α-secondary hydrogen position of NADPH labelled with deuterium 
(red) with regards to DHFR catalysis. B) The carbon-13 positions of NADPH to give a 
primary heavy carbon isotope effect (blue) and secondary carbon isotope effect (red) 
with regards to DHFR catalysis. 
 
1.3.1 α-Secondary hydrogen isotope effects 
α-secondary hydrogen (2°) KIEs arise due to rehybridisation of the carbon atom 
adjacent to the atom that has been substituted, e.g. from an sp3 to sp2 hybridised 
carbon (28). As a result of this, only certain bond vibrational modes alter 
significantly thus affecting the reaction rate. Force constants of stretching modes 
do alter as a bond undergoes rehybridisation. However, the difference is often too 
small to create observable isotope effects. Hence, the main contribution to 
observed 2° KIEs is from differences in bending vibrational modes (37). 
In the case of an sp3 to sp2 rehybridisation, in-plane bending modes are almost 
identical and do not significantly contribute to the isotope effect. However, the 
different steric properties of the two hybridisation states results in a large disparity 
between out-of-plane bending vibrational modes. An sp2 hybridised carbon 
produces very little steric hindrance towards out-of-plane bending of the hydrogen 
atom. Conversely, an sp3 hybridised carbon is sterically hindered, resulting in out-
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of-plane vibrational frequencies of approximately 1350 and 800  cm-1 for an sp3 and 
sp2 hybridised carbon respectively (37). Therefore, large differences in ZPE between 
the two bonds results in a 2° KIE (Figure 1.19). 
As a result of this difference, the mechanism of the reaction can be inferred from 
the magnitude of the 2° KIE. An sp3-sp2 rehybridisation produces normal KIEs, as the 
light atom reacts faster than the heavier isotope (A, Figure 1.19). In contrast, an sp2-
sp3 rehybridisation produces an inverse 2° KIE, as the greater force constant results 
in a larger difference between the light and heavy atom at the TS and a greater 
energy of activation for the lighter isotope (Figure 1.19) (28, 37). In the vast 
majority of enzymes the 2° KIE is between unity and the equilibrium isotope effect 
(EIE). The EIE is defined as KH/KD, and is dependent on the equilibrium distribution 
of isotopes between the reactant and product states, rather than originating from 
changes between the ground state and TS (148). As full rehybridisation has 
occurred between the reactant and product, theoretically 2° EIE ≥ 2° KIE providing 
that no coupling occurs between the 1° and 2° hydrogen (see below). 
 
Figure 1.19 Reaction coordinates of A) an sp3 to sp2 rehybridisation reaction, and B) an sp2 
to sp3 rehybridisation reaction. Figure adapted from ref (37). 
 
Early studies focused on the magnitude of the 2° KIE as an indication of the 
structure of the TS (28), although this approach has been proven to be over-
simplified (149). A reactant-like TS would theoretically have a magnitude close to 
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unity, and a more product-like TS similar to that of the EIE. The appearance of 
exalted 2° KIEs above the EIE (150, 151), led to the proposal by Huskey and 
Schowen that this indicated coupling of the 2° hydrogen motion to the 1° hydrogen 
being transferred, with a concomitant contribution from tunnelling (152).  
Scrutton and coworkers measured 2° KIEs for morphinone reductase (MR) and 
pentaerythritol tetranitrate reductase (PETNR), two enzymes that include the 
reduction of FMN via NADH in their reaction mechanisms (153). MR exhibits a 
temperature dependent 1° KIE whilst PETNR is temperature independent (154). 
However, both enzymes produce temperature independent 2° KIEs with identical 
magnitude, leading to the suggestion that 2° KIE reports on the reaction ready 
configuration (RRC) (153, 155). Furthermore, temperature independent KIEs 
suggest that the arrangement of FMN-NADH does not alter significantly over the 
temperature range, whilst identical magnitude was said to imply that the 
arrangement was similar between the two enzymes (153).  
 
1.3.2 Heavy atom isotope effects 
A TS lifetime is on the same time scale as a single bond vibration (fs), and thus 
direct observation is inherently difficult (156). Isotope effects are therefore 
powerful analytical tools, as they arise from changes in the vibrational state 
between the reactant state and TS, hence allowing the reaction coordinate to be 
probed directly (157). The magnitude of the heavy atom KIE reports on the 
environment of the specific atom in the TS, with a KIE of 1 implying the atom's 
bonding environment has not changed. A KIE >1 signifies that the labelled atom has 
become less constrained in the TS thus enabling the lighter isotope to react faster. 
Conversely, a value <1 is caused by the labelled atom being found in a more 
constrained environment in the TS, causing a greater difference in ZPE level 
between the two isotopes at the TS compared to the GS (similar to the effect of 
rehybridisation observed above). As a result the heavier isotope reacts at a greater 
rate (158). 
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As discussed above, numerous tunnelling models suggested that heavy atom 
motions modulate the DAD, thus directly promoting the transfer of the lighter 
isotope during hydrogen transfer reactions (25, 38-42). Whilst a role for long-range, 
slower (ms-ns) motions and fs motions from the enzyme have seemingly been ruled 
out, there is still uncertainty surrounding the contribution from fast bond vibrations 
in the substrate. By substituting specific atoms at the reaction centre any ultrafast 
vibrations that may affect the reaction rate can be assessed, determining the role of 
these motions in enzymatic reactions. Furthermore, once a number of KIEs have 
been measured for a specific reaction the data can then be used to predict a TS 
structure. Current methods involve structure interpolation, resulting in a number of 
TS produced computationally (159, 160). KIEs are calculated for each theoretical TS 
and a structure is generated where all calculated KIEs coincide with the 
experimental data obtained. Calculation of a TS structure opens the potential to 
synthesise TS analogues, compounds that have shown to be incredibly effective 
inhibitors. This technique has been used extensively by Schramm and coworkers to 
investigate a number of enzyme TS, including: purine nucleotide phosphorylase (see 
below), HIV-1 protease (161), methylthioadenosine phosphorylase (162-164) and 
nicotinamide phosphoribosyltransferase (165). 
In theory, heavy atom isotope effects can be used to probe all enzymatic reactions. 
However, there are a number of practical limitations surrounding these isotope 
effects that has restricted their use to date. The first problem is that the magnitude 
of the isotope effect is small, thus requiring complex measurements to determine 
the KIE. A typical heavy atom KIE is <1.1, with semi-classical values calculated as: 
12C/14C = 1.09, 12C/13C = 1.04, 14N/15N = 1.04 and 16O/18O = 1.07 at 25 °C (28, 147). 
This often results in the use of complex techniques, involving remote radiolabelling 
(166), isotope ratio mass spectrometry (167), whole molecule mass spectroscopy 
(168) and NMR (169). Furthermore, isolation of the isotopically dependent step is 
inherently difficult in many enzyme systems, ruling them out as suitable targets for 
heavy atom KIE analysis. Finally, the synthesis of specific isotopically labelled 
substrates is often difficult, expensive and time consuming. 
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1.3.3 Purine nucleoside phosphorylase 
One of the best examples of the use of heavy atom isotope effects to investigate 
the TS is the case of human and bovine purine nucleoside phosphorylase (hPNP and 
bPNP). PNP catalyses the reversible phosphorolysis of inosine, releasing 
hypoxanthine and a ribose-phosphate moiety (Scheme 1.3). Early studies focused 
on bPNP due to the similarity with its human counterpart (87% sequence identity) 
and its availability. Schramm and coworkers synthesised a number of inosine 
isotopologues that incorporated 3H-, 14C- and 15N- at specific positions around the 
molecule from labelled glucose and adenine. Biosynthetic methods were utilised, 
thus allowing a single route to produce 7 different isotopologues (170-172). 
 
Scheme 1.3 Reaction catalysed by PNP. 
 
 
 
Figure removed for copyright reasons. 
See legend for reference. 
 
 
Figure 1.20 The labelled isotopologues, intrinsic KIEs measured and calculated TS 
structures for bPNP and hPNP. The intrinsic KIE values are given as percentages. Figure 
taken from Schramm, V.L., (2011), Enzymatic transition states, transition-state analogs, 
dynamics, thermodynamics, and lifetimes. Annu. Rev. Biochem., 80, 703-732. 
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Competitive KIE measurements were used to determine intrinsic KIEs for each 
labelled atom. This data was subsequently used to calculate the TS structure, and 
applied to the design of TS analogues (Figure 1.20) (173). Binding studies on hPNP 
with TS analogues based on the TS of bPNP found that despite the high sequence 
identity between the two enzymes, the TS of hPNP differed significantly (174). 
Subsequent TS analysis of hPNP led to the development of specific TS analogues 
towards the human enzyme, with Kd values in the low pM, a 2 million fold increase 
in affinity than the natural substrate (175, 176). 
 
1.4 DHFR inhibition and TS analysis 
The crucial role DHFR plays in numerous metabolic pathways of the cell has led to 
this enzyme being a key drug target (177, 178). Many inhibitors of DHFR have been 
produced by the pharmaceutical industry to treat a wide range of illnesses (Figure 
1.21). Methotrexate is one of the earliest anti-cancer agents developed, having 
been used in patients since the 1940's, and is used to treat cancers, such as 
leukaemia and breast cancer, as well as serious cases of rheumatoid arthritis (179, 
180). Methotrexate has a very high binding affinity to DHFR, over a 1000-fold higher 
affinity to DHFR compared to folate, but is also unspecific in its binding to DHFRs 
from other species (181). Pemetrexed is also an anti-cancer agent, used to treat 
lung cancer (182). Trimethoprim and pyrimethamine are DHFR inhibitors that show 
specificity to non-human DHFRs. Trimethoprim is an antibacterial agent due to its 
higher affinity for bacterial DHFRs relative to human DHFRs, whilst pyrimethamine 
is an anti-protozoal agent used in the treatment of malaria (183-186). 
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Figure 1.21 Examples of inhibitors of dihydrofolate reductase. A) Methotrexate, B) 
Trimethoprim, C) Pemetrexed and D) Pyrimethamine. 
 
Despite their success, DHFR inhibitors have been developed through traditional 
means, e.g. fragment based design from structural data (187). TS analysis, through 
KIE measurements, could potentially lead to a new class of potent DHFR inhibitor. 
However, as with other enzymes, the ability to measure heavy atom isotope effects 
depends on the ability to synthesise numerous substrate and cofactor 
isotopologues, with isotope incorporation specifically around the reaction centre. 
To date, this approach has not been applied to this important family of enzymes. 
However, the biosynthetic pathways of NADPH and DHF provide an excellent 
starting point from which a single method can be developed to obtain the required 
isotopologues.  
 
1.4.1.1 NADP+ Biosynthesis 
All organisms are able to synthesise NAD(P)+ de novo, and although two different 
pathways exist in nature, they converge at the key intermediate quinolinic acid 
(QA). Eukaryotic organisms synthesise QA solely from the precursor tryptophan, 
through the action of 5 enzymes (Scheme 1.4). The first two enzymes, tryptophan-
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2,3-dioxygenase and N-formylkynurenine formamidase, catalyse the cleavage of 
tryptophan to N-formylkynurenine and the subsequent removal of the formyl group 
to yield kynurenine (188, 189). Hydroxylation by kyneurine-3-monooxygenase 
followed by cleavage of the amino acid side chain by kynureninase produces 3-
hydroxyanthranilate. The final enzymatic step catalysed by 3-hydroxyanthranilate-
3,4-dioxygenase sees the oxidative rearrangement of the product to form QA (190-
193). Whilst the enzymes involved in this pathway have been identified, they have 
proved difficult to study up to this point, thus relatively little is known about their 
mechanism of action.  
 
Scheme 1.4 Production of quinolinic acid from tryptophan in eukaryotic cells. 
 
The second route to QA is from L-aspartate and dihydroxyacetone phosphate 
(DHAP), catalysed through the action of L-aspartate oxidase (LAO) and quinolinate 
synthase (QS) (Scheme 1.5). This was thought to be the only synthetic route used by 
prokaryotic organisms (194), however, incubation with labelled tryptophan has 
shown that a number of bacterial species are able to utilise both de novo routes to 
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QA (195). LAO is an FAD dependent enzyme that oxidises aspartate to 
iminoaspartate (196). This enzyme is able to utilise both fumarate and oxygen to 
recycle FADH2 back to FAD, depending on the aerobic/anaerobic nature of the 
environment (197). It has also been shown that iminoaspartate can be generated 
chemically through Schiff's base formation, by ammonia and oxalacetate (198), 
therefore LAO is not essential in the development of the NADP+ biosynthetic 
pathway. 
QS catalyses the condensation of iminoaspartate and DHAP to form QA, resulting in 
the carbon adjacent to the phosphate in DHAP becoming C4 of QA and 
subsequently C4 of NAD(P)H (199). Despite numerous studies the reaction 
mechanism is still unknown, with studies hampered by the presence of an [4Fe-4S] 
cluster that is essential for catalysis (200, 201). Early investigations were unaware of 
the presence of this cluster (202), and it was not until circa 2005 that evidence of 
the labile [4Fe-4S] complex was confirmed (200). Sequence analysis has highlighted 
the fact that only three cysteine residues coordinate to the cluster, and this may 
influence the stability. A fourth site of coordination is thought to occur with a 
reaction intermediate (Figure 1.22) (200, 203), and potentially facilitates a 
dehydration reaction that is common to other Fe-S cluster containing enzymes 
(204).  
 
Figure 1.22 Coordination of quinolinic acid intermediate with the [4Fe-4S] cluster of QS. 
 
NADP+ is synthesised from the precursor quinolinic acid through the action of four 
enzymes (Scheme 1.5): quinolinate phosphoribosyltransferase (QAPRT), nicotinic 
acid mononucleotide adenylyltransferase (NAMNT), NAD synthetase and NAD 
kinase (194, 205, 206). QAPRT is classed among the type II 
phosphoribosyltransferases (PRTs) due to its tertiary structure that incorporates the 
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active site into a seven stranded α/β fold (207). This enzyme catalyses the addition 
of a phosphoribose moiety from phosphoribose pyrophosphate (PRPP) to QA, with 
subsequent decarboxylation, forming nicotinic acid mononucleotide (208). It has 
been proposed that the pyrophosphate group dissociates from the phosphoribose 
moiety and stabilises the subsequent oxocarbenium ion (194). Nucleophilic attack 
by the lone pair of the QA nitrogen results in the formation of quinolinic acid 
mononucleotide, with decarboxylation at the C2 position the final step of the 
reaction. However, no direct evidence exists to fully confirm the order of reaction. 
The decarboxylation step is proposed to occur after the addition of the 
phosphoribosyl group, due to similarities with the reaction catalysed by OMP 
decarboxylase (209). Calculations have shown that decarboxylation at the C2 
position following formation of the mononucleotide is more energetically 
favourable, due to the presence of a stabilising positive charge on the adjacent 
nitrogen atom (210). 
 
Scheme 1.5 NADP+ biosynthesis in E. coli. 
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NAMNT catalyses the addition of adenosine to nicotinic acid mononucleotide to 
form nicotinic acid adenine dinucleotide (211). Whilst this enzyme is able to 
catalyse the addition of adenosine to nicotinamide mononucleotide, the conversion 
rate is compromised significantly (211). The third enzyme in the pathway, NAD 
synthetase, is responsible for the ATP dependent conversion of nicotinic acid 
adenine dinucleotide to nicotinamide adenine dinucleotide (NAD+) (212). This 
family of enzymes is split into two distinct classes: glutamine dependent and 
ammonia dependent (213). In both classes the carboxylate group is first activated 
by adenylation followed by the nucleophilic attack of ammonia. The glutamine 
dependent enzymes contain a glutaminase domain/subunit, and following cleavage 
the ammonia molecule is channelled directly into the amination active site, without 
dissociation into solvent. As a result, all glutamine-dependent NAD synthetase 
enzymes (eukaryotic and some bacterial) contain two domains, whereas ammonia-
dependent NAD synthetases (bacterial) have a single domain (213). 
The final reaction in the pathway is the phosphorylation of NAD+ to NADP+ by NAD 
kinase (214). This is an important enzyme due to the distinct roles that NAD(H) and 
NADP(H) play in catabolism and anabolism respectively (215). NAD kinase catalyses 
the phosphorylation of the 2' position of the adenine-ribose group to afford NADP+, 
thus is involved in maintaining cellular levels of each cofactor. As gene sequences, 
purification methods and activity assays have been reported for each individual 
enzyme (200, 201, 208, 211, 214, 216, 217), the E. coli de novo NADP+ biosynthetic 
pathway seems an ideal target to reconstitute in the laboratory. This has the 
potential to enable incorporation of isotopic labels into the nicotinamide ring of 
NADP+, a process that has never been performed via biosynthetic means. 
 
1.4.1.2 DHF Biosynthesis 
DHF and derivatives are essential cofactors for survival, however, vertebrates are 
unable to synthesise these compounds (218). Instead they are dependent on 
nutritional sources. Conversely, plants and bacteria are able to synthesise these 
compounds de novo, using a pathway that incorporates 6 steps to produce DHF 
from GTP (Scheme 1.6) (218-220). 
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The first committed step in DHF biosynthesis is the cyclisation of GTP to form 
dihydroneopterin triphosphate (221, 222). This reaction is catalysed by GTP 
cyclohydrolase I, a Zn2+ dependent enzyme, which hydrolyses the guanine base 
resulting in the loss of the C8 atom in the form of formic acid. An Amadori 
rearrangement then occurs involving the ribose moiety to form the 
dihydroneopterin triphosphate product (223). This enzyme is a member of a family 
of four GTP cyclohydrolases: I, II, III and MptA. GTP cyclohydrolase II and III are 
involved in riboflavin and flavo-coenzymes (although the exact role of GTPCHIII is 
still unclear), whilst MptA is an archaeal enzyme that converts GTP to 
dihydroneopterin-2,3-cyclic phosphate, an early intermediate in THF biosynthesis in 
this class of organisms (224). 
The mechanism for the subsequent removal of phosphate to yield dihydroneopterin 
has been an area of discussion for a number of years. Early reports suggested that a 
non-specific phosphatase and pyrophosphatase were responsible (225), although in 
recent years the appearance of enzymes that show specific activity towards 
dihydroneopterin triphosphate have altered this theory (226). In previous studies 
alkaline phosphatase has successfully been employed to remove the phosphate 
moieties, removing the need for a specific phosphatase to be produced and purified 
(220). Dihydroneopterin is cleaved to hydroxymethyl-dihydroneopterin by the 
action of dihydroneopterin aldolase (227). This enzyme performs a retro-aldol 
reaction, resulting in the release of glycoaldehyde (220). 
The three remaining steps incorporate the addition of the p-aminobenzoic acid and 
glutamate portions of DHF. Firstly, activation of the hydroxymethyl-
dihydroneopterin occurs through the addition of a pyrophosphate moiety catalysed 
by hydroxymethyl-dihydroneopterin pyrophosphokinase (228, 229). Subsequently, 
dihydroneopteroate synthetase (DHPS) catalyses the addition of p-aminobenzoic 
acid (228), a product of the shikimate pathway (230). DHPS is also a well known 
drug target, and often a combination of drugs that inhibit DHPS and DHFR are used 
in treatments (231). The final addition of glutamate by dihydrofolate synthetase 
(DHFS) produces the desired product DHF. In E. coli, DHFS also shows 
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folylpolyglutamate synthetase activity (232), and as such is capable of adding 
multiple glutamate molecules onto the product. 
All these enzymes have been characterised in E. coli (227, 228, 232-235). This 
knowledge from previous studies provides an excellent framework for the 
development of biosynthetic methods to provide DHF isotopologues. 
 
 
Scheme 1.6 Biosynthesis of DHF from GTP in E. coli. 
 
1.5 Aims 
The overall aim of this investigation was to explore the nature of catalysis in DHFR, 
using a number of different isotope effects. This was divided into two separate 
approaches; investigating the effect that isotopic substitution, particularly around 
the reaction centre in the cofactor/substrate, has on hydride transfer, and the role 
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that fs vibrations play on enzyme catalysis, both on the hydride transfer step and 
catalysis as a whole. 
Recently, numerous DHFR enzymes, and variants, have been studied via 
comparison of the "light", unlabelled and "heavy", 13C15N2H isotopically labelled 
enzymes (117, 118, 236). "Enzyme KIEs" highlight the role that ultrafast, short-
range vibrations of the enzyme play during the catalytic cycle. Whilst long range 
promoting motions that couple to hydride transfer have been ruled out in all DHFRs 
studied to date (113, 126, 136), relatively little information has been published on 
the role of these fs vibrations. Following on from these investigations, the 
investigation of a "heavy" BsDHFR would enable a more complete picture of any 
general trend across DHFR enzymes. Steady state and pre-steady state analysis, at 
pH 7, would enable both the whole catalytic cycle and the chemical step to be 
analysed. 
The contribution of specific atomic motions from the substrate to DHFR catalysis 
was to be analysed through α-secondary hydrogen (2°) and heavy atom KIEs, with 
the focus on the magnitude of these effects at pH 7 (rather than at elevated pH 
often employed for these type of studies (88)). Previous investigations have utilised 
2° KIEs in the investigation of other NAD(P)H dependent enzymes (151, 153), as well 
as EcDHFR at elevated pH (88) and TmDHFR (155). 2° KIEs have been proposed to 
report on the coupling of the 2° hydrogen motion to the transfer of the primary 
hydrogen (152), and/or the configuration of the reaction coordinate immediately 
prior to the transfer of the 1° hydrogen (153). To our knowledge, there are no cases 
of heavy atom KIEs being utilised in the investigation of DHFR, and in fact there is 
very little literature surrounding the use of these isotope effects to investigate 
enzymatic hydride transfer in general. The role of heavy atom motions is key to 
numerous tunnelling models (see above), as well as the potential production of TS 
analogues, therefore incorporation of stable isotopes at specific locations in the 
substrate would potentially enable the role that they play in the formation of the 
reaction coordinate and transition state to be analysed. 
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However, to enable heavy atom KIEs to be measured, isotopically labelled cofactor 
and substrate must be produced in significant amounts that allow kinetic analysis to 
be undertaken. Thus, a main priority of this investigation was to reconstitute the 
biosynthetic pathways of NADP+ and DHF from E. coli in vitro. This will provide a 
facile route to isotopically labelled NADPH and DHF isotopologues that are currently 
extremely difficult and expensive to synthesise chemically. The biosynthetic genes 
for both the NADP+ and DHF pathway were to be cloned from E. coli K-12 strains 
into expression vectors, allowing large scale production and purification of the 
enzymes. As previous literature exists for each E. coli enzyme (see above), the focus 
was to incorporate as many steps of the biosynthetic pathways together as 
possible. There have been no previous reports of large-scale biosynthesis of NADPH 
or DHF de novo. The successful reconstitution of these pathways will allow a single 
route to a large number of isotopologues, using only simple starting materials that 
are commercially available. 
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2 CATALYSIS BY G. STEAROTHERMOPHILUS DHFR  
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2.1 Preface 
Geobacillus stearothermophilus DHFR (named BsDHFR in the literature) is a 
moderately thermophilic enzyme that shares a very similar tertiary structure with 
that of the mesophilic EcDHFR (132). Previous studies have shown that the catalytic 
cycle of BsDHFR differs from that of EcDHFR, a long standing paradigm for enzyme 
catalysis (see Introduction). Thus the role of protein motions in catalysis may also 
be different between these two enzymes (132, 138). Here, we aimed to analyse the 
chemistry of BsDHFR in a detailed manner by measuring the primary kinetic isotope 
effect (KIE) on hydride transfer by using enzyme isotopic labelling with 13C, 15N and 
2H. This allowed a comparison between "light" (natural abundance) and "heavy" 
(isotopically labelled) BsDHFR. Both isotopically labelled enzymes and substrates 
were employed in this investigation and mentioned in the discussion. Throughout, 
"enzyme KIE" refers to kLE/kHE and "hydride KIE" refers to kNADPH/kNADPD. 
 
2.1.1 Kinetic characterisation of enzyme catalysis 
2.1.1.1 Steady state kinetics 
The simplest enzymatic reaction between an enzyme and substrate can be 
represented by: 
 
where E is the enzyme, S the substrate, ES the enzyme-substrate complex and P the 
product of the reaction. This representation works on the assumption that the 
reverse reaction (k-2) is negligible and therefore can be ignored. The initial rate of 
reaction, v, can be defined as: 
         
However, the concentration of ES is also dependent on rate constants other than 
k2: 
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Rate of formation of ES = k1[E ][S ] 
Rate of decomposition of ES = (k-1 + k2)[ES ] 
Steady state kinetics are based on the assumption that the concentration of 
enzyme-substrate complex does not change over the time-frame of the reaction i.e. 
the rate of formation and decomposition of ES are equal, thus: 
                      
If [E] is replaced by [Et]-[ES], i.e., the total amount of enzyme minus the enzyme 
bound to the substrate, the equation above can be rearranged to give: 
      
       
         
   
  
 
 
where (k2 + k-1/k1) is the Michaelis constant, KM, giving: 
      
       
      
 
By substituting v = k2[ES] into the equation above we get: 
  
         
      
 
This equation can be further simplified as the maximum rate, Vmax, occurs when the 
enzyme is saturated, i.e. Vmax = k2[Et], therefore: 
  
       
      
 
This is the Michaelis-Menten equation, and gives the relationship between the rate 
of an enzyme reaction and the substrate and total enzyme concentrations. It also 
gives the practical definition of KM:  
      , when    
    
 
 
In practice, the steady-state conditions are maintained by using a much higher 
concentration of substrate compared to enzyme during the reaction. The DHFR 
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reaction can be followed by monitoring the decrease in absorption at 340 nm as 
NADPH is oxidised to NADP+ during the course of the reaction, via UV-Vis 
spectroscopy. The rate of reaction can be calculated from this change in absorption 
through the Beer-Lambert law: 
         
where A is the change in absorption, l is the pathlength and c and ε are the 
concentration and extinction coefficient of absorbing species respectively (ε  = 
11,800 M-1 cm-1) (84). 
 
2.1.1.2 Pre-steady state kinetics 
Previously, it has been shown that at pH 7, i.e. a physiologically relevant pH, the 
hydride transfer step in BsDHFR is only partially rate limiting (132). Hydride transfer 
in BsDHFR catalysis therefore could not be characterised by steady-state turnover 
(kcat) measurements, as it is masked by kinetic complexity.  Consequently, pre-
steady state or transient state kinetics are needed to monitor the rate of hydride 
transfer (kH). Stopped-flow spectroscopy has been used widely to investigate 
hydride transfer in DHFR catalysis at pH 7 (86, 120), and uses an excess of enzyme 
and substrate compared to the cofactor concentration to maintain single turnover 
conditions.  
The stopped-flow apparatus consists of two syringes, the first containing enzyme 
and cofactor and the second containing substrate (Figure 2.1). The enzyme is 
preincubated with NADPH to avoid hysteresis (87). The syringes are injected using a 
single syringe drive plate to ensure equal volumes from each syringe are injected, 
and the solutions are rapidly mixed before passing through the detector. This 
method allows for very fast measurements to be recorded, as the machine has a 
dead time of only a few milliseconds during which the rapid mixing of solutions 
occurs. The stopped-flow apparatus allows the chemical step to be monitored via 
Förster resonance energy transfer (FRET) and absorption. 
 
Catalysis by G. stearothermophilus DHFR 
 
57 
 
 
Figure 2.1 The mechanism of action of a stopped-flow spectrometer. Syringe A contains 
enzyme and cofactor and syringe B contains substrate. The reaction can be followed by 
absorption (abs) or fluorescence (fluor). 
  
2.2 Results and discussion 
2.2.1 Purification and structural characterisation of light and 13C15N2H 
labelled DHFR 
The plasmid containing the BsDHFR gene was expressed using E. coli BL21 StarTM 
(DE3) cells in M9 minimal media. The characteristics of the target enzyme allowed 
the crude lysate to be heat-shocked, enabling many of the native E. coli proteins to 
precipitate whilst the thermophilic BsDHFR stayed in solution. Further purification 
was performed using anion-exchange chromatography followed by size-exclusion 
chromatography (Figure 2.2). For the 2H-, 13C- and 15N-labelled "heavy" enzyme, the 
host cells were grown in M9 minimal media that contained isotopically labelled 
glucose, ammonium chloride and D2O as the only sources of carbon, nitrogen and 
hydrogen. The same purification procedure was used, and they gave identical 
elution traces in DEAE and size-exclusion chromatographic purifications. 
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Figure 2.2 (previous page) A) Chromatogram of the elution trace (red) of light BsDHFR 
from the DEAE column and the corresponding NaCl concentration (green). The fractions 
containing BsDHFR (1-14, M = marker) were analysed via SDS-PAGE before purification 
via size exclusion (B). C) The elution traces of light (red) and heavy (blue) BsDHFR from 
the Superdex75 size-exclusion column. D) Final purifed fractions of light and heavy 
BsDHFR (light = light BsDHFR, heavy = 13C15N2H BsDHFR, M = marker). 
 
ESI-MS was performed to confirm the purification for both the light and heavy 
BsDHFR (performed by Robin Hicks and Dr. Louis Luk). The deconvoluted mass 
spectrum of BsDHFR that is composed of naturally abundant isotopes showed a 
peak at 18696.2, which matches well with the theoretical mass of 18694.7 (Figure 
2.3). On the other hand, the 'heavy' BsDHFR mass spectrum showed a peak of 
20740.0, indicating a ~10% molecular weight increase. This can be accounted by 
99.8% of the carbon, nitrogen and non-exchangeable hydrogen atoms being 
labelled by their heavier counterparts. 
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Figure 2.3 ESI-MS chromatogram of light (A) and heavy (C) BsDHFR. The deconvoluted 
spectra are also shown (B and D). 
Circular dichrosim (CD) spectra of the light and heavy enzymes were obtained to 
verify if heavy isotope substitutions have an effect on protein structural 
organisation. The light enzyme (Figure 2.4) exhibited characteristic signals of a 
folded protein, with two minima at 222 and 206 nm and a maximum at 195 nm, 
signifying the existence of α-helices and β-sheets. At all the examined temperatures 
(10, 20 and 35 °C), BsDHFR remained properly folded and showed no sign of 
unfolding. Most importantly, the MRE of the light and heavy BsDHFR were super-
imposable, confirming that there was no disparity between the isotopologues 
(Figure 2.4D). Hence, any reactivity difference between the light and heavy BsDHFR 
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will be caused by a difference in mass-dependent vibrations rather than structural 
difference. 
 
Figure 2.4 CD spectra of light BsDHFR (red) and heavy BsDHFR (blue) at 10 (A), 20 (B) and 
35 (C) °C and at all temperatures (D). Each spectrum is an average of at least three 
measurements per temperature per enzyme. 
 
2.2.2 Steady state kinetic analysis of light and heavy BsDHFR 
Kinetic measurements were carried out to investigate the effect of heavy isotope 
substitution on the catalysis of BsDHFR (data measured with Dr. Louis Luk). The 
temperature dependence of kcat was measured from 10 to 45 °C (due to the 
technical difficulty in lowering the temperature of the cell-holder, we were unable 
to accurately measure kinetics at 5 °C). The measured enzyme KIE on catalytic 
turnover (kcat) was ~2.6, appearing to be temperature independent (Table 2.1, 
Figure 2.5), and is considerably larger than that measured with other DHFRs. 
EcDHFR, whose catalytic cycle was thoroughly characterised previously (86), 
showed a considerably smaller enzyme KIE that increases steadily from unity at 10 
°C to 1.15 ± 0.02 at 40 °C (117). This was attributed to the large conformational 
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change involved in the rate-limiting product release (69, 86). On the other hand, the 
rate of catalytic turnover of the catalytically compromised mutant EcDHFR-
N23PP/S148A is not isotopically sensitive, giving an enzyme KIE of unity across the 
temperature range measured (118). This observation agrees well with the fact that 
this mutant is unable to form the occluded conformation and lacks the large scale 
loop movement needed for cofactor NADP+ release, the rate limiting step in this 
mutant (117, 118). A similar isotope effect investigation has been conducted on 
another thermophilic homologue TmDHFR, which is extremely rigid and locked in 
the open conformation (236). This enzyme produced a temperature independent 
enzyme KIE of approximately 1.3 across the measured temperature range. TmDHFR 
is unique among DHFRs in that it forms a dimer in its native state, and it is argued 
that the enzyme KIE of 1.3 is as a result of intersubunit interactions that are 
isotopically sensitive (236).  
 
Table 2.1 Temperature dependence of kcat for unlabelled and labelled BsDHFR, and the 
enzyme KIE, at pH 7. 
T (°C) 
kcat (s
-1) 
Enzyme KIE 
Unlabelled BsDHFR 13C15N2H BsDHFR 
10 4.71 ± 0.23 2.22 ± 0.15 2.13 ± 0.22 
15 8.44 ± 0.37 3.42 ± 0.14 2.47 ± 0.15 
20 15.64 ± 0.01 6.41 ± 0.44 2.44 ± 0.24 
25 24.94 ± 0.56 9.14 ± 0.99 2.73 ± 0.19 
30 41.32 ± 3.82 13.87 ± 2.76 2.98 ± 0.35 
35 53.45 ± 0.53 19.79 ± 3.63 2.70 ± 0.18 
40 76.67 ± 0.99 30.93 ± 2.93 2.48 ± 0.18 
45 99.34 ± 1.72 37.42 ± 1.79 2.65 ± 0.33 
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Figure 2.5 A) Temperature dependence of kcat for light (red) and heavy (blue) BsDHFR at 
pH 7. B) Temperature dependence of the enzyme KIE on kcat for light and heavy BsDHFR 
at pH 7. C) Corresponding Arrhenius plot of the temperature dependence of kcat of light 
and heavy BsDHFR (red and blue respectively) at pH 7. D) Corresponding Eyring plot of 
the temperature dependence of kcat of light (red) and heavy (blue) BsDHFR at pH 7. 
The temperature independent enzyme KIE on kcat for BsDHFR suggests that a large 
loop movement or conformational change is not involved in the catalytic cycle of 
this enzyme. This is supported by the fact that evidence of the occluded 
conformation has never been documented in the case of BsDHFR, and thus large 
conformational changes are absent from the catalytic cycle in much the same way 
as with the triple mutant EcDHFR and TmDHFR (enzymes that show similar 
temperature independent enzyme KIEs).  
The magnitude of the enzyme KIE in BsDHFR is likely due to a number of factors. 
BsDHFR has shown to be inherently more flexible than EcDHFR (133, 134), and as 
such atomic motions on a global scale would be expected to show a greater isotope 
dependence. It has also been shown that hydride transfer is partially rate 
determining at pH 7 (unlike in EcDHFR) as a KIE of ~2 was measured when NADPD 
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was used under steady state conditions (132).  This kinetic complexity surrounding 
the catalytic cycle suggests a number of steps may be affected by isotopic 
substitution, rather than a single large conformational change as witnessed in 
EcDHFR, and may contribute to the larger enzyme KIE seen in BsDHFR. Higher pH 
measurements would enable the enzyme KIE solely on the chemical step to be 
determined, however, the very slow rate at high pH made a comparison between 
the two isotopologues impractical due to significant experimental error.   
 
Table 2.2 Activation parameters for light and heavy BsDHFR at pH 7 under steady state 
conditions. 
 Ea (kJ mol
-1) AH (s
-1) 
ΔH‡        
(kJ mol-1) 
ΔS‡                  
(J K-1 mol-1) 
ΔG‡ (kJ mol-1) 
(at 25 °C) 
Light 
BsDHFR 
65.4 ± 3.1 (6.57 ± 0.3) x 1012 62.9 ± 3.1 -7.9 ± 0.4 65.3 ± 3.2 
Heavy 
BsDHFR 
62.0 ± 1.5 (6.57 ± 0.2) x 1011 59.6 ± 2.0 -27.0 ± 1.0 67.6 ± 2.2 
 
 
The difference in catalytic turnover (kcat) was further analysed by deducing the 
activation parameters of the light and heavy BsDHFR (Table 2.2). Because the 
observed enzyme KIE is temperature independent, activation energies (Ea) as well 
as the enthalpies of activation ΔH‡ are identical between the light and heavy 
enzymes. Interestingly, the entropy of activation ΔS‡ (and consequently the AH 
value) underlies the difference in reactivity. The transition state of the heavy 
BsDHFR is more ordered, and the calculated ΔS‡ is approximately 20 J K-1 mol-1 
lower than that of the light enzyme (-7.91 ± 0.4 and -27.0 ± 1.0 J K-1 mol-1 for the 
light and heavy enzyme respectively). This implies that the enzyme has become 
more rigid upon heavy isotope substitution, and energetically less favourable for 
conformational sampling. Therefore, a slightly higher reorganisation energy is 
required (51, 118, 237), and a slower reaction rate was observed. BsDHFR is known 
to be more flexible than EcDHFR (134), and this could explain the greater 
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magnitude of enzyme KIE effect as the inherent flexibility results in a greater 
entropic burden on the thermophilic enzyme when a rigid conformation is adopted.  
 
 
Figure 2.6 Effect of cofactor (left) and substrate (right) concentration at 10 (A), 20 (B) and 
35 (C) °C on the apparent (app) kcat value for light and heavy BsDHFR (red and blue 
respectively) at pH 7. 
 
The Michaelis constants (KM) for the light and heavy enzyme were determined at 
10, 20 and 35 °C for both the cofactor NADPH and substrate DHF (Figure 2.6). The 
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cofactor KM for the light and heavy BsDHFR at 20 °C was 127 ± 13.8 and 124 ± 14.9 
µM, respectively, showing no difference between the two enzymes. Similarly, at 10 
°C and 35 °C the KM
NH values for the light and heavy BsDHFR were identical within 
error, suggesting no significant variation caused by heavy isotope substitutions 
(Table 2.3). Therefore, the observed difference on the rate of catalytic turnover 
likely occurs after formation of the Michaelis complex.  
It should be noted that the Michaelis constant for NADPH is noticeably higher than 
that of other characterised DHFRs. This is due to a conserved glutamine residue 
normally present in the ABD being replaced with alanine, a more thermostable 
residue. Previous studies have shown the A104Q mutant of BsDHFR has a fourfold 
higher affinity to NADPH (138). For DHF, the nature of tight binding is similar to 
other DHFRs and remains unchanged upon isotope labelling, with KM values 
measured to be approximately 1 µM (Table 2.3). 
 
Table 2.3 Apparent kcat and KM values for light and heavy BsDHFR at 10, 20 and 35 °C at 
pH 7. 
°C BsDHFR 
App kcat 
(s-1) 
KM
NADPH (μM) KM
DHF (μM) 
10 
Light 
Heavy 
4.7 ± 0.2 86 ± 15.8 0.98 ± 0.18 
2.2 ± 0.2 112.5 ± 15.7 0.79 ± 0.23 
20 
Light 
Heavy 
15.6 ± 0.1 127 ± 13.8 0.56 ± 0.14 
6.4 ± 0.4 124 ± 14.88 0.84 ± 0.15 
35 
Light 
Heavy 
53.5 ± 0.5 88.2 ± 12.5 1.01 ± 0.17 
19.8 ± 3.6 112 ± 11.52 0.57 ± 0.1 
 
 
2.2.3 Pre-steady state kinetic analysis of light and heavy BsDHFR 
2.2.3.1 Hydride transfer and kinetic isotope effect of BsDHFR and heavy 
BsDHFR 
The effect of heavy isotope substitution on the BsDHFR catalysed hydride transfer 
was measured in single-turnover experiments. Previously, the rate constant of 
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hydride transfer (kH) was measured by fluorescence resonance energy transfer 
(FRET), in which a tryptophan residue inside the active site serves as the donor 
chromophore, while the nicotinamide ring in NADPH serves as the acceptor 
chromophore. However, this technique often produced data with a low signal to 
noise ratio, especially at low temperature (Figure 2.7). In fact, the rate constant of 
hydride transfer could not be measured accurately at 5 °C. To improve the quality 
of data, absorbance was measured at 340 nm. The measured kH values obtained by 
absorbance are in good agreement with that by FRET, and data can be obtained 
accurately even at 5 °C (Table 2.4). Hydride transfer rate constants were 
determined between 5 and 45 °C for both light and heavy BsDHFR (Table 2.5). 
 
Table 2.4 Comparison of kH values obtained via absorbance and FRET measurements. 
T (°C) 
kH (s
-1) 
Absorbance FRETA 
5 46.7 ± 3.2 - 
10 67.1 ± 1.2 68.3 ± 8.3 
15 84.7 ± 3.9 79.2 ± 3.7 
20 112.3 ± 5.0 102 ± 5 
25 139.5 ± 2.4 131 ± 2 
30 154.2 ± 5.9 160 ± 8 
35 188.3 ± 8.9 184 ± 6 
40 213.8 ± 21.0 218 ± 7 
45 256.3 ± 26.2 249 ± 12 
A Data measured by J. Guo (136) 
 
       
Figure 2.7 Comparison of traces obtained via FRET (A) and absorption (B) measurements. 
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Table 2.5 kH and kD rate constants for light and heavy BsDHFR and the calculated KIE for 
kH/kD 
T         
(°C) 
Light BsDHFR Heavy BsDHFR 
kH kD KIE kH kD KIE 
5 46.7 ± 3.2 7.7 ± 1.5 6.1 ± 0.3 28.3 ± 2.5 3.3 ± 0.3 8.7 ± 0.6 
10 67.1 ± 1.2 13.2 ± 0.7 5.1 ± 0.3 49.4 ± 2.6 6.4 ± 1.3 7.7 ± 0.8 
15 84.7 ± 3.9 19.7 ± 0.6 4.3 ± 0.3 71.4 ± 3.3 19.1 ± 1.9 3.7 ± 0.2 
20 112.3 ± 5.0 32.2 ± 2.5 3.5 ± 0.4 91.4 ± 5.0 32.5 ± 0.8 2.8 ± 0.1 
25 139.5 ± 2.4 43.9 ± 4.5 3.2 ± 0.3 122.2 ± 4.0 45.9 ± 2.7 2.7 ± 0.1 
30 154.2 ± 5.9 60.7 ± 11.4 2.5 ± 0.5 139.8 ± 8.8 61.1 ± 3.6 2.3 ± 0.1 
35 188.3 ± 8.9 69.1 ± 8.8 2.7 ± 0.6 186.1 ± 4.6 75.0 ± 3.1 2.5 ± 0.1 
40 213.8 ± 21.0 76.6 ± 6.4 2.8 ± 0.6 215.5 ± 10.8 94.4 ± 8.3 2.3 ± 0.1 
45 256.3 ± 26.2 97.2 ± 15.5 2.6 ± 0.5 235.3 ± 7.2 123.1 ± 21.9 1.9 ± 0.2 
 
 
Figure 2.8 A) Graph showing the kH (diamonds) and kD (circles) rate constants for light and 
heavy BsDHFR (red and blue respectively).  
 
Intriguing observations were seen in the hydride transfer rate constant 
measurements.  Between 5 and 45 °C, hydride transfer (kH) of the light enzyme 
ranges from 46.7 ± 3.2 to 256.3 ± 26.2 s-1. The rate constant dropped significantly 
when labelled substrate NADPD was used, with kD spanning from 7.7 ± 2.5 to 97.2 ± 
7.2 s-1 at the corresponding temperatures. The calculated "hydride KIE" (kH/kD) is 
approximately 2.5 between 20-45 °C, but increases steeply at low temperature, 
giving a KIE of 6.1 ± 0.3 at 5 °C. The strong temperature dependence resembles that 
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discovered in the studies of the hyperthermophilic homologue TmDHFR (120) and a 
moderately thermophilic alcohol dehydrogenase BsADH (21). Interestingly, this 
biphasic behaviour is further magnified when isotopically labelled enzyme was 
employed. kH ranges from 28.3 ± 1.5 to 235.3 ± 15.5 s
-1, whereas kD starts from 3.3 
± 0.3 to 123.1 ± 21.9 s-1 between 5 to 45 °C for the heavy enzyme (Figure 2.8). 
Hence, a similar breakpoint at ~20 °C was observed, giving a calculated KIE that 
increases from 2.7 ± 0.1 at 25 °C to 8.7 ± 0.6 at 10 °C (Figure 2.10).  
 
Table 2.6 Enzyme KIE values on hydride and deuteride transfer 
T (°C) Enzyme KIEH Enzyme KIED 
5 1.65 ± 0.09 2.32 ± 0.25 
10 1.36 ± 0.04 2.07 ± 0.21 
15 1.18 ± 0.04 1.03 ± 0.05 
20 1.23 ± 0.04 0.99 ± 0.04 
25 1.14 ± 0.02 0.96 ± 0.06 
30 1.10 ± 0.04 0.99 ± 0.10 
35 1.01 ± 0.03 0.92 ± 0.06 
40 0.99 ± 0.05 0.81 ± 0.05 
45 1.09 ± 0.06 0.79 ± 0.09 
 
 
 
Figure 2.9 Enzyme KIE on hydride (A) and deuteride (B) transfer at pH 7. 
 
The effect of enzymatic isotopic substitution was assessed by calculating the 
enzyme KIEH (kH
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temperature dependence. As temperature increases from 5 to 20 °C, the enzyme 
KIEH drops sharply from 1.65 to 1.23. However, at 25 °C and above, the enzyme KIEH 
becomes significantly less temperature dependent, and eventually reaches unity at 
40 °C, indicating that enzymatic isotope substitution causes no effect on the rate 
constant of hydride transfer. For the labelled cofactor NADPD, enzyme KIED 
(kD
LE/kD
HE) also decreases from 2.33 at 5 °C to 0.99 to 20 °C. Interestingly, at high 
temperature the rate constant of deuteride transfer in the heavy BsDHFR is higher 
than that in the light counterpart. The enzyme KIED was calculated to be 0.81 at 40 
°C, implying that the efficiency of deuteride transfer was actually enhanced when 
the mass-dependent vibrations of the enzyme were reduced.  
 
Table 2.7 pKa values for the hydride transfer reaction of light and heavy BsDHFR at 10, 20 
and 35 °C 
 
pKa 
10 °C 20 °C 35 °C 
Light BsDHFR 6.64 ± 0.1 6.41 ± 0.1 6.75 ± 0.2 
Heavy BsDHFR 6.33 ± 0.2 6.33 ± 0.1 6.92 ± 0.1 
 
The pKa was measured at 10, 20 and 35 °C for light and heavy BsDHFR to rule out a 
change between the two enzymes as the cause of the observed hydride/enzyme 
KIE. Measurements were performed using MTEN buffer between pH 4.5 and 9 
(Table 2.7). There was no difference between the two enzymes at each 
temperature, indicating that a change in pKa is not the cause of the interesting 
results. 
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Figure 2.10 Arrhenius plot of the kH and kD (diamonds and circles) for the light and heavy 
BsDHFR (red and blue). 
 
Table 2.8 Activation energy and Arrhenius prefactor values of light and heavy BsDHFR 
under pre-steady state conditions at pH 7 between 5 and 45 °C 
T (°C)  
Light BsDHFR Heavy BsDHFR 
NADPH NADPD NADPH NADPD 
5-20 
Ea (kJ mol
-1) 38.4 ± 2.1 63.6 ± 2.3 52.8 ± 7.0 107.7 ± 9.6 
AH(D) (s
-1) 9.5 (± 0.4) x108 7.0 (± 0.2) x1012 2.5 (± 0.3) x1011 5.6 (± 0.5) x1020 
ΔEa (kJ mol
-1) 24.8 ± 3.2 54.9 ± 11.4 
AH/AD 1.8 (± 0.1) x10
-4 4.5 (± 0.6) x10-10 
20-45 
Ea (kJ mol
-1) 24.8 ± 1.0 32.6 ± 3.0 29.8 ± 2.2 40.0 ± 1.4 
AH(D) (s
-1) 3.0 (± 0.08) x106 2.2 (± 0.2) x107 2.0 (± 0.1) x107 4.6 (± 1.3) x108 
ΔEa (kJ mol
-1) 7.8 ± 3.1 10.2 ± 2.6 
AH/AD 0.14 ± 0.01 0.04 ± 0.002 
 
The biphasic behaviour observed in the hydride transfer rate constant 
measurement was characterised by calculating two sets of activation parameters 
(Table 2.8). At temperatures above 20 °C, the hydride KIE is weakly temperature 
dependent and showed a small difference in activation energies (ΔEa = 7.8 ± 3.1 and 
10.2 ± 3.1 kJ mol-1 for light and heavy BsDHFR respectively). However, because the 
KIE is strongly temperature dependent at 5-20 °C, the magnitude of ΔEa greatly 
increased. Moreover, the change in activation energy for heavy enzyme (54.9 ± 11.4 
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kJ mol-1) is almost twice that in the unlabelled enzyme (24.8 ± 3.2 kJ mol-1). Both the 
light and heavy enzyme also display strongly inverse AH/AD values (1.8 (± 0.1) x10
-4 
and 4.5 (± 0.6) x10-10 respectively) in the low temperature region. 
Similar kinetic behaviour has been seen in BsADH (21) and TmDHFR (120). It was 
originally proposed that this dramatic change in hydride KIE was caused by a 
contribution from "promoting motions", which function at a physiologically relevant 
temperature by modulating hydride transfer through the barrier height and/or 
width (21, 41). These hypothetical promoting motions range from femtosecond (fs) 
bond vibrations to millisecond (ms) structural changes. Several experiments have 
been designed to probe for the existence of these "promoting motions". A role for 
long range dynamic coupling has been ruled out in the studies of EcDHFR, MpDHFR, 
TmDHFR and BsDHFR, since increasing viscosity of the reaction medium by varying 
solvent compositions does not affect the nature of hydride transfer. Instead, the 
electrostatic properties of the reaction medium appear to correlate to the 
efficiency of hydride transfer (105, 113, 126, 138). Furthermore, fast protein 
vibrations do not seem to promote catalysis by coupling to the chemical coordinate 
of hydride transfer. A computational study of heavy EcDHFR and its catalytically 
compromised mutant N23PP/S148A indicated that the tunnelling coefficient (i.e. 
the probability of hydride tunnelling) remains unaffected upon heavy isotope 
substitution of the enzyme (117, 118). Additionally, isotopic labelling of TmDHFR 
caused no observable effect on the rate constant of hydride transfer (236), again 
indicating the absence of vibrational coupling to the reaction coordinate. Together 
these results strongly challenge the existence of promoting motions with regards to 
DHFR catalysis. Accordingly, the reactivity difference in BsDHFR between NADPH 
and NADPD, and that caused by enzymatic isotope substitution, is unlikely due to a 
change in the contribution of promoting motions.  
Instead, there are a number of factors that could affect the efficiency of hydride 
transfer in BsDHFR. During catalysis most enzymes undergo conformational 
sampling, by which an ideal electrostatic environment is preorganised for the 
transition state of the chemical transformation. In DHFR, this process greatly affects 
the rate constant of hydride transfer. This is demonstrated by the studies of 
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EcDHFR and its catalytically compromised mutant N23PP/S148A (110). Reduction of 
the hydride transfer rate constant in the EcDHFR-N23PP/S148A catalysed reaction 
is mainly caused by poor electrostatic preorganisation and consequently an 
increase of reorganisation energy (110). Furthermore, conformational sampling 
likely relies on structural flexibility of the enzyme and is consequently sequence-
specific. In the thermophilic homologue TmDHFR, conformational sampling is 
thought to be limited because it is locked in the open conformation (121), thus 
contributing to the relatively low rate constant of hydride transfer observed (120). 
Also, the frequency of dynamic recrossing, the conversion of product back to 
reactant through the transition state dividing surface, could be a factor that slows 
the hydride transfer rate in the BsDHFR reaction (27). Previous computational 
studies revealed that heavy isotope replacement of EcDHFR disturbed the detailed 
thermodynamic balance of the reaction coordinate by slowing mass-dependent 
protein environmental motions (117). Recrossing events in the heavy EcDHFR 
therefore increased, and the corresponding coefficient deviates further from unity 
than that of the light enzyme (117). Even though the exact mechanism has not been 
elucidated, further analysis indicated that dynamic recrossing is actually enhanced 
when coupling of femtosecond vibrations of the enzyme to the reaction centre is 
enhanced, compromising catalytic efficiency (118). Results obtained in the heavy 
enzyme studies of TmDHFR agree well with this conclusion; the rate constant of 
hydride transfer was shown to be unaffected by enzymatic isotopic substitutions 
(236).  
While the exact cause of the strong temperature dependence in both the hydride 
and enzyme KIE has not been fully solved, some explanations are postulated in this 
thesis. The large increase in hydride KIE below the breakpoint suggests that 
formation of an active site conducive to deuteride transfer is more difficult. The 
heavy enzyme is affected in the same manner, with an identical hydride KIE trend 
observed. To begin with, the reactivity difference between NADPH and NADPD, 
resulting in a biphasic hydride KIE plot, could arise from conformational sampling 
(110, 113). Previous studies have highlighted that EcDHFR samples multiple 
substrates during the catalytic cycle, with high energy conformations adopted 
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before proceeding to the subsequent step (71). At low environmental 
temperatures, conformational sampling of active sites complementary to the TS 
would be hindered in BsDHFR, highlighted by the substantial increase in Ea below 
the breakpoint (Table 2.8).  
It has also been hypothesised that certain enzymes can adopt multiple conformers 
that are favourable for chemical transformation and lead to an abnormal hydride 
KIE trend (238). The biphasic Arrhenius plot discovered in BsDHFR (Figure 2.10) can 
be interpreted as evidence of a switch in equilibrium between these conformers 
(239). This hypothetical change in conformational equilibrium would account for 
the biphasic hydride KIE at low temperature, with one conformer favouring hydride 
transfer over the other. Conformational sampling and changes to recrossing 
frequency (see below) would also be relevant in this case, with different 
conformers affected to different degrees across the temperature range. However, 
there is no direct evidence to date of multiple conformers existing in any DHFR 
homologue.  
Additionally, the hydride KIE can be explained using ensemble-averaged variational 
transition state theory that is incorporated with multidimensional tunnelling (EA-
VTST/MT). This theoretical framework has been used to explain the temperature 
dependence of the hydride KIE in EcDHFR (240). It was postulated that the reaction 
pathway changes with temperature, leading to different tunnelling and recrossing 
coefficients. Accordingly, as BsDHFR is considerably more flexible, a greater change 
in reaction coordinate at low temperature could result in the observed hydride KIE. 
In all likelihood, a contribution from all the above factors to varying extents causes 
the weakly temperature dependent KIE above the breakpoint and strongly 
temperature dependent trend below it. 
At physiologically relevant temperatures (>25 °C), the magnitude of the average 
enzyme KIEH is approximately 1.07 and is analogous to that observed in EcDHFR. 
Accordingly, the lower hydride transfer rate constant in the heavy BsDHFR reaction 
can be reasoned by an increase in the frequency of dynamic recrossing (117). On 
the other hand, the sudden increase of the enzyme KIEH at low temperature (1.65 
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at 5 °C) has never been observed in previous heavy enzyme studies. Since BsDHFR is 
the most flexible thermophilic homologue that has been studied by enzymatic 
isotope substitutions, a greater entropic burden is expected for conformational 
sampling, thus a greater disparity of enzyme KIEH was expected. This could 
contribute to the large magnitude in enzyme KIEH at low temperature, in much the 
same manner as the observed trend in hydride KIE. The possible existence of 
multiple conformers would also affect the heavy enzyme, to a greater extent than 
the lighter enzyme, contributing to the increase in enzyme KIEH. As the hydride KIE 
is also sensitive to enzyme labelling (Table 2.6), it implies that the reaction 
coordinate is affected by the change in protein mass-dependent vibrations. 
Nevertheless, all of these hypotheses require verification, and additional 
computational studies are needed to pinpoint the exact effect of enzymatic isotopic 
substitution in the catalysis by BsDHFR (see below).  
At 20 °C and above, the rate of deuteride transfer is faster in heavy BsDHFR, a trend 
also observed in heavy EcDHFR (unpublished) and PETNR (19). This phenomenon is 
particularly perplexing, since many current theoretical models assume that slowing 
mass-dependent motions would decrease the reactivity of an enzyme (54). One 
possible explanation is that slower fs vibrations along the reaction coordinate 
and/or higher temperatures actually result in favourable enzyme-TS interactions. 
This tighter interaction would result in a more constrained TS compared to the GS, 
thus inverse secondary KIEs would result (241). A role for fs motions towards this 
interesting finding cannot be ruled out, or proven at this time. Further EA-VTST 
calculations of the deuteride transfer will provide a clearer explanation to the 
observed inverse enzyme KIED. 
 
2.2.3.2 Solvent isotope effect of light and heavy BsDHFR 
Hydride transfer rate constants in light and heavy BsDHFR were measured in 
reaction medium composed of D2O. At pH 7 in 100 mM KiPO4, 100 mM NaCl, 10 
mM βME buffer, a normal SKIE (kH2O/kD2O) was observed at 5 and 10 °C, and an 
inverse SKIE between 15 and 45 °C.  
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Table 2.9 kH values for light and heavy BsDHFR in H2O and D2O and the subsequent SKIE. 
T      
(oC)  
Light BsDHFR Heavy BsDHFR 
kH (H2O) kH (D2O) SKIE kH (H2O) kH (D2O) SKIE 
5 46.7 ± 3.2 41.7 ± 0.9 1.17 ± 0.08 28.3 ± 2.5 29.0 ± 0.5 1.12 ± 0.07 
10 67.1 ± 1.2 62.0 ± 1.4 1.07 ± 0.08 49.4 ± 2.6 47.0 ± 0.9 1.05 ± 0.09 
15 84.7 ± 3.9 87.4 ± 1.1 0.90 ± 0.01 71.4 ± 3.3 76.0 ± 2.3 0.84 ± 0.09 
20 112.3 ± 5.0 129.8 ± 1.7 0.87 ± 0.05 91.4 ± 5.0 116.3 ± 4.8 0.75 ± 0.04 
25 139.5 ± 2.4 157.5 ± 1.9 0.93 ± 0.03 122.2 ± 4.0 161.7 ± 9.0 0.73 ± 0.04 
30 154.2 ± 5.9 186.3 ± 3.0 0.84 ± 0.02 139.8 ± 8.8 185.7 ± 11.0 0.65 ± 0.06 
35 188.3 ± 8.9 222.7 ± 5.4 0.84 ± 0.03 186.1 ± 4.6 264.2 ± 5.3 0.71 ± 0.05 
40 213.8 ± 21.0 244.8 ± 5.6 0.84 ± 0.02 215.5 ± 10.8 297.8 ± 7.2 0.66 ± 0.04 
45 256.3 ± 26.2 279.3 ± 5.5 0.91 ± 0.06 235.3 ± 7.2 318.1 ± 19.2 0.66 ± 0.05 
 
 
 
Figure 2.11 SKIE on kH of light and heavy BsDHFR (red and blue respectively) between H2O 
and D2O 
 
An inverse SKIE indicated that the reaction rate is higher in the deuterated solvent 
(Figure 2.11), agreeing with trends seen in EcDHFR, TmDHFR and MpDHFR (113, 
124). The light enzyme has an average SKIE of 0.88 ± 0.04 between 15 and 45 °C, 
whilst heavy BsDHFR has a greater inverse SKIE of 0.71 ± 0.07 over the same 
temperature range. At low temperatures the SKIE increases to above unity for both 
enzymes. The SKIE was measured to be 1.17 ± 0.08 and 1.12 ± 0.07 for the light and 
heavy enzyme respectively. The pKa was measured in D2O at 10, 20 and 35 °C to 
determine whether the observed SKIE was due to a significant change between the 
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light and heavy enzyme at different temperatures (Table 2.10).  The results show no 
significant differences across the temperature range that would explain the sudden 
change in SKIE that is observed at low temperature.  
 
Table 2.10 pKa values for the hydride transfer reaction of light and heavy BsDHFR at 10, 
20 and 35 °C in D2O. 
 pKa 
10 °C 20 °C 35 °C 
Light BsDHFR 6.77 ± 0.0 6.71 ± 0.1 6.76 ± 0.1 
Heavy BsDHFR 6.48 ± 0.1 6.58 ± 0.2 6.62 ± 0.1 
 
The cause for this increase in SKIE for both enzymes is unclear. The "normal" SKIE 
below 15 °C could support the idea of two conformers in equilibrium with each 
other. However, without significant evidence of multiple conformers, this cannot be 
confirmed. In addition to the theories postulated above, a "super heavy" enzyme is 
created when D2O was used as reaction medium, as all the exchangeable hydrogen 
are replaced with deuterium. This increases the mass by a further 1.6%, and could 
contribute to the skewed kinetics observed. Overall further experiments are 
needed to enable full interpretation of the SKIE results that are observed at low 
temperatures for light and heavy BsDHFR. 
 
2.2.4 Current progress on the computational studies of BsDHFR 
Preliminary results accomplished by Moliner and coworkers (unpublished) have 
revealed some insights into the mechanism of the BsDHFR catalysed reaction. 
These preliminary results suggest that temperature dependent deviations in the 
reaction pathway are not the sole cause of the observed hydride KIE trend. There is 
little difference in recrossing coefficient (γ) between 5 and 25 °C, (0.619 and 0.611 
respectively) for the light enzyme. In fact, this difference increases above the 
breakpoint with γ= 0.611 and 0.527 at 25 and 45 °C respectively. This implies that 
the large increase in magnitude of hydride KIE at low temperature stems from 
formation of the reaction coordinate, rather than significant deviations in reaction 
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pathway. This would be expected, as fs vibrations on a global scale, previously 
shown to affect recrossing events (117), are not altered in the measurement of the 
hydride KIE.  Future calculations involving transfer of deuteride will provide further 
insights into the observed affects at low temperature, and elucidate if tunnelling 
coefficients differ significantly above or below the breakpoint. 
The contribution of tunnelling in hydride transfer drops with increasing 
temperature, since the corresponding coefficient (κ) decreases from 4.2 ± 0.5 at 
298 K to 2.9 ± 0.5 at 318 K (Table 2.11). This agrees well with the phenomenon that 
tunnelling is temperature independent, while barrier crossing increases at high 
temperature. Moreover, this parameter remains unaffected by enzymatic isotope 
substitutions and gives essentially identical tunnelling coefficients between light 
and heavy BsDHFR at each examined temperature. The height and/or width of 
barrier crossing is therefore independent of mass-dependent motions of the 
enzyme.  
 
Table 2.11 Preliminary tunnelling (κ) and recrossing (γ) coefficients for hydride transfer in 
light and heavy BsDHFR at 278, 298 and 318 K.  
 
278 K 298 K 318 K 
κ γ κ γ κ γ 
Light BsDHFR 4.2 ± 0.5 0.619 3.5 ± 0.3 0.611 2.9 ± 0.5 0.527 
Heavy BsDHFR 4.2 ± 0.5 0.402 3.5 ± 0.5 0.559 2.9 ± 0.3 0.534 
Calculations performed by Moliner and coworkers (unpublished results) 
 
The reactivity difference between the light and heavy BsDHFR originates from a 
difference in the calculated recrossing coefficients (Table 2.11). At 5 °C, dynamic 
recrossing is enhanced in the heavy enzyme, with γ deviated further from unity 
than that of the light enzyme (γLE = 0.619 vs. γHE = 0.402). However, this difference 
in the recrossing coefficients reduces at 25 oC (γLE = 0.611 vs. γHE = 0.559) and 
essentially diminishes at 45 °C (γLE = 0.527 vs. γHE = 0.534). Studies on isotopically 
labelled EcDHFR-N23PP/S148A have indicated that enhanced femtosecond motions 
Catalysis by G. stearothermophilus DHFR 
 
79 
 
compromised the catalytic efficiency of the enzyme (118). Accordingly, in BsDHFR 
combined experimental and computational results indicate that the coupling 
between fast protein vibrations and the reaction coordinate are enhanced at low 
temperature. However, the exact cause for this interaction has not been identified. 
 
2.3 Conclusion 
13C, 15N, 2H isotopically labelled "heavy" BsDHFR was prepared. The ESI-MS analysis 
showed a mass increase of 10.93%, corresponding to 99.8%% of the non-
exchangeable atoms having been isotopically labelled. Analysis of the tertiary 
structure via CD spectroscopy showed no structural change at 10, 20 and 35 °C, and 
no significant difference between the light and heavy isotopologues at these 
temperatures was observed. This allowed any subsequent conclusions to be based 
on the mass increase of the protein rather than a structural variation between the 
two enzymes. 
Steady state kinetic analysis of light and heavy BsDHFR showed a large enzyme KIE, 
particularly when compared to the previously measured EcDHFR equivalent. This 
can be explained by the greater flexibility of BsDHFR in comparison to its mesophilic 
counterpart. Thus conformational changes that occur on a global scale in the 
protein during the catalytic cycle would cause a large enzyme KIE. The Michaelis 
constants show no effect from the isotope labelling, implying that the enzyme KIE is 
not due to binding interactions. The temperature independence of the enzyme KIE 
suggests that a significant loop movement is not rate determining. It is likely that 
release of DHF or NADP+ is rate limiting, as with other DHFRs, but that a large 
conformational change does not accompany this step.  
The chemical step in light BsDHFR was shown to be biphasic, with a hydride KIE that 
is weakly temperature dependent above 20 °C but becomes strongly temperature 
dependent below this point. This phenomenon has been seen in other thermophilic 
enzymes. This was viewed to be as a result of restricted conformational sampling at 
low temperature, plus the possibility of multiple conformers, the equilibrium of 
which is switched as a consequence of temperature. SKIE results support a potential 
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reaction coordinate change at low temperature, or the existence of multiple 
conformers in equilibrium. The heavy enzyme shows a similar trend in hydride 
transfer and KIE values, implying that the reaction coordinate is also affected by 
mass-dependent protein vibrations. Hence, the observed hydride KIE trend is likely 
affected by numerous factors. Future NMR analysis may divulge evidence, if any, of 
multiple conformers that could exist across the experimental temperature range. 
Preliminary calculations, performed by our collaborators, have highlighted 
differences in the frequency of recrossing between the two isotopologues. A 
significant increase in recrossing events is predicted at low temperature in the 
labelled enzyme, causing the large enzyme KIEH. At high temperatures, the 
recrossing coefficient of light BsDHFR actually deviates further from unity compared 
to the heavy enzyme, explaining the enzyme KIEH trend. As with other labelled 
enzymes, isotopic labelling of BsDHFR has no effect on tunnelling contribution. 
Further computational studies are required to fully determine the specific role that 
these mass-dependent motions play in the case of BsDHFR, particularly during 
deuteride transfer. 
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3 PRODUCTION OF LABELLED NADPH 
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3.1 Preface 
The proposed KIE experiments (see Chapter 1) require the preparation of labelled 
NADPH compounds with heavy isotope atoms incorporated at specific positions of 
the nicotinamide ring. These compounds can be generated via a synthetic pathway 
of the isotopically labelled nicotinamide precursor, followed by an enzymatic 
exchange with thio-NAD+ using NADase (Scheme 3.1) (242-244).  
 
 
Scheme 3.1 A) Chemical synthesis of [4-13C]-nicotinamide (243). Labelled atom indicated 
by *. B) Exchange of nicotinamide with thio-NAD+ to give NAD+, catalysed by NADase. 
 
The synthetic methods for labelling the C2, C4, C5 and C6 positions of the 
nicotinamide ring have been reported (243-247), but these methods are all low 
yielding, thus are prohibitive when expensive, isotopically labelled starting 
materials are used. For example, the most recent reported chemo-enzymatic 
method of [4-13C]-NAD+ synthesis gave a final yield of 0.8%, from a 2%-yield 
pathway of [4-13C]-nicotinamide (243). Moreover, it is rather difficult to label other 
positions of the ring due to the symmetry of the chemical reactions involved and 
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the difficulty in preparing the corresponding labelled starting materials (243). 
Perhaps most importantly, this synthetic method is rather unpractical, as a large 
proportion of the labelled starting material is lost. Hence, a method that can 
produce these isotopologues in high yield, purity and regiospecificity is highly 
desired. 
The biosynthetic pathway of NAD(P)+ is an ideal platform to prepare various 
isotopically labelled compounds for kinetic and NMR studies of the DHFR reaction 
(Scheme 3.2). Previously, the pentose phosphate pathway and NAD+ salvage 
pathways were employed to incorporate heavy isotopes into the ribose and 
adenosine moieties by feeding 3H and/or 14C-labelled glucose and ATP as starting 
materials (Figure 3.1) (248). The nicotinamide moiety however has never been 
labelled, with the exception of commercially available [1-15N]-nicotinamide, 
because the de novo NADP+ biosynthetic pathway was omitted in the reported 
method (248). Enzymes, including quinolinate synthetase, L-aspartate oxidase, 
quinolinate phosphoribosyltransferase and NAD kinase, are needed in order to label 
the nicotinamide ring. Given that all of these enzymes have been biochemically 
characterised (200, 201, 208, 211, 216, 217, 249, 250), it presented an excellent 
opportunity to develop a synthetic biology approach to synthesise NADPH 
containing heavy isotope labels at specific positions in the nicotinamide ring.  
 
Figure 3.1 Labelled NAD+ produced from (248). Labelled atom indicated by *. 
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Scheme 3.2 de novo NADP+ biosynthesis pathway from E. coli. 
 
3.2 Production and purification of NADP+ biosynthesis enzymes 
3.2.1 PCR amplification and expression vector production 
The six de novo NADP+ biosynthesis genes involved in the NADP+ salvage pathway 
were amplified from chromosomal E. coli DNA by PCR. Primers were designed to be 
complementary to gene sequences found in the Genbank® database, and in all 
cases the sequence from E. coli K-12 substrains were used due to availability of E. 
coli K-12 substrain XL1-Blue in the laboratory. The primers were designed to be 
used with Phusion® high-fidelity polymerase, which necessitated primer melting 
temperatures below 72 °C, and incorporated restriction sites at the beginning and 
end of the target gene to enable further DNA manipulation (Figure 3.2). 
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5’-catatgccgcctcgccgctataa-3’ 
      atgccgcctcgccgctataaccctgacacccgacgtgacgagctgctgga 
acgcattaatctcgatatccccggcgcggtggcccaggcgctgcgggaagatttag
gcggaacag...//...tgctggataacttcgaaacagaacagatgcgcgaagccg
tcaaacgcaccaacggcaaggcgctactggaagtgtctggcaacgtcactgacaaa
acactgcgtgaatttgccgaaacgggcgtggactttatctccgtcggtgcgctaac
taaacacgtacaagcactcgacctttcaatgcgttttcgctaa  
               3’-gctggaaagttacgcaaaagcgattattcgaa-5’ 
 
Figure 3.2 The start and end of the nadC sequence encoding quinolinic acid 
phosphoribosyltransferase (black) and the forward and reverse primers designed for PCR 
amplification (blue). The primers were engineered with restriction sites (underlined) and 
an extra stop codon at the end of the sequence (bold). 
 
The PCR conditions were optimised for each individual gene by performing six 
reactions over a 10 °C temperature gradient that spanned the calculated melting 
temperature. In the case of nadA, nadB, nadC, nadE, and nadK the recommended 
conditions for the Phusion® polymerase were successful (Table 3.1), with the 
exception that initial denaturation was increased to 3 minutes. This was due to the 
fact that chromosomal DNA from a single colony was used as the template, rather 
than purified DNA. Agarose gel electrophoresis was used to visualise the DNA after 
PCR amplification to determine the reaction conditions that produced the highest 
yield of DNA (Figure 3.3). The nadD gene required more reaction cycles, 40 
compared to 35, to produce approximately the same yield as the other genes. 
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Table 3.1 PCR amplification conditions for the NADP+ biosynthesis genes. 
Step nadA nadB, nadC nadD, nadE nadK 
Denaturation 10 s, 98 °C 
Annealing 60 s, 69 °C 60 s, 67 °C 30s, 44.5 °C 30 s, 65 °C 
Extension 45 s, 72 °C 90s, 72 °C 45 s, 72 °C 30 s, 72 °C 
The denaturation, annealing and elongation step was cycled 35 times, except for nadD 
which was cycled 40 times. 
 
 
Figure 3.3 Agarose gel showing the PCR product from the amplification of the nadD gene. 
M = marker, A) - F) nadD PCR amplification reactions at 40 - 50 °C.  
 
The PCR products were ligated into cloning vectors to avoid the need to repeat the 
PCR reaction in the future. The StrataClone PCR cloning vector (Agilent) or the 
pPCR-Script cloning vector (Agilent) were used, as the PCR product could be used 
directly in the ligation reaction without the need for purification. The ligated vector 
was transformed into super-competent E. coli XL1-Blue cells, enabling plasmid to be 
acquired and sequenced (performed by Eurofins) to confirm that the correct gene 
sequence had been amplified during PCR. The cloned genes were then digested 
from the holding vector using the restriction enzymes that corresponded to the 
sequences inserted in the primers, and the target expression vector was also 
digested using the same restriction enzymes. The digests were typically left for 4 
hours at 37 °C per enzyme before the cut vector and gene insert were visualised via 
agarose gel electrophoresis (Figure 3.4) and the digested DNA subsequently 
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purified. The purified vector and gene insert were ligated together using T4 DNA 
ligase over a period of 2 hours at 37 °C before transformation into super-competent 
E. coli XL1-Blue cells. In all cases three ligation reactions were performed per gene 
with varying ratios of vector to insert (1:3, 1:5 and 1:10 vector to gene insert 
respectively).  
 
Figure 3.4 Agarose gel of the undigested pET28a(+) vector. M = marker, U = undigested 
pET-28a vector and D = vector digested with NdeI and HindIII restriction enzymes 
 
The nadA, nadB, nadC, nadD, and nadE genes were ligated into the pET-28a 
expression vector, which contains a T7 promoter for controlling gene expression. E. 
coli BL21 (DE3) strains are an ideal host for expressing these genes, because the 
chromosome contains the gene for T7 RNA polymerase, whose expression is 
regulated by the lac operon and thus allows gene expression to be controlled by 
IPTG. Also, this vector encodes an N-terminal His tag that allows purification of the 
expression products via nickel affinity chromatography. The expression of nadK 
however is controlled by a T5 promoter following ligation into a pNCO expression 
vector, therefore E. coli strain BL21 (DE3) was not needed. This plasmid also 
encodes a C-terminal hisactophilin fusion protein that also allows purification via 
nickel affinity chromatography. To ensure that no mutations had occurred during 
the ligation reactions the ligated vectors were sequenced again (Eurofins) to 
confirm the correct gene sequence before enzyme production and purification. 
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3.2.2 Enzyme production and purification 
The expression vectors containing the nadA, B, C, D and E genes were transformed 
into E. coli BL21 (DE3) and BL21 StarTM(DE3) cells for initial test expressions of the 
target genes. The cells were grown at 37 °C until a OD600 0.6 when IPTG was added 
to give a final concentration of 0.5 mM. Samples were taken after 4 hours, 5 hours 
and overnight at 37 °C before analysis via SDS-PAGE, which showed that E.coli BL21 
StarTM(DE3) cells produced greater amounts of protein than E. coli BL21(DE3) cells. 
All the proteins showed clear expression bands after 4 hours, with the exception of 
nadE where the protein band after expression at 37 °C overnight was clearer (Figure 
3.5). These successful conditions were scaled up for the large scale production (3 L) 
of the target enzymes, with the exception of quinolinate synthetase (section 
3.2.2.1). nadK was cloned into a pNCO expression vector and so E. coli JM101 cells 
were used for protein production. The test expression E. coli JM101 cells were left 
overnight before analysis was performed using SDS-PAGE (Figure 3.5). A clear 
protein band can be seen on the poly-acrylamide gel, showing that the T5 promoter 
that controls the expression of the nadK gene can be used by native E. coli 
polymerases to produce NAD kinase on a larger scale. 
 
Figure 3.5 A) SDS-PAGE showing the test expression of nadK encoding NAD kinase 
overnight (o/n) compared to the point of induction. B) SDS-PAGE showing the test 
expression of nadE encoding NAD synthetase at the point of induction, after 4 hours and 
overnight. M = marker, 0h = time of induction, 4h = four hours after induction and o/n = 
overnight after induction. 
 
Production of labelled NADPH 
 
89 
 
As all the nad genes were cloned into expression vectors containing a his-tag (N-
terminal his-tag and C-terminal hisactophilin fusion protein for pET-28a and pNCO 
respectively) the enzymes resulting from the over-expression were purified via Ni2+-
affinity chromatography. All of the proteins produced were purified under the same 
conditions, with the exception of quinolinate synthetase (section 3.2.2.1). The 
pelleted cells were resuspended in 50 mM Tris, 300 mM NaCl and 20 mM imidazole 
at pH 8, sonicated and clarified via centrifugation before the supernatant was 
applied to Ni2+-resin equilibrated with the same buffer. The column was washed 
with the same buffer to remove any proteins that were weakly bound before the 
target protein was eluted with 50 mM Tris, 50 mM NaCl and 250 mM imidazole at 
pH 8. The supernatant, flow through and elution were collected and samples were 
visualised via SDS-PAGE (Figure 3.6). In all cases the purified protein was shown to 
be >90 % pure, allowing further characterisation of the NADP+ biosynthesis 
enzymes. 
 
Figure 3.6 SDS-PAGE of NAD synthetase purified via Ni2+-affinity chromatography. M = 
marker, S = supernatant, FT = flow through, 1, 2 and 3 = washes and E = elution 
 
3.2.2.1 Quinolinate synthetase production and purification 
Since quinolinate synthetase (QS) contains an oxygen-sensitive iron-sulfur cluster in 
the active site, and is particularly prone to oxidative degradation, a special 
expression and purification method was needed. As with the other genes, nadA was 
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expressed in LB medium in BL21 StarTM(DE3) cells, but these cells also contained the 
pB1282 vector. pB1282 encodes part of the isc operon responsible for Fe-S cluster 
formation in Azotobacter vinelandii (Figure 3.7), a kind gift from Prof. Squire Booker 
at Pennsylvania State University (200). Each of these genes encodes a protein that 
has an important role in Fe-S cluster biosynthesis: iscS encodes a cysteine 
desulfurase, iscU and iscA are scaffold proteins, hscB and hscA are molecular 
chaperones and fdx a ferrodoxin protein. The isc operon components are under the 
control of an arabinose promoter. The plasmid also confers ampicillin resistance, 
enabling selection of colonies containing both the pET-28a and pB1282 from agar 
plates containing both kanamycin and ampicillin. The expression cells were grown 
until an OD600 of 0.3 was reached, when arabinose was added to induce the 
expression of the Fe-S cluster biosynthesis genes followed by the addition of IPTG 
and FeCl3 to induce nadA expression at OD600 0.6. QS was produced on a 6 L scale, 
and cells were frozen before enzyme purification. 
 
 
Figure 3.7 A) Isc operon contained in the pB1282 plasmid. 
 
While the gene was expressed under aerobic conditions, the enzyme needed to be 
isolated in an environment that had low levels of oxygen. A completely anaerobic 
purification protocol was performed in the laboratory of Professor N. Scrutton at 
the Manchester Institute of Biotechnology, using oxygen-free glove boxes for all the 
purification steps. These glove boxes allowed the enzyme to be purified in an inert 
N2 atmosphere, with levels of O2 lower than 8 ppm at all times, thus the integrity of 
the [4Fe-4S] cluster remains undisturbed. The purification method was essentially 
the same as those of other NADP+ biosynthesis enzymes, with the exception that 
HEPES was used to replace Tris, as the primary amine may interfere with the Schiff 
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base formation of iminoaspartate (see below). A desalting column was used instead 
of dialysis to speed up the removal of imidazole from the enzyme solution.  
We also developed a purification protocol in Cardiff University, without the use of a 
glove box. The purified QS was shown to be as active as the one that was purified 
from a completely anaerobic environment (see below). The key to this success was 
to perform the purification in a timely manner. Firstly, the enzyme was purified 
within 60 minutes after the cells were sonicated. A desalting chromatographic 
method, was also used in this process to remove the need for dialysis. To avoid 
degradation of the cofactor, the buffers were thoroughly purged with inert gas, by 
first bubbling N2 for 4 hours and argon for a further 30 minutes. βME was added to 
the buffers to maintain a reducing atmosphere during purification (stronger 
reducing agents, such as DTT and TCEP, cannot be used, as they interfere with the 
binding between the his-tagged protein and the Ni2+-NTA resin). In both purification 
protocols, the resulting enzyme solutions were brown, a general characteristic of 
proteins carrying an intact [4Fe-4S] cofactor (Figure 3.8). 
 
          
Figure 3.8 Aerobically purified QS. A) SDS-PAGE of quinolinate synthetase purified via 
Ni2+-affinity chromatography. B) Pure quinolinate synthetase following purification. M = 
marker, S = supernatant, FT = flow through, 1, 2 and 3 = washes and E = elution 
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3.3 Characterisation of NADP+ biosynthesis enzymes 
The NADP+ biosynthesis enzymes were characterised by various analytical methods. 
Whereas SDS-PAGE analysis allows the characterisation of the denatured monomer 
for each enzyme, size exclusion chromatography was used to verify the native state 
of the protein. CD spectroscopy was employed to determine if all these proteins 
were correctly folded in their native states. Additionally, UV-Vis spectroscopy was 
used to characterise the iron-cluster cofactor of quinolinate synthetase. Activities of 
these enzymes were assayed by UV-Vis spectroscopy where appropriate. 
 
3.3.1 Size-exclusion chromatography 
Size-exclusion chromatography was used to confirm that the native state of each of 
the seven proteins involved in NADP+ biosynthesis was correct. Purified protein was 
loaded onto a Superdex 200 column and compared to a set of known protein 
standards (Figure 3.9), allowing each of the enzymes' quaternary structures to be 
determined. This was done by calculation of the Kav value for each protein using the 
equation below and plotting it against log MW of each standard, 
      
     
     
 
where Vo is the void volume of the column, Ve is the elution volume from the 
column and Vc is the geometric column volume. L-aspartate oxidase and NAMNT 
were both purified as monomers, while QAPRT was shown to be a dimer in the 
native form (Figure 3.9). These findings all support previous studies, providing 
further evidence of the successful production and purification of NADP+ 
biosynthesis enzymes from E. coli (208, 211, 216, 250). QS has previously been 
reported as a mixture of dimer and monomer (201), and in this investigation the 
monomer was the main form present. Contrary to previous studies, NAD 
synthetase appears as a monomer rather than a dimer (217, 249). A possible 
explanation is that insertion of a His-tag at the N-terminal end disrupts the stability 
of the dimer. Nevertheless, since the enzyme was active in the monomeric form, no 
attempt was made to remove the his-tag. Likewise, NAD kinase was purified as a 
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dimer, instead of the hexameric form as previously reported (214), probably 
because of the insertion of the C-terminal hisactophilin fusion protein. Fortunately, 
the purified NAD kinase was shown to be capable of catalysing the phosphorylation 
of NAD+ to NADP+ successfully (section 3.3.4), thus the fusion protein was not 
removed from the kinase.  
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Figure 3.9 A) Standard proteins and the Kav values used to calibrate the size-exclusion 
column. B) - G) Chromatograms of QS (B), LAO (C), QAPRT (D), NAMNT (E), NAD 
synthetase (F), and NAD kinase (G).  
 
3.3.2 Circular dichroism spectroscopy 
CD spectroscopy was performed on each protein to confirm their native folded 
state. CD spectra were measured from 190 to 400 nm in 10 mM potassium 
phosphate buffer at pH 7 and 20 °C. Most of the spectra showed characteristics of 
folded proteins; all of them contained minima at 206 and 222 nm, indicating that 
the proteins are a mixture of α-helices and β-sheets (Figure 3.10). Unfolded 
enzymes have very distinct CD signals with signals close to zero in the far UV region, 
and it is clear that none of the CD spectra obtained show unfolded protein. 
Little information was revealed from the CD spectrum of the QS enzyme. Since the 
[4Fe-4S] cluster absorbs at around 420 nm (see below), CD signal were collected 
from 190 to 500 nm. However, no signal was seen between 400 and 500 nm . This is 
most likely due to the weak molar absorption of the cluster (see below) and the low 
concentration of enzyme required for CD samples. It has also been reported that 
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magnetic CD and UV-Vis spectroscopy are potentially more powerful tools for 
characterising specific Fe-S clusters due to variation exhibited among proteins with 
the same type cluster when using normal CD spectroscopy (251, 252). Moreover, 
signal around 200 nm is generally unreadable because of the presence of the 
reducing agent βME, which is needed to prevent the degradation of the iron-sulfur 
cluster. Thus far, there are no reported CD spectroscopic studies of QS. In order to 
obtain useful information from CD spectroscopy, the sample preparation and 
measurement may need to be performed in a glove box to remove the need of 
βME, potentially allowing a more concentrated sample to be analysed. 
For NAD synthetase and NAD kinase, although their quaternary structures are 
different from those in previous reports (214, 217, 249), the CD spectra of both 
showed characteristics of a folded protein. This further confirmed that it is 
unnecessary to remove the purification tags to enable both enzymes to be active.  
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Figure 3.10 CD spectra of the NADP+ biosynthesis enzymes. A) Quinolinate synthetase, B) 
L-aspartate oxidase, C) quinolinate phosphoribosyl transferase, D) nicotinic acid 
mononucleotide adenylyltransferase, E) NAD synthetase and F) NAD kinase 
 
3.3.3 UV-Vis spectroscopy 
UV-Vis spectroscopy was used to assess the presence of the [4Fe-4S] cluster in QS. 
Unlike in the CD spectroscopic data, the UV-Vis spectrum indicated the presence of 
the [4Fe-4S] cluster, with a moderate absorbance peak at 420 nm (Figure 3.11) 
(252). Since the estimated molar absorptivity (Ɛ420 = 4000 M
-1 cm-1) was relatively 
weak, this may account for the absence of CD signal, which was derived from the 
small difference between the absorbance readings of left and right polarised light. 
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Figure 3.11 UV-Vis spectra of QS showing the absorption at 420 nm of the [4Fe-4S] 
cluster. 
 
3.3.4 Activity assays 
Certain enzymes in the NADP+ biosynthesis pathway can be assayed by UV-Vis 
spectroscopy. The LAO reaction can be followed directly by monitoring the 
formation of FADH2, or indirectly by a coupled assay that consumes the product. On 
the other hand, the NAD kinase reaction can only be followed 
spectrophotometrically by an enzyme-coupled assay. Other enzymes in the NADP+ 
biosynthesis pathway were unable to be assayed by UV-Vis spectroscopy, as assays 
for these reactions are lacking or rely on measuring the release of phosphate 
moieties, a technique that is to prone to false positives. Hence, their activities were 
assessed by purifying and characterising the reaction products via NMR 
spectroscopy and mass spectrometry. 
 
3.3.4.1 L-aspartate oxidase 
The activity of LAO was monitored either directly or indirectly in an enzyme-
coupled assay. In the direct enzyme assay, the reduction of FAD to FADH2 was 
followed by a decrease in absorbance at 450 nm. There is a clear decrease in signal 
upon the addition of LAO to a cuvette containing L-aspartate and FAD in 50 mM 
HEPES at pH 8. However, it was found that oxygen could diffuse into the reaction 
buffer, despite being thoroughly degassed and purged with inert gases, and recycle 
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FADH2 to FAD. The signal therefore returned to the starting absorbance over time 
(Figure 3.12). To circumvent the problem, the reaction was monitored using a 
coupled assay, which uses hydrogen peroxide to oxidise o-dianisidine by the action 
of horseradish peroxidase (Scheme 3.3) (197). The oxidised product in the coupled 
assay can be monitored by an increase in absorbance at 436 nm. When adding LAO 
to a cuvette containing L-aspartate, FAD, horseradish peroxidase and o-dianisidine, 
there was clear increase in absorbance at 436 nm (Figure 3.12). These assays 
together showed that the purified LAO is active. 
 
Scheme 3.3 HRP coupled assay to monitor LAO activity. 
 
 
 
Figure 3.12 A) UV-Vis spectrum of direct LAO activity assay. B) UV-Vis spectrum of the 
HRP coupled assay when LAO is added (red) compared to no enzyme (blue). 
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3.3.4.2 NAD kinase 
The activity of NAD kinase was monitored by another photometric coupling assay 
(Scheme 3.4), which converts NADP+ to NADPH by Thermoanaerobacter brockii 
alcohol dehydrogenase (TbADH) (253). In a cuvette containing NAD+, ATP, TbADH 
and isopropanol, the enzyme NAD kinase was added and absorbance at 340 nm was 
monitored by a UV-Vis spectrometer. The production of NADPH was indicated by 
the increase of absorbance and verified that the purified kinase was active (Figure 
3.13) 
 
Figure 3.13 Chromatogram showing the conversion of NADP+ to NADPH upon addition of 
NAD kinase (red), and when no enzyme (blue) is added to the assay. 
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Scheme 3.4 NAD kinase/TbADH coupled assay. The production of NADPH can be 
monitored at 340 nm. 
 
3.4 Unlabelled NADP+ biosynthesis 
To verify if the biosynthetic pathway of NADP+ can be reconstituted in the 
laboratory, the reaction conditions for each of the recombinant enzymes was 
systematically characterised. This optimised these enzymes for maximal activity. 
Starting from unlabelled glucose, we managed to obtain NADP+, and subsequently 
the reduced form NADPH (~2% yield). 
3.4.1 Quinolinic acid biosynthesis 
In E. coli L-aspartate is oxidised by the action of LAO to iminoaspartate, which then 
condenses with dihydroxyacetone phosphate (DHAP) in the QS reaction to generate 
quinolinate (QA). In the laboratory the LAO reaction was actually omitted (section 
3.3.4, Table 3.2), though it was demonstrated to be active. This is because 
formation of iminoaspartate can be achieved by condensing oxaloacetate and 
ammonium chloride in a simple Schiff's base forming reaction (Scheme 3.5) (198). 
In turn, to obtain DHAP commercially available aldolase and triose phosphate 
isomerase (TIM) were used, with fructose-1,6-bisphosphate as substrate. 
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Scheme 3.5 In situ production of iminoaspartate from oxaloacetate and ammonia 
 
Initially, much effort was made to optimise the synthesis of QA. Numerous reaction 
conditions were tested by varying different concentrations of substrate, enzymes, 
and pH as well as the reaction buffers (Table 3.2). It was only when a relatively large 
amount of QS (80 μM) was used that the product was able to be purified from the 
reaction. The yields were determined by comparing the area of the product peak to 
known concentrations of QA (Figure 3.14). QS purified with or without the use of a 
glovebox gave essentially identical yield (46% and 48% respectively). Hence, we 
concluded that this enzyme could be purified without a glove box. As a matter of 
fact, this finding supports earlier literature, in which aerobic techniques were used 
to purify active QS (196, 198, 202, 254). Furthermore, production of iminoaspartate 
by either the LAO reaction or the Schiff's base condensation gave identical yield of 
QA (45%). This therefore implies that the QS reaction is the limiting factor. 
Table 3.2 Conditions tried during the optimisation of QA biosynthesis. 
[QS]  
μM 
Anaerobic/ 
Aerobic 
[LAO] 
μM 
[Aspartate] 
μM 
[OAA/NH4Cl] 
μM 
pH Time Yield % 
5 Aerobic 20  - 8 6 h - 
10 Aerobic 20  - 8 24 h - 
10 Aerobic -  20 8 24 h - 
25 Anaerobic -  20 8 48 h 8 
50 Anaerobic -  20 8 48 h 22 
80 Anaerobic -  20 8 48 h 46 
80 Aerobic 20  - 8 48 h 38 
80 Aerobic -  20 8 48 h 48 
 
Next, we expanded the biosynthetic pathway of QA by feeding unlabelled glucose 
as the starting material (Scheme 3.6). Glucose is desired, because the 
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corresponding 13C and/or 2H-labelled isotopologues are readily available at 
reasonable prices; thus, isotope labelling of quinolinate at the C4, C5 and C6 
positions becomes accessible. Three commercially available enzymes, hexokinase, 
phosphoglucoisomerase and phosphofructokinase, are required to convert glucose 
to fructose-1,6-bisphosphate. 
 
Scheme 3.6 Biosynthesis of QA from glucose using the glycolysis enzymes. 
 
Following an overnight incubation of these enzymes with glucose, QA was 
generated by adding aldolase, TIM, QS, oxaloacetate and ammonium chloride into 
the mixture. Although the reaction was successful (Figure 3.14) the additional steps 
resulted in a decreased yield (5% yield from glucose vs. 45% from fructose-1,6-
bisphosphate). The addition of glycolysis enzymes appeared to decrease the 
reaction yield extensively. For future studies, it might be ideal to obtain these 
enzymes by recombinant techniques and optimise each of them in order to 
increase the yield of QA. The purified QA was analysed via 1H-NMR spectroscopy 
(Figure 3.15), with two doublets corresponding to the C4 and C6 protons at 8.1 and 
8.5 ppm respectively, and a triplet (C5 proton, 7.5 ppm) in the aromatic region. 
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Figure 3.14 A) Chromatogram showing purification of QA from anaerobic QS reactions 
using enzyme concentrations of 25 μM (blue), 50 μM (red) and 80 μM (black). B) 
Chromatogram showing purification of QA from aerobic QS reactions starting with 
glucose (red) and fructose-1,6-bisphosphate (blue). C) Standards used to calculate yield of 
QS reactions.  
 
Figure 3.15 1H-NMR spectrum of QA (300 MHz, D2O) 
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3.4.2 Nicotinic acid mononucleotide biosynthesis 
Once QA could be prepared enzymatically, we focused on introducing this 
compound into the NADP+ biosynthetic pathway. This can be achieved by reacting 
phosphoribosyl pyrophosphate (PRPP) with QA in the QAPRT reaction to form 
nicotinic acid mononucleotide (NAMN). In turn, PRPP can be produced in situ from 
ribose-5-phosphate (R5P) using PRPP synthetase (Scheme 3.7), which was 
expressed as a his-tag recombinant protein from a vector kindly provided from 
Professor Jamie Williamson at The Scripps Research Institute (255).  
 
 
Scheme 3.7 In situ production of PRPP and the subsequent QAPRT catalysed reaction. 
 
It has been reported that PRPP synthetase requires a high concentration of 
phosphate buffer to function, therefore the reaction was performed using KiPO4 (50 
mM, 20 mM MgCl2, 50 mM KCl, pH 7) (256, 257). The reaction was driven to 
completion by using a threefold excess of R5P and the addition of myokinase, PK 
and PEP to recycle the ATP. The reaction was performed at 37 °C for 3-4 hours 
before purification via anion-exchange chromatography (Figure 3.16). Reverse 
phase HPLC was also performed using a C18 column, but no separation could be 
achieved. On the other hand, even though NAMN does not bind to the anion-
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exchange column, the other reagents, including QA, AMP, ADP and ATP, do and 
elute at a later time. Hence, anion-exchange chromatography was preferred to 
'semi-purify' NAMN for subsequent enzymatic reactions. 
 
Figure 3.16 Chromatogram showing the purification of NAMN via SAX. The peaks are 
labelled with their corresponding product/reactant. 
 
NAMN was characterised by 1H-NMR spectroscopy (Figure 3.17). The ribose moiety 
is indicated by the following signals, including: the distinct doublet at 6 ppm that 
corresponds to the anomeric proton, a two-proton multiplet at 4.4 ppm that 
corresponds to 5'-Hs, as well as the one-proton multiplets at 4.3, 4.0 and 3.8 ppm 
that accounts for the 2'-, 3'- and 4'-Hs. The nicotinic acid ring is evident by the four 
proton signals found in the aromatic region (8-10 ppm). A combination of two 
doublets and one triplet are characteristic coupling pattern among the 
neighbouring protons at the C4, C5 and C6 positions. Most importantly, the singlet 
signal for the C2 proton at 9.1 ppm confirms the activity of QAPRT, since the 
starting material needs to be decarboxylated at the corresponding position in order 
to yield the product. Lastly, ESI-MS was also used to analyse the product peak from 
the QAPRT reaction. Since NAMN has a positively charged nicotinamide ring, the 
peak at 335.94 m/z corresponds to the (M+0) state of the compound (Figure 3.18).  
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Figure 3.17 1H-NMR spectrum of NAMN (300 MHz, D2O) 
 
 
Figure 3.18 ESI-MS of NAMN 
 
3.4.3 Nicotinic acid adenine dinucleotide biosynthesis 
The adenosine moiety of NADP+ originates from ATP, which is introduced to the 
biosynthetic pathway under the action of NAMNT. This enzyme converts the 
intermediate NAMN to nicotinic acid adenine dinucleotide (NAAD), consuming one 
equivalent of ATP during the reaction.  
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Scheme 3.8 NAMNT catalysed addition of adenosine to NAMN. 
 
Similar to the QAPRT reaction, an excess of ATP was used to drive the reaction 
towards completion. However, this led to difficulty in purifying NAAD, because it 
was co-eluted with ATP in the C18-HPLC run. Even though a reasonably shallow 
gradient was used (0.5% increase of acetonitrile per minute), separations between 
these compounds still could not be resolved. To solve this problem, the mixture was 
first semi-purified by anion-exchange chromatography to which ATP binds more 
tightly than NAAD. The starting material NAMN and NAAD were eluted in the void 
volume, and they were consequently separated by HPLC (Figure 3.19). The reaction 
does not seem to reach completion even in the presence of excess ATP. 
Nevertheless, the starting materials were always recycled for additional adenosine 
addition reactions. 
 
Figure 3.19 Chromatogram showing NAAD purification via HPLC 
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The 1H-NMR spectrum of NAAD revealed signals that originate from the adenosine 
moiety (Figure 3.20). These include the additional anomeric proton signal at 6 ppm 
as well as the 'duplicated' multiplets at 4-4.5 ppm. Moreover, in the aromatic 
region, there are two new singlet peaks at 8 and 8.3 ppm, which originate from the 
two protons in the adenine base. In the ESI-MS analysis, the m/z peak of 665.02 
matches well with the calculated MW of this compound (MW = 665.10, Figure 
3.21). 
 
Figure 3.20 1H-NMR spectra of NAAD (300 MHz, D2O) 
 
An attempt to carry a one-pot conversion from QA to NAAD was made. However, 
there was no evidence of NAAD being synthesised. In fact, there was no report 
regarding this one-pot reaction. It is suspected that one or both of the participating 
enzymes QAPRT and NAMNT were inhibited by an intermediate. 
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Figure 3.21 ESI-MS of NAAD (MW = 665.10) 
 
3.4.4 NAD+ biosynthesis 
The subsequent step in the biosynthetic pathway introduces an ammonia group 
into the nicotinic acid moiety of NAAD to yield NAD+ (Scheme 3.9). Two classes of 
NAD synthetase exist in nature; both of which require ATP for catalysis, but one 
class is glutamine-dependent while the other is ammonia-dependent (213). The E. 
coli enzyme is preferred, as it utilises ammonia instead of glutamine as the source 
of nitrogen (258). Hence, it will facilitate 15N-labelling of the amide group for future 
experimental use from the significantly cheaper and readily available 15NH4Cl. This 
E. coli enzyme was reported to be inhibited by the previous intermediates of the 
reaction pathway (248), therefore no attempt was made to carry out the one-pot 
reaction. In a potassium buffer solution (50 mM, 20 mM MgCl2, 50 mM KCl, pH 7), 
NAD synthetase was added with 2 equivalents of ATP and ammonium chloride. As 
shown in the HPLC trace, the peak corresponding to NAAD decreased as the 
reaction progressed, indicating that the starting material was consumed (Figure 
3.22).  
 
Scheme 3.9 Reaction catalysed by NAD synthetase 
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Figure 3.22 Chromatogram showing NAAD (red) and NAD+ (blue) purification via HPLC 
 
The 1H-NMR spectrum of NAD+ highly resembles to that of NAAD. This is not 
surprising because of their structural similarity (Figure 3.23). However, all of the 
aromatic signals in NAD+ were slightly shifted downfield by 0.25 ppm. This agrees 
with previous studies on NAD synthetase activity (259). The ESI-MS analysis showed 
a positive molecular ion peak at 664.12, confirming the introduction of an amide 
group (calculated MW is 664.12 for NAD+ vs. 665.10 for NAAD, Figure 3.24)  
 
Figure 3.23 1H-NMR spectrum of NAD+ (500 MHz, D2O) 
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Figure 3.24 ESI-MS of NAD+ 
 
Even though our research goal was to synthesise isotopically labelled NADPH, many 
enzymology models, such as lactate dehydrogenase, employ NADH as cofactor. It is 
therefore worthwhile to verify if NADH can be made using this biosynthetic 
pathway, and yeast alcohol dehydrogenase (yADH) was chosen to reduce NAD+ to 
NADH using ethanol as the hydride source (260). The purified NAD+ was reacted 
with yADH for 1 hour in 50 mM KiPO4, 50 mM KCl before subjecting it to anion-
exchange chromatographic separation. Elution of NADH could be readily identified, 
as it is the only compound that absorbs strongly at 340 nm (Figure 3.25).  
Furthermore, the ESI-MS showed a (M-H)- peak at 664.31 m/z (calculated MW is 
665.13, Figure 3.26). 
 
Figure 3.25 Chromatogram showing elution of NAD+ (blue, 260 nm and red, 340 nm) and 
NADH (green, 260 nm) from the anion-exchange column. 
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Figure 3.26 ESI-MS of NADH (calculated MW 665.13). 
 
3.4.5 NADP+ and NADPH biosynthesis 
With the use of NAD kinase, a phosphate group is added onto NAD+ to yield NADP+. 
This enzymatic reaction was performed in KiPO4 buffer (50 mM, 50 mM KCl, pH 7), 
supplemented with 20 mM of the cofactor MgCl2 and an excess of ATP (3 
equivalents). After 3 hours incubation at 37 oC, the crude reaction was loaded onto 
anion-exchange chromatography column, and the product NADP+ was eluted 
before ADP and ATP. Similarly, the product 1H-NMR spectrum is reminiscent of the 
NAD+ and NAAD spectra. The downfield shift of the 2''-H signal (5 ppm) is caused by 
the introduction of a strongly electron-withdrawing phosphate group. 
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Figure 3.27 1H-NMR spectrum of NADP+ (500 MHz, D2O). 
 
Finally, we obtained our final product NADPH (or NADPD) via a hydride transfer 
reaction that is catalysed by a thermophilic ADH from Thermoanaerobacter brockii 
(TbADH). In this reaction, 2-propanol (or 2H8-2-propanol) serves as the hydride 
source for reducing NADP+ (253). The reaction product was also purified via anion-
exchange chromatography and identified by its characteristic absorbance at 340 
nm. Because NADPH elutes at the same concentration of salt as ATP does, it is more 
practical to perform stepwise reactions rather than a one-pot biosynthesis from 
NAD+ to NADPH. 
 
3.5 Labelled NADPH biosynthesis 
Since we had successfully synthesised NADPH by feeding simple starting materials 
into the biosynthetic pathway, we then focused on generating isotopically labelled 
products. As the DHFR reaction centres at the nicotinamide group of NADPH, 
isotopic labels will be incorporated into this functionality by synthesising 15N and 
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13C-labelled quinolinic acid. In this thesis, commercially available 15NH4Cl and [1,6-
13C2]-glucose were used for heavy isotope labelling.  
 
3.5.1  [4-13C]-QA and [1-15N]-QA biosynthesis 
This first goal was to introduce a 13C label into C4 of QA, at which hydride transfer 
happens in the DHFR reaction. This can be established by feeding [1-13C]-
dihydroxyacetone phosphate ([1-13C]-DHAP) into the biosynthetic pathway of 
NADP+. In turn, this labelled starting material could be made using the glycolysis 
pathway. Due to the symmetrical production of DHAP in this pathway, both the C1 
and C6 position of glucose need to be labelled (Figure 3.28), thus [1,6-13C2]-glucose 
was converted to [4-13C]-QA by the simple one-pot method, as described in Section 
3.4.1.  
 
Figure 3.28  [1,6-13C2]-glucose and the subsequent labelled [1-
13C]-DHAP and [4-13C]-QA. 
13C isotope represented by the *. 
 
Three reactions were performed using separate batches of freshly purified QS to 
convert a total of 100 mg labelled glucose to QA, and the product from each trial 
was pooled and purified via HPLC. In the 1H-NMR spectrum of [4-13C]-QA, the 
doublet corresponding to the C4-H further splits into a doublet of doublets, due to 
direct coupling to the adjacent 13C atom (Figure 3.30). Also, the 13C-NMR spectrum 
showed a single peak corresponding to the C4 position at 137 ppm that was verified 
by comparing it to a standard 13C-spectrum of unlabelled QA (Figure 3.29). There 
were no other signals originating from QA, indicating that the label was 
incorporated specifically into the C4 position, although a small impurity was present 
as indicated by the peak at 185 ppm. The overall yield of [4-13C]-QA synthesis was 
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1%, slightly lower than that of the unlabelled one (5% yield). It is possible that some 
of the commercial enzymes had become less active over time, thereby contributing 
to the lower yield. In the future, freshly prepared recombinant enzymes will be 
employed to maximise the yield.  
 
Figure 3.29 13C-NMR spectra of [4-13C]-QA and unlabelled QA (150 MHz, D2O) 
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Figure 3.30 1H-NMR spectrum of [4-13C]-QA (600 MHz, D2O) 
 
Another isotopologue of QA was made by incorporating a 15N label into the 
aromatic ring. 15N-iminoaspartate was prepared chemically by condensing 
oxaloacetate with 15NH4Cl, and it is reacted with DHAP in the QS reaction to 
generate [1-15N]-QA. As the early glycolysis enzymes are not needed to synthesise 
this isotopologue, most of the starting materials were retained, and a final yield of 
36% was achieved after HPLC purification. The 1H-NMR spectrum of 15N-QA showed 
three peaks in the aromatic region as expected. Furthermore, all of them showed 
additional splitting, due to the coupling with the 15N atom (Figure 3.31). Likewise, 
there are two doublets (123 and 148 ppm) in the 13C spectrum, because the C2 and 
C6 couple to the neighbouring 15N nucleus (Figure 3.32). Lastly, a single sharp peak 
appears in the 15N-NMR spectrum of the 15N-QA (Figure 3.33) as anticipated. 
Despite the success in [1-15N]-QA synthesis, [1-15N]-NADPH has not been made yet, 
as this isotopic label is fairly distant from the reaction centre with regards to the 
DHFR reaction. Hence, kinetic studies were focused on [4-13C]-NADPH (see Chapter 
4). Nevertheless, these experimental results together prove that any position of the 
quinolinic acid can be labelled with heavy atom by using the de novo biosynthetic 
pathway. 
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Figure 3.31 1H-NMR of 15N-QA  (600 MHz, D2O) 
 
Figure 3.32 13C-NMR of 15N-QA (150 MHz, D2O) 
 
Figure 3.33 15N-NMR spectrum of 15N-QA (60 MHz, D2O) 
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3.5.2  [4-13C]-NAD+ biosynthesis 
[4-13C]-QA was converted to [4-13C]-NAD+ using the enzymatic reactions that were 
tested with the unlabelled reactants earlier (section 3.4). A ribose group was added 
in the QAPRT reaction to yield [4-13C]-NAMN. After anion-exchange 
chromatography purification, the intermediate transformed into [4-13C]-NAAD in 
the NAMNT reaction. The 1H-NMR spectrum of the HPLC-purified [4-13C]-NAAD 
showed evidence of direct coupling between the 13C and 1H atoms at the 4-position, 
giving a measured J constant of 160 Hz, whilst other signals remain identical to 
those of the unlabelled one (Figure 3.34). 
 
Figure 3.34 1H-NMR spectrum of [4-13C]-NAAD (500 MHz, D2O). 
 
Next, [4-13C]-NAD+ was made in the NAD synthetase reaction and was purified by 
HPLC. Similarly, the signature 13C-1H coupling was observed in the 1H-NMR 
spectrum (J = 185 Hz, Figure 3.35). ESI-MS analysis of [4-13C]-NAD+ showed an 
molecular ion peak at 665 m/z, showing an increase of one a.m.u. from that of the 
unlabelled compound (Figure 3.36). These data together strongly supports the 
conclusion that [4-13C]-NAD+ was successfully synthesised from [4-13C]-QA. To 
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further confirm its chemical structure, a small amount of the labelled product was 
incubated with yADH. This enzyme readily catalyses the hydride transfer and 
generate [4-13C]-NADH, as indicated by absorbance reading at 340 nm. The yield of 
[4-13C]-NADH was estimated by absorbance reading (Ɛ340 = 6220 M
-1 cm-1), and 
approximately 41% of [4-13C]-QA was converted to product. This is comparable to 
other reported yields for enzymatic NAD+ biosynthesis that utilise the NAD+ salvage 
pathway to produce unlabelled NAD+ (261). 
 
Figure 3.35 1H-NMR spectrum of [4-13C]-NAD+ (500 MHz, D2O) 
 
 
Figure 3.36 ESI-MS of [4-13C]-NAD+ 
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3.5.3 [4-13C]-NADPH and [4-(R)-2H,4-13C]-NADPH biosynthesis 
[4-13C]-NADPH synthesis was accomplished by first phosphorylating [4-13C]-NAD+ in 
the NAD kinase reaction and then transferring a hydride/deuteride in the following 
TbADH reaction. The purified [4-13C]-NAD+ was reacted with excess ATP and the 
NAD kinase before purification via anion-exchange chromatography. A considerable 
amount of labelled material was lost (60%) during the phosphorylation reaction. It 
was not clear the cause of this likely hydrolysis, as it was not observed when 
unlabelled substrate was used.  
Nevertheless, enough product could be isolated for basic NMR and MS analysis. The 
1H-NMR spectra shows the characteristic 13C-1H coupling at the 4-position, as well 
as the downfield shift of 3''-H signal to 5 ppm as a result of phosphate addition 
(Figure 3.37). The ESI-MS shows a M-2 ion peak of 743 m/z, corresponding to the 
negatively charged molecular ion (Figure 3.38). As there is one a.m.u. increase from 
the molecular ion peak of the unlabelled NADP+, it implies that a 13C atom has been 
successfully incorporated into this compound. Unfortunately, the 13C-NMR spectra 
only showed one singlet at 160 ppm, which derives from the contaminant 
ammonium carbonate, and the expected doublet for 4-13C seems to be 
overshadowed even after multiple scans were collected due to the loss of material 
during the reaction.  
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Figure 3.37 1H-NMR spectrum of [4-13C]-NADP+ (600 MHz, D2O) 
 
 
Figure 3.38 ESI-MS spectrum of [4-13C]-NADP+ (MW 745) 
 
To generate useful compounds for DHFR studies, the labelled NADP+ was reduced 
to [4-13C]-NADPH and [4-(R)-2H,4-13C]-NADPH with TbADH serving as the catalyst. 
Isopropanol or its deuterated isotopologue (2H8-isopropanol) were used as 
substrate. The reaction was followed by absorbance reading at 340 nm and the 
products were purified by anion-exchange chromatography. Due to the low yield 
from the previous NAD kinase reaction, the concentration of the protiated product 
[4-13C]-NADPH was too low to be characterised by NMR spectroscopy. On the other 
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hand, a reasonably clear 1H-NMR spectrum of the deuterated product [4-(R)-2H,4-
13C]-NADPH was collected, and it showed that signals of the oxidised nicotinamide 
ring has disappeared (Figure 3.39). Instead, evidence for deuteride transfer has 
become prominent. These include the new singlet at 7 ppm, which corresponds to 
the C2-H of the reduced nicotinamide ring, as well as the doublet of broad peaks at 
2.67 ppm (13C-1H J = 60 Hz), which represents the (S)-hydrogen at the C4 position. 
The hydrogen signal at 2.76 ppm that is found in unlabelled NADPH could not be 
seen, indicating that the pro-(R) hydrogen at the C4 position has been replaced. The 
ESI-MS also confirmed the reduction of NADP+ by TbADH, as the negative (M-H)-1 
peak at 745.15 is one a.m.u. higher than the unlabelled analogue (Figure 3.40). 
 
Figure 3.39 1H-NMR spectrum of [4-13C]-NADPD (600 MHz, D2O) 
 
 
Figure 3.40 ESI-MS of [4-13C]-NADPH (MW = 746.09) 
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3.5.4 [amino-15N]-NAD+ 
Compared to the 13C-labelled NADPH, preparation of the [amino-15N]-NAD+ is 
relatively simple and only requires the use of 15NH4Cl in the NAD synthetase 
reaction. 1H-NMR spectrum of the HPLC-purified product is identical to that of 
unlabelled NAD+. However, the 15N-NMR spectrum shows a single peak at 200 ppm, 
signifying the incorporation of 15N (Figure 3.41, free 15NH4Cl in solution produces a 
peak at 20 ppm). The ESI-MS shows a molecular ion peak of 665.05, agreeing well 
with molecular weight of this inherently positive compound (MW 665.10, Figure 
3.42). Although this ESI-MS data is extremely similar to that of the starting material 
NAAD (M+1 = 665 m/z), all of these analytical characterisations together (1H-NMR, 
15N-NMR and HPLC analysis) indicate that the enzymatic reaction was successful. 
Lastly, since yADH was able to transform this compound to [amino-15N]-NADH, it 
further confirms the chemical structure of [amino-15N]-NAD+. 
 
Figure 3.41 15N-NMR spectrum of [amino-15N]-NAD+ (50 MHz, D2O) 
 
 
Figure 3.42 ESI-MS of [amino-15N]-NAD+ 
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3.6 Conclusions 
In summary, the E. coli de novo NADP+ biosynthetic pathway has been reconstituted 
in the laboratory. The six E. coli enzymes involved in NADP+ biosynthesis were 
successfully cloned and purified, and together they could synthesise the desired 
isotopically labelled cofactors. This allows a one-pot synthesis of selectively labelled 
quinolinic acid. This is exemplified by the production of 15N-QA and [4-13C]-QA. As 
demonstrated in this chapter, [4-13C]- and [amino-15N]-NAD+ as well as [4-13C]-
NADP+ were prepared accordingly. To the best of our knowledge, this is the first use 
of the de novo biosynthetic pathway to synthesise isotopically labelled NAD+ and 
NADP+. Commercially available 13C-aspartate (instead of 13C-glucose) would enable 
the labelling of the C2, C3 and the carbonyl group positions around the ring in the 
future using this method developed here. This finding is particularly exciting, as this 
work indicates that a large variety of NADPH isotopologues can be made, with 
heavy atom labelled at any desired location. In turn, these compounds have 
numerous applications in enzymology studies, most notably for KIE and NMR 
studies.
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4 ANALYSIS OF THE DHFR REACTION COORDINATE  
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4.1 Preface 
Kinetic isotope effect studies have been used to probe the nature of the hydrogen 
transfer in enzymatic reactions. In the DHFR reaction, the pro-R hydride at the C4 
position of the nicotinamide ring is transferred to DHF, and primary hydrogen KIE 
measurements were performed by employing cofactor that carries a deuterium (or 
tritium) label at this position (87, 88). Homologues from different species, including 
the mesophile E. coli (EcDHFR) and psychrophilic M. profunda (MpDHFR) (113) as 
well as the thermophiles G. stearothermophilus (BsDHFR) (132) and T. maritima 
(TmDHFR) (120), have been tested. While the chemistry of hydride transfer has 
become well-characterised by this method, our understanding on enzyme catalysis 
can be enormously advanced by measuring KIEs with isotopologous cofactors that 
carry label(s) in the other positions of the nicotinamide ring. These alternative 
experiments include: α-secondary (2o) hydrogen KIE measurements, which employ 
cofactor that carries a deuterium label at the pro-S position, and heavy atom KIE 
measurements, which use 13C-labelled cofactor. Results derived from these 
measurements can provide insightful details regarding the impact of hybridisation 
change upon hydride transfer. Accordingly, in combination with the primary KIE 
data, the short-lived transition state can be precisely illustrated at an atomic scale. 
Perhaps most importantly, this fundamental knowledge will help in unravelling the 
role of protein dynamics in enzyme reactions, and specifically to the controversial 
existence of "promoting motions", an area of research that is thought to be 
essential to our understanding of the immense catalytic power of enzymes.  
Eyring first proposed the idea of an activated complex that is formed during enzyme 
catalysis. Whilst this has long been accepted, analysis of this activated complex (i.e. 
the transition state) remains difficult. Transition state theories (TST), including the 
Bell tunnelling correction, were found to be inadequate to explain complex enzyme 
systems, particularly those involving quantum mechanical tunnelling. This has led to 
more complex models, including variational TST and Marcus-like models (see 
Introduction for a more detailed explanation). In the case of DHFR, if the enzyme 
has evolved to promote hydride transfer by modifying the barrier width, these non-
statistical motions likely act via the neighbouring atoms, such as the C4 and the pro-
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S hydride, in order to narrow the donor-acceptor distance (DAD). To verify the 
proposed existence of these "promoting motions", it is of great interest to analyse 
the role of these atoms in the transition state of hydride transfer. 
The 2° KIE was previously determined for TmDHFR at pH 7 (155), whereas for 
EcDHFR this parameter was only determined at pH 9, where hydride transfer is 
mostly rate-limiting and the authors could measure this parameter by a competitive 
KIE method. However, it is desirable to measure this parameter under 
physiologically relevant conditions, as it permits characterisation of the transition 
state most resembling that in its natural environment. Even though the magnitude 
of 2o KIE is generally small (1.05-1.20), we perceived that this parameter can be 
measured by direct comparison using a pre-steady state stopped-flow setup, 
because this method can distinguish rates that are differed by only ~3% (153, 155). 
Similarly, 13C heavy atom isotope effects can be measured by the same method, 
when this parameter is above 1.03-1.04. We believed that the 13C KIE parameter 
would likely be higher than this value (at least at low temperature), as quantum 
mechanical tunnelling dominates in the DHFR reaction (87, 88, 240). In addition to 
the factors mentioned above, 13C heavy atom KIE measurement has never been 
reported in the studies of DHFR, likely because of the inherent difficulties in 
preparing [4-13C]-NADPH.  
Here, we report the α-secondary hydrogen KIEs for EcDHFR, MpDHFR and BsDHFR 
measured under physiologically relevant conditions. Also, we report the first 13C KIE 
measurement on the hydride transfer step catalysed by EcDHFR. These results shed 
light onto the mechanism of the DHFR reaction. 
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4.2 Results and Discussion 
4.2.1 α-secondary hydrogen kinetic isotope effects 
2° KIEs were measured between NADPH and (S)-NADPD at pH 7 for EcDHFR as well 
as the extremophiles MpDHFR and BsDHFR. The labelled cofactor was prepared 
based on the method developed by Ottolina and coworkers (262), which uses 
glucose dehydrogenase to introduce a deuterium label into the si face of the C4 in 
NADP+ (Scheme 4.1).  
 
 
Scheme 4.1 Synthesis of (S)-[2H]-NADPH from NADP+ and [1-2H]-glucose through the 
action of glucose dehydrogenase. 
 
These parameters were measured using a stopped-flow setup, which monitored the 
decrease in FRET signal. Since the C4 position of NADPH changes from sp3 to sp2 
hybridisation during catalysis, a normal secondary KIE over 1 was expected (see 
Introduction for more details). The average 2° KIE values were evaluated to be 
1.044 ± 0.01 for MpDHFR, 1.058 ± 0.02 for EcDHFR and 1.048 ± 0.02 for BsDHFR 
(Table 4.1, Figure 4.1). At 10 °C, the 2° KIE for BsDHFR contains a relatively large 
error (1.092 ± 0.054), likely due to the poor signal-to-noise ratio in the FRET 
measurement (see Chapter 2. For future reference, we will likely perform the 
experiment again by measuring the decrease of absorbance at 340 nm.). 
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Table 4.1 Temperature dependence of α-secondary hydrogen KIEs for Mp, Ec, Bs and 
TmDHFR at pH 7. 
T (°C) MpDHFR EcDHFR BsDHFR TmDHFRA 
5 1.040 ± 0.010 1.066 ± 0.020 - 1.068 ± 0.003 
10 1.040 ± 0.031 1.055 ± 0.028 1.092 ± 0.054 1.063 ± 0.010 
15 1.055 ± 0.018 1.059 ± 0.033 1.044 ± 0.016 1.064 ± 0.007 
20 1.036 ± 0.025 1.083 ± 0.031 1.044 ± 0.021 1.032 ± 0.009 
25 1.037 ± 0.023 1.049 ± 0.012 1.037 ± 0.015 1.072 ± 0.007 
30 1.059 ± 0.006 1.060 ± 0.043 1.037 ± 0.029 1.056 ± 0.006 
35 - 1.033 ± 0.013 1.053 ± 0.027 1.043 ± 0.005 
40 - - 1.049 ± 0.027 1.054 ± 0.007 
45 - - 1.045 ± 0.021 1.040 ± 0.013 
50 - - 1.032 ± 0.009 1.049 ± 0.018 
55 - - - 1.040 ± 0.040 
60 - - - 1.032 ± 0.014 
Average 1.044 ± 0.01 1.058 ± 0.02 1.048 ± 0.02 1.052 ± 0.02 
A Values taken from ref (155) 
 
 
Figure 4.1 Temperature dependence of α-secondary KIEs at pH 7 for A) MpDHFR, B) 
EcDHFR and C) BsDHFR. 
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There seemed to be no apparent difference for the 2° KIE values between the ones 
measured in this investigation and those measured for TmDHFR (155) (Table 4.1).  
Kohen and coworkers previously studied EcDHFR at pH 9 and showed that the 
intrinsic 2° KIE is 1.052 ± 0.007. This correlates well with the value measured in this 
investigation (1.058 ± 0.02), although the experimental methods differ greatly (88). 
All of these parameters are temperature independent (Table 4.2), with no 
significant difference in activation energies between the isotopologous cofactors. 
 
Table 4.2 Average α-2° KIE and ΔEa for Mp, Ec, Bs and Tm DHFR at pH 7. 
 MpDHFR EcDHFR BsDHFR TmDHFRA 
Average α-2° KIE 1.044 ± 0.01 1.058 ± 0.02 1.048 ± 0.02 1.052 ± 0.02 
ΔEa (kJ mol
-1) 0.7 ± 1.1 0.53 ± 0.99 0.52 ± 0.59 0.4 ± 0.5 
A  Values taken from ref (155) 
 
In order to extrapolate the meaning of these findings, we have to compare these 
values with the equilibrium isotope effect (EIE). EIE is defined as the equilibrium 
distribution of isotopes between two stable states, i.e. the reactant and product 
states, whereas KIEs describes the difference between ground state and transition 
state (148). In other words, comparing the magnitude of KIE with that of EIE would 
reveal details about the hybridisation state of the transition state. Huskey and 
Schowen have hypothesised that, when a 2° KIE exceeds the equilibrium isotope 
effect (EIE), there is a coupling of the motion between the primary and secondary 
hydrogen, with a concomitant contribution from tunnelling (152). This theory was 
applied to the investigation of yeast ADH and showed exalted 2° KIEs above the 
experimental EIE (150, 151). In the case of the DHFR reaction the EIE was 
determined to be 1.13 (149). The lower magnitude of 2° KIE measured here implies 
that there is no coupling between the motion of the α-secondary hydrogen and the 
primary hydride that is transferred in all three DHFR enzymes.  
Additionally, the relationship between primary and secondary KIE has been 
investigated by Scrutton and colleagues. In their studies, morphinone reductase 
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(MR) and pentaerythritol tetranitrate reductase (PETNR), a pair of related enzymes 
that use NADH as hydride source, were tested. Although both of these enzymes 
catalyse the hydride transfer to flavin mononucleotide (FMN) and they are 
structurally similar, the temperature dependence of primary KIE widely differed. In 
MR the hydride KIE drops noticeably with increasing temperature, while the 
corresponding KIE in PETNR remains constant at most temperatures (154). In 
contrast, the 2° KIEs for both of these enzymes are essentially identical and are not 
sensitive to temperature changes (153). Consequently, the authors hypothesised 
that the 2° KIE actually reports on the reaction ready configuration (RRC), which 
refers to the NADH-FMN arrangement that is subsequent to conformational 
sampling/preorganisation but immediately prior to tunnelling (153). The similarity 
in the magnitude of secondary KIE suggested that MR and PETNR adopt similar 
NADH-FMN arrangement, and a temperature independent 2° KIE was considered as 
proof that this arrangement does not alter significantly over the tested 
temperature range (153). 
In the case of DHFR, the pattern of primary KIE changes greatly among homologues. 
For EcDHFR and MpDHFR the primary KIEs are only weakly temperature dependent 
(87, 113), but for BsDHFR there is a biphasic plot on 1° KIE (Chapter 2), which has a 
strong temperature dependence at 5-20 °C. Since the measured 2° KIEs are 
apparently temperature-independent and are essentially the same among all tested 
DHFR homologues, this parameter also likely reports on the configuration 
immediately before the tunnelling event (153). Even though these enzymes greatly 
differ in their flexibility, conformational preferences and likely their conformational 
sampling/preorganisation behaviours (113, 117, 236), the secondary KIE results 
suggest that substrate-cofactor configurations immediately before tunnelling are 
essentially the same among these enzymes (155). 
 
4.2.2 12C/13C Isotope effects on EcDHFR catalysis 
This thesis also presents the first 13C isotope effect studies on the DHFR reaction. 
[4-13C]-NADPH and (R)-[4-2H,13C]-NADPH were prepared via the E. coli NADP+ 
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biosynthetic machinery (Chapter 3). In short, these cofactors were prepared by 
incorporating a 13C label into the C4 position of the nicotinamide ring in NADP+, 
which was then reduced stereoselectively by Thermoanaerobacter brockii alcohol 
dehydrogenase (Figure 4.2). Although carbon isotope effects have been used in a 
number of enzyme reactions, to our knowledge this technique has only been used 
on one previous to investigate enzymatic hydrogen tunnelling reaction (263). 
Additionally, this study only utilised carbon isotope effects at a single temperature, 
compared to the temperature dependence of the isotope effect studied here (263). 
 
 
Figure 4.2 Structures of [4-13C]-NADPH and (R)-[4-2H,13C]-NADPH showing the positions of 
the isotopic labels. 
 
To determine the effect of 13C labelling on the EcDHFR catalysed hydride transfer, 
the rates of the chemical step were measured between 5 and 35 °C at pH 7 (Figure 
4.3). When NADPH and its 13C-labelled isotopologue were employed, the 12C/13C 
isotope effect (k12C/k13C) is close to unity above 15 °C (~1.02) but increases sharply 
to 1.10 ± 0.03 at 5 °C (Table 4.3, Figure 4.3). Interestingly, the magnitude and 
temperature dependence of the carbon isotope effects reported in this 
investigation have never been observed in any other enzymatic system. Previous 
calculations on simple molecules, such as methane, propane and other gaseous 
alkanes, have indicated that a typical vibrational frequency difference between a 
12C-H and 13C-H bond is approximately 20-60 cm-1 (264, 265). Accordingly if there is 
a 20 cm-1 vibrational frequency difference, the theoretical 12C/13C isotope effect 
calculated by the Arrhenius equation would be 1.04 at 25 °C and it would decrease 
by approximately 0.05-1% over the temperature range of ~30 °C (28). Owing to the 
structural complexity of NADPH, the 12C-H and 13C-H stretching vibrational 
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frequencies have not been determined at this time. Furthermore, the EcDHFR 
active site involves numerous interactions with the nicotinamide ring, most notably 
hydrophobic interaction with Ile14 and Tyr100, and a hydrogen bond network 
involving Ser49 and a water molecule (76). Nevertheless, for the purpose of 
discussion, we hypothesise that there might be a theoretical vibrational frequency 
difference of 40 cm-1 between NADPH and 13C-NADPH. This would result a 12C/13C 
isotope effect of 1.1 at 5 °C, a similar magnitude to the observed value. However, 
this argument does not hold true for the observed temperature dependence. The 
theoretical 12C/13C KIE would only drop by 1% from 5 to 20 °C, but the experimental 
KIE dropped markedly by ~10%.  
Whilst the stretching vibrational mode will contribute most to the observed isotope 
effect, a contribution from other vibrational modes should also be taken into 
consideration. In the DHFR reaction, NADPH is oxidised to NADP+ therefore the C4 
atom is rehybridised from sp3 to sp2. Since the out-of-plane bending modes differ 
significantly between sp3 and sp2 hybridised states, this might contribute to the 
observed KIE. As discussed above, the measured secondary hydrogen KIEs are 
temperature-independent, whereas the observed 13C heavy atom isotope effect 
displays a relatively strong temperature dependence. Rehybridisation alone 
therefore could not be used to explain the sudden increase in magnitude at low 
temperature. 
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Table 4.3 Temperature dependence of 12C/13C isotope effects between 5 and 35 °C at pH 
7. 
T (°C) NADPH/[4-13C]-NADPH KIE (R)-[4-2H]-NADPH/(R)-[4-2H,13C]-NADPH KIE 
5 1.10 ± 0.03 1.15 ± 0.02 
7 - 1.13 ± 0.02 
10 1.10 ± 0.03 1.12 ± 0.02 
12 - 1.10 ± 0.02 
15 1.05 ± 0.02 1.11 ± 0.03 
20 1.01 ± 0.04 1.11 ± 0.03 
25 1.02 ± 0.03 1.07 ± 0.04 
30 1.03 ± 0.03 1.07 ± 0.04 
35 1.03 ± 0.03 1.03 ± 0.03 
 
 
Figure 4.3 Temperature dependence of the 12C/13C KIE on hydride transfer (blue) and 
12C/13C KIE on deuteride transfer (red) at pH 7. 
 
The reacting atoms in the DHFR reaction were further investigated by measuring 
the heavy atom isotope effect with deuterated cofactors, NADPD and 13C-NADPD. A 
similar trend of temperature dependence was observed, with 13C/12C isotope effect 
decreasing from 1.15 ± 0.02 at 5 °C to 1.03 ± 0.03 at 35 °C. Because the reduced 
mass difference is greater upon deuterium incorporation (Table 4.4), it is not 
unexpected that the isotope effects are generally higher than that of the protiated 
equivalent. Moreover, the increased mass difference could also lead to a greater 
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disparity in vibrational frequency. For a theoretical difference of 60 cm-1 between 
the labelled and unlabelled cofactors, the calculated KIE would be 1.16 at 5 °C. 
However, it would also lead to an isotope effect that greatly differs from the 
experimental one at 20 °C. This implies that a difference in vibrational frequencies 
could not be the sole factor affecting the observed 12C/13C isotope effects. 
 
Table 4.4 The reduced mass of a C-H and C-D bond involving a 12C and 13C atom. 
 12C-H 13C-H 12C-D 13C-D 
Reduced mass 0.923 0.929 1.714 1.733 
Difference between 12C and 13C 0.006 0.019 
 
Recently, Singleton and coworkers reported an exalted 12C/13C isotope effect of 
1.16 at -100 °C on the ring opening of a cyclopropylcarbinyl radical species (Figure 
4.4). Based on their VTST-MT calculations, the exalted isotope effect can be 
explained by a contribution from heavy atom tunnelling (266). Nevertheless, in the 
DHFR reaction, the transfer of the hydrogen dominates the chemical coordinate, 
thus the likelihood for a significant contribution from heavy atom tunnelling is 
extremely low. An alternative explanation to the observed isotope effect is 
consequently needed.  
 
Figure 4.4 Ring-opening reaction of cyclopropylcarbinyl radical studied by Singleton and 
coworkers (266). The atoms subjected to heavy atom KIE measurements are noted by red 
circles.  
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Two explanations are available to explain the observed 12C/13C isotope effect. 
Firstly, the heavy atom incorporation may affect either the tunnelling probability or 
the frequency of recrossing events. As explained above, Marcus-like models invoke 
enzyme dynamics that include a distance sampling term. As this variable is mass- 
and temperature dependent and likely channels through the C4 position of NADPH, 
the exalted 12C/13C isotope effect at low temperature can be viewed as a result of 
changing the barrier width i.e. changing the tunnelling probability. Upon 13C-
labelling, the frequency of fs bond vibration of the C-H decreases and this might 
subsequently affect hydrogen transfer if the chemical coordinate is coupled to 
"promoting motions" (Figure 4.5). However, a previous investigation of EcDHFR by 
enzyme isotope substitution revealed that protein dynamics are not coupled to the 
barrier height and/or width. Instead, fs bond vibrations in EcDHFR coupled to the 
reaction coordinate through the frequency of dynamic recrossing rather than the 
shape of the reaction barrier (117). Thus, the observed increase in 12C/13C at low 
temperature may be due to changes in the recrossing coefficient between the light 
and heavy cofactor. 
 
Figure 4.5 Example of increased barrier width upon direct coupling of the C4 atom to the 
primary hydrogen. The coupled and uncoupled reaction pathways are shown in blue and 
red respectively. 
 
Alternatively, the large effects at low temperature may link to a microscopic 
mechanism that affects the observed pre-steady state rate. That is, the observed 
isotope effect could report on the step of hydride transfer as well as other step(s) 
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that are isotopically sensitive in the DHFR catalysis. This hypothetical step likely 
occurs after electrostatic preorganisation, which should not be isotopically sensitive 
as indicated by the Born-Oppenheimer approximation. The C-H bond vibration 
could affect step(s) immediately before the formation of the RRC. Given that the 
RRC is relatively static as revealed by the 2° KIE studies, the experimental 13C 
isotope effect could be accounted by a change in reorganisation energy of the 
reactants. At high temperatures reorganising the substrate dipole is not rate 
determining, but when temperature is below 15 °C the energy commitment for 
reorganisation becomes partially rate limiting and produces the profound carbon 
isotope effects (Table 4.5). When a deuteride is inserted at the C4 position, the 
postulated reorganisation energy further increases and provides a greater 
difference in activation energy between 12C-NADPD and 13C-NADPD (ΔEa 4.3 kJ   
mol-1) (Table 4.5).  
 
Table 4.5 Activation energy of NADPH and labelled isotopologues 
 NADPH [4-13C]-NADPH (R)-[4-2H]-NADPH (R)-[4-2H,13C]-NADPH 
Ea (kJ mol
-1) 31.8 ± 0.8 33.7 ± 1.0 41.7 ± 0.5 46.0 ± 1.0 
ΔEa (kJ mol
-1) 1.8 ± 1.2 4.33 ± 1.1 
 
 
4.2.3 Effect of 13C isotopic substitution on the 1° KIE of EcDHFR 
Numerous Marcus-like models suggest that heavy-atom motions promote the rate 
of reaction by modulating the barrier width between the substrate and reactant.  If 
promoting motions indeed enhance hydride tunnelling via the C4 atom, the 
magnitude of primary hydride KIE would consequently be affected upon 13C 
labelling (Figure 4.6). This would theoretically allow the 12C/13C isotope effect 
observed above to be designated as a promoting motion or as a result of recrossing 
or reorganisational changes.  
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Figure 4.6 A) Reaction barrier of EcDHFR as implied from previous KIE studies, B) 
Theoretical reaction barrier upon decreasing hypothetical "promoting motions", causing 
the barrier width to increase. 
To verify this hypothesis, the unlabelled (k12C-NADPH/k12C-NADPD) primary KIE was 
compared to the 13C-labelled 1° KIE (k13C-NADPH/k13C-NADPD). The resulting 
13C-labelled 
primary hydrogen KIE was calculated to be 3.66 at 5 °C and decreased to 2.01 at 35 
°C (Table 4.6). When these values are compared to the unlabelled (12C) primary KIE, 
there seems to be no significant difference (Figure 4.8). 
 
Figure 4.7 Rate of hydride transfer with NADPH (light blue), [4-13C]-NADPH (dark blue), 
(R)-[4-2H]-NADPH (light red) and (R)-[4-2H,13C]-NADPH (dark red) at pH 7. 
 
Table 4.6 Temperature dependence of the primary hydrogen KIE of EcDHFR with 12C 
NADPH and 13C NADPH at pH 7. 
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T (°C) 13C labelled primary hydrogen KIE Primary hydrogen KIE 
5 3.66 ± 0.39 3.05 ± 0.29 
10 3.12 ± 0.12 3.07 ± 0.11 
15 2.79 ± 0.32 2.64 ± 0.31 
20 2.81 ± 0.19 2.54 ± 0.17 
25 2.59 ± 0.16 2.46 ± 0.13 
30 2.36 ± 0.16 2.27 ± 0.24 
35 2.01 ± 0.03 1.99 ± 0.05 
 
 
Figure 4.8 Temperature dependence of the primary hydrogen KIE (blue) and 13C-labelled 
primary hydrogen KIE (red) at pH 7. 
 
The lack of change of the 13C-labeled primary KIE suggested that promoting motions 
do not act via the C4 atom in NADPH. A drop in primary KIE would be expected as a 
consequence of 13C labelling because the barrier width for hydride transfer 
increases. Furthermore, the proposed recrossing or reorganisation effects (see 
above) should not cause any obvious changes in the primary KIE, as a similar 
magnitude of isotope effect is observed for both 13C-NADPH and 13C-NADPD thus 
cancelling out any effect. Overall, based on our speculations, the 12C/13C KIE 
measurements should report on the mass- and temperature-dependent 
reorganisation process, which occurred prior to tunnelling, or an alteration in the 
reaction pathway that results in more recrossing events upon isotopic labelling of 
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the C4 position. Nonetheless, current limitations in the experimental methods must 
be taken into account. 
The primary hydrogen KIE results suggested that 13C labelling is not causing any 
profound effect on the barrier width that affects hydride transfer. However, the 
difference imposed by 13C labelling is minimal when compared to that by deuterium 
substitution, thus reactivity difference caused by 13C labelling might be masked by 
the primary hydrogen KIE. Competitive KIE measurements might be needed to 
verify if there is any subtle difference on the primary KIE that might have been 
overseen in this investigation. However, these are incredibly difficult to measure at 
pH 7. Similarly, EA-VTST calculations could determine if any of the components of 
the transmission coefficients are being altered. This would locate which 
components of the reaction coordinate that are isotopically sensitive. 
 
4.2.4 Future studies 
Our investigations clearly showed that the pro-S hydride as well as the C4 atom 
participate in the transition state of the DHFR reaction. For future studies, it is of 
great interest to analyse the role of other atoms in the nicotinamide ring. For 
example, investigating the isotope effects of the C3 and C5 atoms would highlight if 
any coupling motions would act via these atoms as a method to enhance the rate of 
hydride transfer. Furthermore, nitrogen isotope effect studies on the N1 position 
and the amide moiety could reveal effect of charge change and the function of 
hydrogen bonding in the reaction, respectively. Lastly, a competitive method that 
can be performed at pH 7 will need to be developed in order to fully characterise 
the transition state of DHFR under physiologically relevant conditions. An 
alternative DHFR homologue in which hydride transfer is more rate-limiting might 
be needed. This will provide more insights, as the intrinsic KIEs and the forward 
commitment factors can be extrapolated.  
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4.3 Conclusion 
In this investigation, the α-secondary hydrogen isotope effects (2° KIEs) at pH 7 
were measured for EcDHFR, MpDHFR and BsDHFR. The measured isotope effects 
are essentially the same among one another, including TmDHFR which was 
previously investigated. Furthermore, the observed 2° KIEs were significantly lower 
than the calculated EIE, ruling out the potential coupling between the primary and 
secondary hydrogen atoms at the C4 position of NADPH. This also coincides with 
the results for TmDHFR, and supports the argument that α-secondary hydrogen 
isotope effect reports on the RRC immediately prior to hydride transfer.  
This thesis also documented the first 13C isotope effect measurement on the 
hydride transfer catalysed by EcDHFR. These studies clearly showed that the C-4 
position participate in the transition state of DHFR, but the temperature 
dependence of the 12C/13C isotope effects (on both hydride and deuteride transfer) 
cannot be explained by semi-classical or simple tunnelling models. While there is a 
strong carbon isotope effect at low temperature, 13C labelling does not seem to 
change the magnitude of primary hydride KIE. This contradicts the hypothetical 
promoting motions postulated in the modified Marcus theories (25, 39, 41). 
Instead, these results indicate that carbon isotope effect might arise as a 
consequence of reorganisation effects that occur immediately before hydride 
transfer. However, limitations on the pre-steady state rate measurements might 
override the subtle difference caused by 13C labelling, especially on the primary KIE 
calculations. Precise isotope effect measurements by a competitive method and/or 
additional computational studies will therefore be needed in future studies.  
In summary, the 13C isotope effect results could not be explained by current 
Marcus-like theories. In comparison to previous experimental results, work 
presented in this chapter highlights the importance of the reaction ready 
configuration in DHFR catalysis and shows that many different factors contribute to 
the formation of a reaction coordinate conducive to hydride tunnelling.
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5 RECONSTITUTING THE DIHYDROFOLATE 
BIOSYNTHETIC PATHWAY  
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5.1 Preface 
A generic method to regiospecifically label dihydrofolate (DHF) with heavy isotopes 
would be enormously useful in enzymology studies. However, similar to the 
situation of isotopically labelled NADPH (Chapter 3), synthesising DHF 
isotopologues is difficult and not cost-effective. DHF and derivatives are relatively 
complex molecules that serve as one-carbon carriers in key metabolic pathways, 
but enzymes tend to employ only the pterin ring moiety for chemical reactions. As a 
matter of fact, these reactions typically centre around positions at N5, C6 and/or 
N10. One example would be the DHFR reaction, which catalyses a NADPH-
dependent hydride transfer to the C6 position and protonation at the N5 position of 
DHF. The anti-cancer drug target thymidylate synthase is another example, in which 
these atoms in the pterin ring are responsible for the chemistry of the enzyme 
catalysis. With the use of N5,N10-methylene-THF, this enzyme performs a reductive 
methylation of deoxyuridine monophosphate to generate deoxythymidine 
monophosphate in DNA synthesis. Accordingly, to facilitate the studies of these 
DHF-related enzymology studies, it is of great interest to synthesise DHF with 
isotopes labelled at these positions. Current synthetic methods involve adding 
aminobenzoic acid and glutamate moieties to an oxidised pterin ring thus yielding 
labelled folate (267, 268). However, not only were these methods low yielding, the 
regioselectivity of isotopic label incorporation is undesirable due to the symmetrical 
nature of the reagents involved. Furthermore an additional step of reduction is 
required in order to obtain the desired product for this investigation. Hence, a new, 
simple and high-yielding method to synthesise DHF isotopologues is urgently 
needed. 
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Scheme 5.1 Synthesis of [7,9-13C2]-folate from [1,3-
13C2]-acetone, taken from ref (267) 
 
In nature DHF is made via a ring-opening pathway of GTP, which in turn is 
synthesised from glucose. All the enzymes have been biochemically characterised 
with many of them involving interesting chemistry, such as dihydropteroate 
synthetase (DHPS), a well-established drug target (269). With a wealth of 
information available (227, 228, 232-234), it seems feasible to use the DHF 
biosynthetic pathway for heavy isotope incorporation (Scheme 5.2). Indeed, the 
research group of Bacher previously used this pathway to synthesise the 
isotopically labelled intermediate tetrahydropteroate. Interestingly, these enzymes 
have not been employed to label DHF with heavy isotopes (220), even though only 
simple, relatively inexpensive starting materials, such as isotopically labelled 
glucose, are required. Hence, it would be ideal to re-construct the DHF biosynthetic 
pathway in our laboratory. 
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Scheme 5.2 Dihydrofolate biosynthesis pathway from GTP in E. coli. 
 
This chapter outlines our efforts towards preparing the enzymes needed to 
synthesise DHF. As described above, DHF synthesis is extended from the 
biosynthetic pathway of GTP. Fortunately, at the time of this investigation most of 
the enzymes in the GTP pathway, except PRPP synthetase and xanthine-guanine 
phosphoribosyltransferase, were commercially available. On the other hand, 
enzymes that participate in DHF biosynthesis cannot be sourced from any 
biochemical company. Consequently, the genes for these missing enzymes were 
prepared by a variety of methods. Furthermore, the resulting enzymes were 
isolated and initial optimisations were performed.  
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Scheme 5.3 Conversion of glucose to GTP via pentose-phosphate pathway, taken from 
(223). An alternate method from ribose is also shown. HK = hexokinase, G6PDH = glucose-
6-phosphate dehydrogenase, 6PGDH = 6-phosphogluconate dehydrogenase, R5PI = 
ribose-5-phosphate isomerase and XGPRT = xanthine-guanine phosphoribosyltransferase. 
 
5.2 Production and purification of DHF biosynthesis enzymes 
5.2.1 PCR amplification and construction of expression vectors 
Gene sequences encoding DHF biosynthesis enzymes were sourced from E. coli K-12 
using the GenBank® database. folB, C, E, K, and gpt were amplified from E. coli 
strain XL1-Blue chromosomal DNA and cloned into expression vectors in identical 
fashion to the NADPH biosynthesis genes (Chapter 3).  A temperature gradient was 
used to determine the optimal annealing temperature for each set of primers 
(Table 5.1), and agarose gel electrophoresis was used to visualise each gene. The 
folC gene was amplified successfully via PCR, however, one or both of the primers 
also bound to numerous locations on the gene resulting in multiple PCR products 
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(Figure 5.1). PCR amplification of folP, encoding dihydropteroate synthetase, was 
unsuccessful despite numerous conditions attempted. As a result this gene and the 
folC gene were chemically synthesised and cloned into pET-21a expression vector 
(Epoch Life Sciences).  
The purified expression vector constructs were sequenced (by Eurofins) to confirm 
that no mutations had occurred during recombinant DNA manipulation. The gene 
sequence of folB did not match any sequence in the GenBank® database, likely due 
to the fact that the specific E. coli XL1-Blue folB gene sequence has not been 
uploaded at this time. To remove the possibility of inactive enzyme being produced, 
three site-directed mutations were performed to align the sequence with a known 
E. coli sequence in the database. Similarly, the ligation of folE into pET21a had 
resulted in the gene being out of frame, so a single point mutation was performed 
immediately before the start codon of the gene. 
 
Table 5.1 Conditions used for PCR amplification of the genes involved DHF biosynthesis. 
Step 
Target gene 
folB folC, folK folE gpt 
Denaturation* 10 s, 98 °C 
Annealing 30 s, 42 °C 30 s, 43 °C 30 s, 67 °C 60 s, 69 °C 
Extension 45 s, 72 °C 
* The denaturation, annealing and elongation step was cycled 35 times 
 
 
Reconstituting the dihydrofolate biosynthetic pathway 
 
148 
 
 
Figure 5.1 Agarose gel visualising the multiple products obtained from PCR amplification 
of folC. M = marker, A - F = PCR amplifications of folC. 
 
5.2.2 Production and purification of enzymes 
E. coli BL21 StarTM (DE3) cells were choose as host for expressing the genes for DHF 
biosynthetic enzymes, which were cloned into the pET-21a, -21d and -28a vectors. 
Since these genes were regulated by a lac operator/T7 promoter system, the 
corresponding enzymes were translated upon the addition of IPTG.  pET-28a 
encodes a N-terminal his tag, thus the expressed protein can be purified by Ni2+ 
affinity chromatography. Accordingly, the genes for FolB, FolK and Gpt were 
expressed at 37 °C, following IPTG induction when the OD600 of the host cell culture 
reached 0.6. Test expressions were carried out to determine the optimal induction 
time for each protein. In all cases, a profound band of protein was observed after 4 
hrs of induction. Dihydroneopterin aldolase (DHNA), 6-hydroxymethyl-7,8-
dihydropterin pyrophosphokinase (HPPK) and xanthine-guanine 
phosphoribosyltransferase (XGPRT) were purified by Ni2+-affinity chromatography 
(Figure 5.2). All these proteins were isolated with reasonable purity as indicated by 
SDS-PAGE analysis. 
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Figure 5.2 SDS-PAGE analysis of folB expression and DHNA purification. M = marker, 4 hr 
= 4 hours after induction, o/n = overnight after induction, S = supernatant, E1 and E2 = 
elution fractions. 
 
The pET-21a and pET-21d vectors do not encode a N-terminal his-tag, thus anion-
exchange chromatography was used to purify GTP cyclohydrolase I (GTPCI), 
dihydroneopteroate synthase (DHPS) and dihydrofolate synthetase (DHFS). E. coli 
BL21 StarTM(DE3) cells were grown at 37 °C until an OD600 of 0.6 was reached.  
Subsequently, IPTG (0.5 mM) was added to induce gene expression. GTPCI showed 
a clear protein band in SDS-PAGE analysis after 4 hours of incubations at 37 °C. 
However DHPS and DHFS required expression overnight to produce significant 
amounts of protein. As each of these proteins have a theoretical pI below 7, anion-
exchange chromatography was performed using 50 mM Tris, pH 8 buffers, 5 mM 
βME. All three enzymes bind to positively charged quaternary ammonium resins, 
and they were eluted at various concentrations of salt buffer (50 mM Tris, 1 M 
NaCl, pH 8), at 35% for GTPCI, at 40% for DHPS and 35% for DHFS. The SDS-PAGE 
analyses of these samples showed the correct monomeric size for each protein. All 
six proteins gave bands on the SDS-PAGE corresponding to the correct monomer 
size determined from the amino acid sequences. 
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Figure 5.3 A) Chromatogram showing the purification of GTPCI by anion-exchange 
chromatography. UV absorption of eluted protein is shown in blue and concentration of 
NaCl in red. B) SDS-PAGE of fractions corresponding to elution peak from the anion-
exchange column. M = MW marker, A-F = elution fractions corresponding to the region 
between the dashed lines. 
 
5.3 Characterisation of the DHF biosynthesis enzymes 
Size-exclusion chromatography was used to investigate the native quaternary 
structure of the purified enzymes. CD spectroscopy, in turn, was employed to 
determine if each protein contains the appropriate secondary structures. These 
results together indicated that all of the DHF biosynthesis enzymes were purified in 
their folded states. 
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5.3.1 Size-exclusion chromatography 
Size-exclusion chromatography was used to determine the native state of each 
enzyme in the DHF biosynthetic pathway. In the Superdex200 size-exclusion 
chromatographic analysis, the retention volume for each recombinant protein was 
compared with standard proteins that have known size and quaternary structures 
(227, 228, 232-235). As previous studies reported, DHPS and DHFS are stable as 
dimer and monomer, respectively (228, 232). However, the remaining four proteins 
exhibit quaternary properties that are different from reported observations (227, 
233-235). GTP cyclohydrolase I was found to be a trimer (MW approximately 
75000), whereas this enzyme was previously shown to be decameric (MW 250000 ). 
DHNA and XGPRT reportedly form an octamer (MW 110000) and a tetramer (MW 
64000), but presented as a tetramer (approximately 60 kDa) and a dimer (MW 
approximately 40) in this investigation. Although HPPK has previously been 
reported as a monomer with mass 25000 in the native state (234), both the 
monomer and dimer (MW 50000) were purified in this investigation, as there are 
two resolved peaks in the chromatogram (C, Figure 5.4) with the dimer form being 
predominant. 
For XGPRT and DHNA, the differences in their quaternary states are likely due to 
the attachment of a N-terminal his-tag, which affects how the monomer interacts 
with one another. Even though the his-tag can be cleaved with the thrombin 
cleavage site that is inserted in front the recombinant enzyme, these were shown 
to be active despite the different oligomer states (see below). On the other hand, 
recombinant GTPCI does not contain a his-tag at either the N- or C-terminal. It is 
therefore not clear why the decamer species is not observed during this 
investigation. Similar size-exclusion chromatograms were obtained in the presence 
and absence of reducing agent, thus ruling out a role for disulfide bond formation 
as the cause. 
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Figure 5.4 Chromatograms from Superdex200 size-exclusion column. A = GTPCI, B = 
DHNA, C = HPPK, D = DHPS, E = DHFS and F = XGPRT 
 
5.3.2 CD spectroscopy 
The secondary structural organisation of the recombinant proteins were analysed 
by CD spectroscopy. To obtain the mean residue ellipticity, CD signals of these 
samples were measured between 190 and 400 nm in phosphate buffer (10 mM at 
pH 7 and 20 °C). The minima at 222 and 206 nm as well as the maximum at 195 nm 
are indicative of α-helices and β-sheets, suggesting that these proteins are properly 
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folded. The CD spectrum of unfolded protein has a weak signal in the far UV region 
(190-250 nm), but this was clearly not the case in these enzymes. 
Furthermore, the enzymes that exhibited different quaternary structures, including 
GTPCI, DHNA, and XGPRT, presented CD signals of folded proteins (A, B and F, 
Figure 5.5). This provided further additional evidence that protein folding is not 
strongly affected by the difference in the oligomeric state. The spectrum of HPPK 
showed that both the monomer and dimer species are folded (C, Figure 5.5). 
However, it is unclear at this moment whether the dimer species is active as this 
enzyme has not been optimised fully for DHF biosynthesis in vitro up to this point 
(see below).  
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Figure 5.5 CD spectra of the DHF biosynthesis enzymes purified in this investigation. A) 
GTPCI, B) DHNA, C) HPPK, D) DHPS, E) DHFS and F) XGPRT. 
 
5.4 Development of the DHF biosynthesis pathway 
Attempts were made to optimise the activities of the recombinant enzymes, before 
assembling them to synthesise DHF. Analytical techniques, including HPLC, ion-
exchange chromatography, NMR and ESI-MS, were used to characterise each 
enzyme. Reactions involving xanthine-guanine phosphoribosyltransferase, GTP 
cyclohydrolase I and dihydroneopterin aldolase have already been optimised. 
However, the final three steps of the pathway have yet to be optimised on a large 
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scale. Nevertheless, preliminary data showed promising results, and these enzymes 
can likely be used for generating a 'DHF factory'. 
 
5.4.1 Xanthine-guanine phosphoribosyltransferase (XGPRT) 
PRPP synthetase and XGPRT are the two enzymes in the GTP biosynthetic pathway 
that are not commercially available. Fortunately, we received the gene of PRPP 
synthetase cloned into a lac operon/T7 expression vector as a kind gift of Professor 
Jamie Williamson from The Scripps Research Institute. This enzyme was isolated 
using the procedure developed by his group (255-257). XGPRT in turn was cloned 
from the chromosome of E. coli K12 and purified as described above.  
 
Scheme 5.4 Reaction catalysed by XGPRT. 
 
To synthesise GTP, the starting materials ribose-5-phosphate and ATP were 
incubated with these enzymes in KiPO4 buffer (50 mM, pH 8), supplemented with 
50 mM KCl, 20 mM MgCl2 for 3 hours at 37 °C. The system was also included an ATP 
recycling machinery to prevent product inhibition of PRPP synthetase (256, 257).  
The low solubility of guanine at neutral pH presented a major problem in this 
investigation. While it dissolves readily in 1 M NaOH, guanine precipitated 
immediately when introduced to the reaction buffer at pH 8, which was optimal for 
the activity of PRPP synthetase. To circumvent the problem, the nitrogenous base 
was maintained at a concentration below the precipitation limit, by adding small 
aliquots in 10 min intervals. After incubation, excess precipitated guanine base was 
removed by centrifugation. The crude was then subjected to anion-exchange 
chromatography, and a sharp single peak at 260 nm corresponding to GMP was 
observed in the trace (Figure 5.6). 
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Figure 5.6 Chromatogram showing elution of the XGPRT reaction (red) and the blank 
reaction without XGPRT (blue). 
 
Purified GMP was analysed by 1H-NMR spectroscopy (Figure 5.7). In the aromatic 
region, a singlet corresponding to the 8-H on the purine ring was observed at 8.2 
ppm. The characteristic anomeric 1'-H is clearly shown as a doublet at 5.9 ppm. The 
multiplets in the 3.9-4.5 ppm region originate from the ribose signals at C-2',-3' and 
-4'. However, the signal to noise ratio is low due to the presence of salt-hydrate 
complex. On close inspection the signals at 5.1 and 5.3 ppm are in fact two triplets, 
and thus is an impurity as it does not correspond to any proton in the structure of 
GMP. Additionally, the ESI-MS of the XGPRT reaction crude showed a peak at 
363.97 m/z, which matches well with the (M+1) state of GMP (calculated MW = 
363.22).  
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Figure 5.7 1H-NMR spectrum of the product purified from XGPRT reaction. (300 MHz, 
D2O) 
 
 
Figure 5.8 ESI-MS of GMP (MW: 363.22) 
 
5.4.2 GTP cyclohydrolase I (GTPCI) 
The first committed step of DHF biosynthesis transforms GTP to dihydroneopterin 
triphosphate under the action of GTP cyclohydrolase I (GTPCI) (Scheme 5.5). This 
reaction was reported to be rate-limiting in the pathway, and previous studies 
evaded this problem by using large amounts of enzyme (>30 mg freeze-dried 
enzyme/mL) (220). Additionally, GTPCI requires Zn2+ for reaction (270), but the 
enzyme's affinity to this cofactor is unknown. To optimise the conditions, the GTPCI 
reaction was carried out at various pH values (7-9) with or without the addition of 
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ZnCl2. The enzyme was found to be active under all the tested conditions, but the 
highest yield obtained using a phosphate buffer (50 mM) at pH 7.  
The addition of ZnCl2 (1 mM) did not cause an observable effect on the reaction 
yield. This could be that the cationic cofactor was tightly bound to the enzyme. 
Alternatively, the cysteine residues responsible for cofactor binding were oxidised 
during the purification. Indeed, the addition of β-mercaptoethanol in the 
purification and reaction buffers increased the yield, as demonstrated by Antonio 
Angelastro who currently continues the development of this project. The 
production of dihydroneopterin triphosphate was traced by absorbance reading at 
330 nm (ε = 6300 M-1 cm-1, Figure 5.9), and a final yield of 58% was obtained. 
 
 
Scheme 5.5 Reaction catalysed by GTPCI. 
 
Figure 5.9 UV-Vis spectrum of the conversion of GTP to dihydroneopterin triphosphate. 
Measurements were taken every 5 minutes. 
 
Although relatively good yields of dihydroneopterin triphosphate were achieved, 
we experienced a number of difficulties during purifications. HPLC did not seem to 
be applicable, when trying to separate the product from the starting material GTP, 
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both of which contain a triphosphate moiety. Anion-exchange chromatography 
offered marginally improved separation, however it was impossible to completely 
separate the starting material from the product. Furthermore, the product is prone 
to oxidation at C-7 and N-8 positions over time, and neopterin triphosphate is often 
observed during purification. This was indicated by the two maxima at 330 nm in 
the UV-Vis; a clear (M-H) peak 492.33 m/z corresponding to the oxidised product 
(MW = 493.17) in the negative ESI-MS study. As well as this, the (M-H) state of GTP 
(522 m/z, MW = 523.18) was present, highlighting the difficulty of purification 
(Figure 5.11). At this stage it is not certain when the product oxidation occurred. 
The presence of a reducing agent may decrease the rate of oxidation and thus is a 
possible avenue of future investigation.  
 
Figure 5.10 Chromatogram of the purification of the GTP cyclohydrolase I reaction at 260 
nm (blue) and 330 nm (red). A and B correspond to the ESI-MS below (Figure 5.11). 
 
 
 
 
0 
200 
400 
600 
800 
0 10 20 30 
A
b
s 
Time (min) 
A 
B 
Reconstituting the dihydrofolate biosynthetic pathway 
 
160 
 
 
 
Figure 5.11 ESI-MS of dihydroneopterin triphosphate (A, MW = 495.17) and the oxidised 
form, neopterin triphosphate (B, 493.15). In both cases unreacted GTP (MW = 523.18) is 
also present. 
 
5.4.3 Dihydroneopterin aldolase 
Following the GTP rearrangement reaction, the phosphate groups from the 
intermediate are hydrolysed to dihydroneopterin. It remains unclear which enzyme 
is responsible for this reaction in nature, however bovine alkaline phosphatase 
(BAP), a commercially available alkaline-resilient enzyme, was used as the catalyst 
in laboratory. The intermediate dihydroneopterin underwent a retro-aldol cleavage 
reaction to produce 6-hydroxymethyl-dihydroneopterin, under the action of 
dihydroneopterin aldolase (DHNA) (Scheme 5.6). 
 
A 
B 
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Scheme 5.6 Reaction catalysed by DHNA. 
 
Because of the difficulties in purifying dihydroneopterin triphosphate, it was 
decided to perform the phosphatase and aldolase reactions simply using the GTPCI 
reaction crude. GTPCI was removed by filtering the reaction through MW 10000 
spin-column, and the phosphatase and aldolase were added. As BAP requires a 
divalent cation as a cofactor, 1 mM of ZnCl2 was added in the alkaline buffer (50 
mM Tris, pH 9) and the reaction was incubated at 37 °C for 4 hours. A C-18 column 
(semi-prep, 0.22 μM particle size) was used in HPLC purification of the reaction 
crude (Figure 5.12). Likewise, a number of problems presented during this process. 
Two product peaks corresponding to neopterin and 6-hydroxymethyl neopterin 
were seen in the HPLC trace (A and B, respectively). Unfortunately, oxidation of 
these compounds was observed. The ESI mass spectrum also showed the peaks for 
neopterin (251.90 m/z) and 6-hydroxymethyl-neopterin (193.90 m/z), which 
matches well with the calculated MW of these compounds (253.08 and 195 
respectively). At this time it is not clear if DHNA is able to react with neopterin or if 
the tetramer form of DHNA purified in this investigation is affecting the reaction in 
any way. 
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Figure 5.12 Chromatogram showing the purification of DHNA reaction purified via HPLC. 
A) Neopterin, B) 6-hydroxymethyl-neopterin and C) solvent front. 
 
 
 
Figure 5.13 ESI-MS of neopterin (A, MW = 253.08) and 6-hydroxymethyl neopterin (B, 
MW = 193.06). In both cases the dihydroneopterin ring has been oxidised to neopterin. 
 
5.4.4 Further optimisation of the DHF pathway 
Continuation of the work described here, by Antonio Angelastro, has led to the 
production of unlabelled DHF in a 2 pot synthesis from GTP. This indicates that the 
recombinant HPPK, DHPS and DHFS purified in this investigation are indeed active. 
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5.5 Conclusion 
The DHF biosynthesis enzymes have been cloned and purified successfully from E. 
coli chromosomal DNA. The CD spectroscopic analysis indicated that the purified 
enzymes exhibited properly folded secondary structures. Interestingly, GTPCI, 
DHNA and HPPK were found to adopt quaternary structures different from 
previously observed oligomerisation states. The latter two enzymes are affected by 
the N-terminal histidine fusion tag used during Ni2+-chromatographic purifications. 
It is still unclear why GTPCI forms a trimer rather than a decamer, as previously 
reported. Although purification of the intermediate dihydroneopterin triphosphate 
was unsuccessful, the reaction crude could be used for the subsequent 
phosphatase and retro aldol cleavage reactions. Nevertheless, it is unclear if the 
enzymes are operating at a maximum rate at this stage. 
For the GTP biosynthetic pathway, XGPRT was cloned and purified, thus a de novo 
biosynthesis of this nucleotide can be prepared in the laboratory. Even though 
XGPRT was reported to adopt a tetrameric complex, our studies indicated a dimeric 
enzyme. Nevertheless, this enzyme was shown to be active for catalysis. 
Overall the DHF biosynthesis enzymes have successfully been cloned and purified. 
The DHF biosynthesis pathway has begun to be developed in the laboratory, 
although further optimisation of these enzymes is required. Antonio Angelastro, the 
Ph.D. candidate who continues this project, could indeed synthesise DHF from this 
pathway and showed major improvement on the reaction yields following further 
optimisations.
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6 GENERAL CONCLUSIONS  
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This thesis aimed to elucidate the role of femtosecond (fs), short-range bond 
vibrations in enzymatic reactions. Two distinct approaches were employed. These 
include the kinetic investigation of a "heavy", isotopically labelled DHFR as well as 
heavy isotope effect measurements of an NADPH isotopologue labelled at the 
reaction centre. 
 
6.1 The role of fs bond vibrations in the enzyme on catalysis 
Primary KIE measurement of BsDHFR has led to the discovery of an interesting 
biphasic Arrhenius plot. Similar trends have been observed in other thermophilic 
enzymes, such as BsADH (21) and TmDHFR (24), and the strong temperature 
dependence at low temperature can be viewed as a consequence of poor 
conformational sampling. Alternatively, the biphasic behaviour could be explained 
by the existence of multiple conformers, in which equilibrium favourable for 
hydride transfer is temperature dependent. Future NMR studies could help identify 
the dynamic nature of BsDHFR and the possible existence of different conformers 
at low temperature. 
BsDHFR was further characterised by enzyme isotope substitution. The mesophile 
EcDHFR, its catalytically compromised mutant and the hyperthermophile TmDHFR 
have also been investigated by the same approach (117, 118, 236). Steady-state 
kinetic analysis produced a relatively large enzyme KIE (~2.6), and this can be 
reasoned by the highly flexible nature of BsDHFR. On the basis of the temperature 
independence, a physical step in the BsDHFR catalysis is likely rate limiting, but it 
does not require a large conformational change (117, 236).  
At physiologically relevant temperatures, the enzyme KIE on hydride transfer is 
insignificant but increases substantially at low temperature. Based on previous in 
silico studies on EcDHFR (117), we postulated that there are greater dynamic effects 
at low temperature. Preliminary EA-VTST calculations performed by our 
collaborators confirmed this. We also suggested that the intrinsic flexibility of 
BsDHFR contributes to the large enzyme KIE. At low temperature there is a greater 
entropic burden in the process of electrostatic preorganisation, thus leading to an 
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increase in reorganisation energy needed for hydride transfer. While this requires 
additional computational study, the lack of enzyme KIEH at high temperatures 
indicates the dynamic coupling is minimal at physiologically relevant conditions. 
This agrees well with the hypothesis, which stated that efficient enzymes tend to 
minimise the coupling of protein motions to the chemical coordinate, as it can 
cause an anti-catalytic effect. Overall, there seems to be no evolutionary advantage 
towards direct coupling of these ultrafast motions to enzyme catalysis in all DHFRs. 
 
6.2 The role of fs bond vibrations in the substrate in hydride 
transfer reactions 
α-Secondary hydrogen (2°) KIEs report on the effect of rehybridisation upon hydride 
transfer (28), and have been suggested to be insensitive to preorganisation or 
reorganisation effects that occur prior to the reaction. Instead, they report solely on 
the reaction ready configuration (RRC) adopted immediately prior to hydride 
transfer (153, 155). 2° KIEs were measured for EcDHFR, MpDHFR and BsDHFR with 
the intention of determining a general trend for all DHFR enzymes. Even though 
these enzymes displayed greatly different temperature dependence on the primary 
hydride KIE, all of them have essentially the same magnitude of 2° KIE and are 
temperature independent. These findings imply that there are no significant 
differences in the RRC across the experimental temperature range, and suggest that 
the RRC of the substrates is very similar in all members of this enzyme family (155). 
NADPH labelled with a 13C at the 4-position was used in heavy atom isotope effect 
measurement. Between 15 and 35 °C, the 12C/13C KIE on hydride transfer is 
approximately 1.03. Interestingly, it increases sharply to 1.10 at 5 °C. To the best of 
our knowledge, this is the largest reported carbon isotope effect on hydride 
transfer. There is a greater 12C/13C isotope effect observed on deuteride transfer 
(1.15 at 5 °C), likely due to the greater reduced mass increase. This magnitude and 
temperature dependence cannot be explained using semi-classical theory, as 
simple ZPE differences between the stretching or bending vibrational frequencies of 
isotopologues cannot explain the sharp increase at low temperature (28).  
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13C-labelling may affect either the tunnelling probability or the frequency of 
recrossing events. When applying a Marcus-like model, the increased magnitude of 
isotope effect at low temperature could be due to weakening of the "promoting" 
motion that modulates the donor acceptor distance. This would result in a wider 
reaction barrier and an increased isotope effect. Alternatively, it could result from 
an increase in the dynamic recrossing coefficient as a consequence of fs vibrational 
coupling. Lastly, the 13C labelling could affect the reorganisation of the RRC, which is 
theoretically isotopically sensitive. The observed 12C/13C on hydride transfer implies 
that the proposed reorganisation is at least partially rate determining at low 
temperature. At high temperature hydride transfer is rate limiting, thus "normal" 
carbon isotope effects are measured.  
These possibilities were probed further by measuring the carbon isotope effect on 
the primary KIE. 13C labelling has no apparent effect on the primary hydrogen KIE, 
showing values that are essentially the same as the ones obtained from 12C labelled 
cofactors. This indicated that any hypothetical "promoting" motion is unlikely 
exerting its effect via the C4 atom. Future experimental and computational studies 
will focus on any potential difference that could be masked by the limitations of 
stopped-flow spectroscopic measurement. 
Overall, fs bond vibrations in the substrate surrounding the reaction centre do 
couple to enzymatic reactions. However, at present they do not seem to directly 
couple to the barrier width and/or height. Hence, they cannot be classed as 
"promoting motions". 
 
6.3 Reconstitution of the NADP+ biosynthesis pathway 
Most bacterial species synthesise NADP+ from aspartate and dihydroxyacetone 
phosphate, in a biosynthetic pathway involving six enzymes (194). Previous studies 
identified the nad gene cluster in E. coli, and each protein was characterised 
biochemically (200, 201, 208, 211, 214, 216, 217). Accordingly, this pathway can be 
an effective tool towards the production of various isotopically labelled NADP+ 
analogues, particularly those carrying labels in the nicotinamide moiety.  
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The genes encoding the enzymes in the biosynthesis of NADP+ were cloned from E. 
coli K12 substrains and ligated into expression vectors. Each enzyme was purified 
using Ni2+ affinity chromatography, and subsequent size-exclusion chromatography 
and CD spectroscopy analysis confirmed successful production of native protein. 
With the addition of commercially available glycolysis enzymes, [1,6-13C2]-glucose 
was converted to  [3-13C]-dihydroxyacetone phosphate and then to [4-13C]-NADP+. 
Additionally, these enzymes were used to produce [amino-15N]-NAD+ and 15N-
quinolinic acid for our future studies. Our success in synthesising isotopically 
labelled NAD(P)H helps further advance the studies of DHFR, and it also opens the 
possibility to investigate other interesting enzymes that employ this cofactor.  
 
6.4 Future approaches 
This investigation has determined the role that short-range, fs bond vibrations play 
in the hydride transfer step catalysed by DHFR via the use of isotopically labelled 
enzyme and starting material, separately. While both studies cause an observable 
isotope effect, it would be of great interest to how a "heavy" enzyme reacts with 
labelled starting materials. This would enable any coupling between specific 
enzyme dynamics and those from the substrate to be observed. This current 
investigation cannot confirm the exact source for the dynamic coupling between 
enzyme and transition state. Hopefully, this proposed experiment will provide 
additional insights. 
While the NADP+ biosynthetic pathway is successfully reconstructed in the 
laboratory, we are currently focused on fully developing an efficient chemo-
enzymatic synthetic pathway for DHF. Isotope labelling on position, such as C6/N5 
of DHF would facilitate the characterisation of the TS structure. This in turn could 
lead to the development of TS analogues which could be potent inhibitors and drug 
candidates (271). This is particularly relevant in the case of DHFR, as it is valuable 
anti-bacterial and anti-malarial drug target and only few new candidates are 
currently available. 
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Lastly, we would also like to further advance our techniques in characterising the 
transition state of DHFR. In order to measure the heavy atom KIE in a highly precise 
manner required for full TS analysis (271), competitive heavy atom KIE 
measurements will be carried out. Alternative DHFR homologues in which hydride 
transfer is more rate-limiting at pH 7 will be used to minimise the problem of 
kinetic complexity. Other NAD(P)H-dependent enzymes, such as alcohol 
dehydrogenase, will also be investigated in the future. 
 
6.5 Summary 
Overall, this investigation has highlighted the role of fs bond vibrations both from 
the enzyme and the cofactor in DHFR catalysis. Results suggest that protein motions 
are crucial for the cofactor-substrate arrangement immediately prior to hydride 
transfer. However, there is no direct evidence that there is a short-range vibrational 
motion that "promotes" hydride transfer. Together with our previous works on 
DHFR, we concluded that dynamic effects greatly vary among this family of 
enzymes. While investigators often consider EcDHFR as a "paradigm" in enzymology 
studies, the dynamic characteristics of this enzyme are unlikely a universal 
phenomenon.
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7.1 Bacterial strains and their preparation 
7.1.1 Bacterial strains 
Numerous cloning and expression strains of Escherichia coli were used in this 
investigation (Table 7.1). 
 
Table 7.1 E. coli strains used during this investigation 
E. coli strain Use 
XL1-Blue PCR amplification of all genes 
JM101 Expression of nadK from pNCO-nadK 
BL21(DE3) Large scale production of E. coli and M. profunda DHFR  
BL21-CodonPlus(DE3)-RP Expression of nadA, B, C, folB, K from pET28a expression 
vectors 
BL21-StarTM(DE3) Expression of nadD, E, folE, P, C, prsA and gpt from pET 
expression vectors 
Stratagene competent cellsA Production of  cloning vectors from StrataClone Blunt 
vector kit 
XL-10 Gold Kan ultra-
competent cellsB 
Production of cloning vectors from pPCR-Script Amp SK (+) 
vector kit 
A: purchased from Agilent as part of the Strataclone Blunt PCR cloning kit 
B: purchased from Agilent as part of the PCR-Script Amp cloning kit 
 
7.1.2 Competent cells 
7.1.2.1 Calcium chloride buffer I 
Calcium chloride (1.11 g) was dissolved in  80 mL of deionised water. The total 
volume was then taken to 100 mL. The solution was sterilised via autoclave at 121 
°C for 20 minutes. 
 
7.1.2.2 Calcium chloride buffer II 
Calcium chloride (1.11 g) and glycerol (15% v/v) were added to 80 mL of deionised 
water. The total volume was then taken to 100 mL. The solution was sterilised via 
autoclave at 121 °C for 20 minutes. 
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7.1.2.3 Competent cell preparation 
50 L of the desired cell strain (Table 7.1) were incubated in 100 mL non-selective 
LB media overnight at 37 C whilst shaking. In the case of XL1-Blue tetracycline was 
added to the media (50 mg/L). 1 mL of the overnight culture was used to inoculate 
100 mL of non-selective LB media (50 mg/L tetracycline in the case of XL1-Blue) 
until an optical density of 0.6 at 600 nm was obtained. The cells were placed on ice 
for 15 minutes then harvested via centrifugation at 3400 g and the supernatant 
discarded. The cells were re-suspended in 40 mL calcium chloride buffer I (Section 
7.1.2.1), incubated on ice for 15 minutes before the centrifugation step was 
repeated. The cells were re-suspended in 4 mL calcium chloride buffer II (Section 
7.1.2.2), divided into 50 L aliquots and frozen immediately in liquid nitrogen.  
 
7.1.3 Super-competent cells 
7.1.3.1 Rubidium chloride buffer I 
Potassium acetate (0.294 g). rubidium chloride (1.21 g), calcium chloride (1.11 g), 
manganese chloride (0.692 g) and glycerol (15% v/v) were dissolved in 80 mL 
deionised water. The pH was adjusted to 5.8 using dilute acetic acid and the volume 
taken to 100 mL with deionised water. A 0.2 m syringe filter was used to sterilise 
the solution and then stored at 4 C. 
 
7.1.3.2 Rubidium chloride buffer II 
3-(N-morpholino)propanesulfonic acid (0.209 g), calcium chloride (0.832 g), 
rubidium chloride (0.121 g) and glycerol (15% v/v) were dissolved in 80 mL 
deionised water. The pH was adjusted to 6.5 using sodium hydroxide and the 
volume taken to 100 mL with deionised water. A 0.2 m syringe filter was used to 
sterilise the solution and then stored at 4 C. 
 
7.1.3.3 Super-competent cell preparation 
Super competent cells were prepared as with competent cells (Section7.1.2.3) but 
with rubidium chloride buffer I and II (Section 7.1.3.1) in replace of calcium chloride 
buffer I and II (section 7.1.3.2) respectively. 
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7.2 Growth media and sterile solutions 
7.2.1 Luria-Burtani (LB) medium 
Tryptone (30 g), yeast extract (15 g) and NaCl (30 g) were dissolved in 2.5 L of 
deionised water and the final volume taken to 3 L. The solution was sterilised in an 
autoclave at 121 °C and stored at 4 °C. Immediately before use the required 
antibiotic was added under sterile conditions. 
 
7.2.2 LB agar plates 
Tryptone (10.0 g), yeast extract (5.0 g), sodium chloride (10.0 g) and agar (15.0 g) 
were dissolved in 0.9 L of deionised water and the total volume taken to 1 L. The 
solution was sterilised in an autoclave at 121 °C for 20 minutes. When cool enough 
to hold by hand the required antibiotic was added and the LB agar poured into 
plates under sterile conditions. The solution was allowed to cool and the plates 
stored at 4 °C. 
 
 
7.2.3 Isotopically labelled media 
7.2.3.1 Trace elements 
EDTA (5 mg) was dissolved in 800 mL deionised H2O and the pH adjusted to 7.5. 
FeCl3.6H2O (0.83 g), ZnCl2 (84 mg), CuCl2.2H2O (13 mg), CoCl2.6H2O (10 mg), H3BO3 
(10 mg) and MnCl2.4H2O (1.6 mg) were added and the volume adjusted to 1 L with 
deionised H2O. The solution was sterilised in an autoclave at 121 °C, 15 lb.(sq. in)
-1 
for 20 minutes and stored at room temperature. 
 
7.2.3.2 Minimal (M9) media 
Na2HPO4 (6.76 g), KH2PO4 (3 g), NaCl (0.5 g), 1 M MgSO4 (2 mL), 1 M CaCl2 (100 μL) 
and trace elements (600 μL) were added to 900 mL [2H2, 99.9%] H2O. [
15N, 98%] 
NH4Cl (1 g) and [99%, 
13C6; 1,2,3,4,5,6,6-
2H7, 97%] glucose (4 g) were added and the 
volume taken up to 1 L with [2H2, 99.9%] H2O. The media was passed through a 
sterile 0.2 μm filter and stored at 4 °C. Immediately before use the required 
antibiotic was added under sterile conditions. 
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7.2.4 Sterile solutions 
7.2.4.1 Ampicillin solution 
Ampicillin (200 mg) was dissolved in 4 mL deionised H2O to give a concentration of 
50 mg/mL. The solution was filtered with a sterile 0.2 m syringe filter, aliquoted 
and stored at -20 C. 
 
7.2.4.2 Kanamycin solution 
Kanamycin (200 mg) was dissolved in 4 mL deionised H2O to give a concentration of 
50 mg/mL. The solution was filtered with a sterile 0.2 m syringe filter, aliquoted 
and stored at -20 C. 
 
7.2.4.3 Tetracycline 
Tetracycline (200 mg) was dissolved in 4 mL deionised H2O to give a concentration 
of 50 mg/mL. The solution was filtered with a sterile 0.2 m syringe filter, aliquoted 
and stored at -20 °C. 
 
7.2.4.4 Isopropyl--D-1-thiogalactopyranoside solution 
Isopropyl--D-1-thiogalactopyranoside (IPTG) (360 mg) was dissolved in 3 mL 
deionised H2O to give a concentration of 120 mg/mL. The solution was filtered with 
a sterile 0.2 m syringe filter, aliquoted and stored at -20 °C. 
 
7.2.4.5 50% v/v glycerol solution 
100 mL glycerol was added to 100 mL deionised H2O to give a 50% v/v mixture of 
glycerol. The solution was sterilised in an autoclave at 121 °C, 15 lb. (sq. in)-1 for 20 
minutes and stored at 4 °C. 
 
7.3 Cloning 
7.3.1 Polymerase chain reaction amplification of target genes 
Polymerase chain reaction (PCR) was used to amplify all the target genes using E. 
coli XL1-Blue chromosomal DNA as the template (Section 7.3.1.1). The primers 
(Table 7.4) were designed from sequences in the Genbank library (Table 7.2 and 
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Table 7.3) with restriction sites to ligate the target genes into the pNCO expression 
vector (BamHI and HindIII sites) and pET-21a, -21d and -28a expression vectors 
(NdeI/BamHI, NcoI/HindIII and BamHI/HindIII sites). Phusion® high fidelity 
polymerase was used and the components (Table 7.5) and conditions of the PCR 
reaction optimised for this specific polymerase and each set of primers (Table 7.6 
and Table 7.7). The products were visualised via agarose gel electrophoresis 
(Section 7.3.3). 
 
Table 7.2 NADP+ biosynthesis genes and enzymes 
ENZYME GENE NCBI GENE ID  
Quinolinate synthetase nadA 12934034 
L-aspartate oxidase nadB 947049 
Quinolinate phosphoribosyltransferase nadC 12934550 
Nicotinic acid mononucleotide 
adenylyltransferase 
nadD 12932665 
NAD synthetase nadE 12933235 
NAD kinase nadK 947092 
 
Table 7.3 DHF biosynthesis genes and enzymes 
ENZYME GENE NCBI GENE ID 
GTP cyclohydrolase I folE 949040 
Dihydroneopterin aldolase folB 947544 
Hydroxymethyl-dihydroneopterin 
pyrophosphokinase 
folK 948792 
Dihydropteroate synthetase folP 947691 
Dihydrofolate synthetase folC 945451 
Xanthine-guanine phosphoribosyltransferase gpt 944817 
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Table 7.4 Target genes and primers used for PCR amplification 
Target Gene Primers 
nadA Fwd 5'-CATATGAGCGTAATGTTTGATCCAGACAC-3' 
Bwd 5'-AAGCTTATTATCCACGTAGTGTAGCCGC-3' 
nadB Fwd 5'-CATATGAATACTCTCCCTGAACATTCATGTGA-3' 
Bwd 5'-AAGCTTATTATCTGTTTATGTAATGATTGCCGGG-3' 
nadC Fwd 5'-CATATGCCGCCTCGCCGCTATAA-3' 
Bwd 5'-AAGCTTATTAGCGAAAACGCATTGAAAGGTC-3'  
nadD Fwd 5'-GTCGAGAATGGATCCATGAAATCTTTCACG-3' 
Bwd 5'-CTGCGATGTGAAGCTTTCCGGGTAC-3' 
nadE Fwd 5'-CTTTTCTGTCTGGAGGGGATCCATGACATTGCAAC-3' 
Bwd 5'-GGCGTGAACAAAGTAAGCTTTTTCACACAAACC-3' 
nadK Fwd 5'-GGACCTCGGATCCATGAATAATCATTTCAAG-3' 
Bwd 5'-GAGGCTGGAAGCTTATTAGAATAATTTTTTTGACC-3' 
folB Fwd 5'-CATATGGATATTGTATTTATAGAGCAACTTTC-3' 
Bwd 5'-GGATCCTTATTAATTATTTTCTTTCAGATTATTGCC-3' 
folC Fwd 5'-GCGGAACATATGATTATCAAACGC-3' 
Bwd 5'-CCACTAACCGAGGATCCTTATTACTTGCCAC-3' 
folE Fwd 5’-CCATGGATGCCATCACTCAGTAAAGAAGC-3’ 
Bwd 5’-AAGCTTTTATCAGTTGTGATGACGCACAGC-3’ 
folK Fwd 5’-GGGTACCATATGACAGTGG-3’ 
Bwd 5’-CGCAATGGATCCTTATTACCATTTGTT-3’ 
gpt Fwd 5’-CATATGAGCGAAAAATACATCGTCACCT-3’  
Bwd 5’-AAGCTTATTAGCGACCGGAGATTGG-3’  
glyA Fwd 5’-CATATGTTAAAGCGTGAAATGAACATTGCCGATTAT-3’  
Bwd 5’-AAGCTTATTATGCGTAAACCGGGTAACGTGC-3’  
Restriction sites are shown in bold. 
 
 
7.3.1.1 E. coli XL1-Blue chromosomal DNA 
E. coli XL1-Blue cells (~ 40 μL) were defrosted slowly on ice, streaked onto a 
tetracycline selective LB agar plate and incubated overnight at 37 °C. A single colony 
was then dipped into each PCR reaction mixture (Table 7.5) to provide a source of 
E. coli XL1-Blue chromosomal DNA. 
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Table 7.5 Components of the PCR reactions 
Component Volume (μL) 
dNTPs (40 mM total, 10 mM each NTP) 1 
Forward primer (25 μM) 1 
Backward primer (25 μM) 1 
E. coli XL1-Blue chromosomal DNA One colony* 
Phusion polymerase GC buffer 10 
MgCl2 2 μL 
Sterile dH2O Make up to 50 μL 
Phusion® high fidelity polymerase (1 unit/μL) 0.5 
* One colony per reaction was scraped from a plate and dipped into the PCR mixture 
 
Table 7.6 Conditions used for PCR amplification of NADPH biosynthesis genes 
Step 
Target gene 
nadA nadB, nadC nadD, nadE nadK 
Initial 
denaturation 
180 s, 98 °C 
Denaturation* 10 s, 98 °C 
Annealing 60 s, 69 °C 60 s, 67 °C 30s, 44.5 °C 30 s, 65 °C 
Extension 45 s, 72 °C 90s, 72 °C 45 s, 72 °C 30 s, 72 °C 
Final Extension 600 s, 72 °C 
* The denaturation, annealing and elongation step was cycled 35 times, except for nadD 
which was cycled 40 times. 
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Table 7.7 Conditions used for PCR amplification of dihydrofolate biosynthesis genes 
Step 
Target gene 
folB folC, folK folE gpt 
Initial 
denaturation 
180 s, 98 °C 
Denaturation* 10 s, 98 °C 
Annealing 30 s, 42 °C 30 s, 43 °C 30 s, 67 °C 60 s, 69 °C 
Extension 45 s, 72 °C 
Final Extension 600 s, 72 °C 
* The denaturation, annealing and elongation step was cycled 35 times 
 
7.3.2 Site-directed Mutagenesis 
Site-directed mutagenesis was used to insert or alter a number of DNA bases for 
two genes. Specific primers (Table 7.8) were designed to insert one base into the 
folE gene to shift the reading frame, and to introduce three different amino acids 
into the folB gene. 39 L sterile dH2O (sterilised in an autoclave at 121 °C, 15 lb.(sq. 
in)-1 for 20 minutes), 5 L Pfu-polymerase buffer, 1 L dNTPs, 2 L forward and 
backward primers (Table 7.8), 1 L template DNA and 1 L Pfu-polymerase were 
added to a PCR tube and underwent site-directed mutagenesis (Table 7.9). After the 
site-directed mutagenesis was complete the reaction incubated at 37 °C with 1 μL 
DpnI for 1 hour. The reaction was cooled on ice before transformation into XL1-Blue 
E. coli cells.  
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Table 7.8 Primers for site-directed mutagenesis 
Gene Mutation Primers 
pE21d-folE (frame shift) Fwd 5’-GGAGATATACCATGATGCCATCACTCAG-3’ 
Bwd 5’-CTGAGTGATGGCATCATGGTATATCTCC-3’ 
pET28a-folB K38N Fwd 5’-GAAATGGCGTGGGATAACCGTAAAGCGGCGAAAAG-3’ 
Bwd 5’-CTTTTCGCCGCTTTACGGTTATCCCACGCCATTTC-3’ 
pET28a-folB T70A Fwd 5’-GGGGCGCGTTTTGCGCTGGTGGAAC-3’ 
Bwd 5’-GTTCCACCAGCGCAAAACGCGCCCC-3’ 
pET28a-folB A108V Fwd 5’-CGCGGGCGGCGAATGTTGGCGTAATCATTG-3’ 
Bwd 5’-CAATGATTACGCCAACATTCGCCGCCCGCG-3’ 
 
Table 7.9 Conditions used for site-directed mutagenesis 
Step Temperature (°C) Time (min) 
Initial denaturation 95 3 
Denaturation* 
Annealing 
Elongation 
95 
55 
72 
1 
2 
10 
Final Elongation 72 10 
* The denaturation, annealing and elongation step was cycled 15 times 
 
7.3.3 DNA visualisation 
7.3.3.1 TAE buffer 
Tris base (242 g), glacial acetic acid (57.1 mL) and 100 mL EDTA (0.5 M, pH 8.0) were 
dissolved in 900 mL deionised water. The total volume was taken to 1 L with 
deionised water. Immediately prior to use the solution was diluted in a 1:49 ratio 
with deionised water. 
 
7.3.3.2 DNA loading buffer 
Glycerol (3 mL) and 0.5% bromophenol blue solution (2 μL) were added to 7 mL 
deionised water. 
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7.3.3.3 Agarose gel electrophoresis 
Agarose gels were prepared using dilute TAE buffer (Section 7.3.3.1) in a 1% w/v 
ratio. 5 μL DNA loading buffer (Section 7.3.3.2) was added to the DNA sample which 
was then loaded onto the gel and run at a constant voltage of 100 V for 1 hour 
before being placed in a dilute ethidium bromide solution for 10 minutes whilst 
shaking. The DNA bands were visualised using a Syngene GeneFlash UV light box 
(Syngene, Cambridge, UK) and compared to a molecular weight ladder run on the 
same gel. 
 
7.3.4 Cloning of PCR products into holding vectors 
The NADPH and DHF synthesis genes were cloned into pPCR-Script (nadD and nadE) 
and Strataclone holding vectors (all others) directly following the PCR amplification. 
 
7.3.4.1 Cloning into pPCR-Script vector 
pPCR-Script Amp SK(+) cloning vector(1 μL),PCR-Script 10× reaction buffer (1 μL), 10 
mM rATP (0.5 μL), PCR product (2 μL), SrfI restriction enzyme (5 U/μL, 1 μL), T4 DNA 
ligase (4U/μL, 1 μL) and distilled water (3.5 μL) were incubated for 1 hour at room 
temperature. The reaction was then heat shocked for 10 minutes at 65 °C and the 
reaction frozen for later use or immediately used to transform ultra-competent 
cells (Section 7.3.8). 
 
7.3.4.2 Cloning into StrataClone PCR cloning vector 
StrataClone Blunt Cloning Buffer (3 μL), PCR product (2 μL) and StrataClone Blunt 
Vector Mix amp/kan (1 μL) were incubated at room temperature for 5 minutes and 
the reaction frozen for later use or immediately used to transform ultra-competent 
cells (Section 7.3.8). 
 
7.3.5 DNA purification 
7.3.5.1 Miniprep of DNA 
A single colony from an agar plate, or a spike from a glycerol stock, harbouring the 
required transformed cells was used to inoculate 10 mL of LB medium (containing 
the appropriate selective antibiotic) and incubated overnight at 37 °C whilst 
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shaking. Cells were harvested by centrifugation at 3400g for 5 minutes. The 
QIAprep spin miniprep kit (QIAGEN, Crawley, UK) was used with EconoSpin All-in-1 
mini spin columns (Epoch Biolabs, Inc, TX, USA) to purify the plasmid following the 
manufacturer’s protocol.  
 
7.3.5.2 Agarose gel DNA purification 
The required samples underwent agarose gel electrophoresis (Section 7.3.3.3) and 
the DNA visualised by staining in dilute ethidium bromide solution. DNA bands were 
visualised using a Syngene GeneFlash UV light box (Syngene, Cambridge, UK) and 
the appropriate DNA bands cut from the agarose gel using a razor blade. DNA was 
extracted from the agarose gel using a QIAquick gel extraction kit (QIAGEN, 
Crawley, UK) with EconoSpin All-in-1 mini spin columns (Epoch Biolabs, Inc, TX, 
USA) following the manufacturer’s protocol. 
 
7.3.6 Restriction digest of DNA 
Manufacturer’s guidelines regarding temperature, buffers and denaturation were 
followed in all restriction enzyme digests (Table 7.10). Restriction digests involving 
NdeI were performed sequentially with the required restriction enzymes for 4 hours 
each at 37 °C where possible. NdeI was heat inactivated at 60 °C for 20 minutes 
before addition of the second enzyme. In cases where neither enzyme could be 
denatured the first restriction enzyme was incubated for 4 hours at 37 °C followed 
by the addition of the second restriction enzyme for a further 4 hours at 37 °C.  
Restriction enzymes were removed via agarose gel purification (Section 7.3.3). 
 
Table 7.10 Enzymes used for restriction digestion of DNA 
Gene (vector) Restriction enzymes 
nadA, nadB, nadC, gpt (pET28a) NdeI and HindIII 
nadD, nadE (pET28a) BamHI and HindIII 
nadK (pNCO) BamHI and HindIII 
folB, folK (pET28a) NdeI and BamHI 
folC, folP (pET21a) NdeI and HindIII 
folE (pET21d) NcoI and HindIII 
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7.3.7 Ligation of DNA into expression vectors 
Following restriction digest and agarose gel purification, the required gene and 
expression plasmid were ligated to form new expression vector constructs. Plasmid 
and gene in a 1:5 ratio was incubated with 2 μL T4 DNA ligase buffer and sterile 
dH2O (sterilised in an autoclave at 121 °C, 15 lb.(sq. in)
-1 for 20 minutes) in a volume 
of 20 μL. 1 μL T4 DNA ligase was added and the ligation reaction incubated for 2 
hours at 25 °C. The reaction was frozen for later use or immediately used to 
transform ultra-competent cells (Section 7.3.8). 
 
7.3.8 Transformation of competent cells 
The appropriate competent cells and plasmid DNA were allowed to thaw slowly on 
ice. 2 μL plasmid DNA solution (5-10 μL in the case of ligation reactions) was 
transferred to the competent cells and mixed gently. The cell/DNA mixture was 
incubated on ice for at least 20 minutes, heat shocked at 42 °C for 45 seconds and 
returned to ice for at least 2 minutes. Non-selective LB medium (1 mL) was added 
to the cell/DNA mixture and incubated at 37 °C for 1 hour whilst shaking for 
plasmids with ampicillin resistance and 1 hour 15 minutes at 37 °C whilst shaking 
for plasmids with kanamycin resistance. Cells were harvested by centrifugation for 
1 minute at 3300 g (Eppendorf centrifuge 5415R) and the supernatant solution 
discarded. The cell pellet was re-suspended in 100 μL of LB medium, plated on agar 
plates containing the appropriate antibiotic and incubated at 37 °C overnight. 
 
7.4 Gene expression 
7.4.1 Unlabelled enzymes 
E. coli cells containing a plasmid harbouring the target gene were incubated 
overnight  in LB medium (100 mL) at 37 °C overnight whilst shaking and used to 
inoculate LB medium (5 mL of culture per 500 mL of LB medium). The cultures were 
incubated at 37 °C until an optical density of 0.6 AU at 600 nm was reached. 
Isopropyl-β-D-1-thiogalactopyranoside (IPTG) (60 mg) was added to the LB medium 
and incubated for the required time and temperature (Table 7.11 and Table 7.12). 
The induced cells were harvested via centrifugation at 3400 g for 20 minutes. 
Materials & Methods 
 
183 
 
Table 7.11 Conditions used for expression of NADPH and DHF genes 
Gene E. coli expression strain 
Induction 
temperature (°C) 
Time (hours) 
nadA * BL21-CodonPlus(DE3)-RP** 25 Overnight (O/N) 
nadB BL21-CodonPlus(DE3)-RP 25 O/N 
nadC BL21-CodonPlus(DE3)-RP 25 O/N 
nadD BL21-StarTM(DE3) 37 4 
nadE BL21-StarTM(DE3) 25 O/N 
nadK JM101 37 4 
folE BL21-StarTM(DE3) 25 O/N 
folB BL21-CodonPlus(DE3)-RP 37 4 
folK BL21-CodonPlus(DE3)-RP 37 4 
folP BL21-StarTM(DE3) 25 O/N 
folC BL21-StarTM(DE3) 25 O/N 
prsA *** BL21-StarTM(DE3) 37 4 
gpt BL21-StarTM(DE3) 25 O/N 
*  FeCl3 was added to the media at induction to give a final concentration of 50 µM 
**  Cells contained the pB1282 plasmid, a kind gift from Prof Squire Booker, Pennsylvania State 
University. Arabinose was added at OD600=0.3 to induce the expression of the isc operon 
encoded. 
*** The vector containing PRPP synthetase was a kind gift from Prof Jamie Williamson, The 
Scripps Research Institute  
 
Table 7.12 Conditions used for expression of DHFR genes 
DHFR genes E.coli expression cells 
Induction 
temperature 
(°C) 
Time (hours) 
M. profunda DHFR BL21 (DE3) 16 O/N 
E. coli DHFR BL21 (DE3) 37 4 
B. stearothermophilus DHFR BL21-StarTM(DE3) 25 O/N 
 
7.4.2 Isotopically labelled BsDHFR 
E. coli BL21(DE3) Star cells harbouring the recombinant BsDHFR construct from an 
overnight culture in LB medium containing 100 µg/mL ampicillin were washed three 
times with M9 medium and then grown in 1 L M9 medium until the OD600 reached 
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0.6. IPTG (0.5 mM) was added and the culture grown to an OD600 of 2.0. The cells 
were harvested by centrifugation for 30 min at 6000g, and the pellet was 
resuspended in 50 mM Tris (pH 9.0) containing 5 mM β-mercaptoethanol and 
sonicated for 10 min on ice. The cell lysate was heated to 55 °C for 15 min and 
precipitated proteins were separated by centrifugation for 30 min at 16000 g. The 
supernatant solution containing BsDHFR was fractionated by HiPrep 16/10 DEAE 
anion-exchange chromatography (GE Healthcare) in 50 mM Tris pH 9.0 with a 
gradient of 0-1 M NaCl. The pooled DHFR fractions were concentrated and 
subjected to size-exclusion chromatography using a Superdex75 column (320 mL 
column volume (CV), GE Healthcare) in 50 mM potassium phosphate (5 mM β-
mercaptoethanol, pH 7). Labelled (heavy) BsDHFR was produced as described for 
the unlabelled enzyme in M9 medium using [2H2, 99.9%] H2O supplemented with 1 
g/L [15N, 98%] NH4Cl and 2 g/L [99%, 
13C6; 1,2,3,4,5,6,6-
2H7, 97%] glucose (heavy 
medium). The purity of the enzyme was assessed by SDS-PAGE. 
 
7.5 Enzyme purification 
7.5.1 Phosphate stock solutions 
7.5.1.1 1 M KH2PO4 
KH2PO4 (68.1 g) was added to 450 mL deionised water. The volume was taken to 
500 mL and the solution was stored at 4 °C. 
 
7.5.1.2 1 M K2HPO4 
K2HPO4 (87.1 g) was added to 450 mL deionised water. The volume was taken to 
500 mL and the solution was stored at 4 °C.  
 
7.5.2  Purification buffers 
7.5.2.1 Purification buffer A 
Tris base (6.1 g), NaCl (17.5 g), and imidazole (1.4 g) were added to 950 mL of 
deionised water. The pH was adjusted to 8.0 using 6 M HCl and the total volume 
taken to 1 L with deionised water to give a final concentration of 50 mM Tris base, 
300 mM NaCl and 20 mM imidazole. The solution was filtered and degassed via 
vacuum pump (Vacuubrand GmbH +CO KG, MD4C, Werthein, Germany) and stored 
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at room temperature. 
 
7.5.2.2 Purification buffer B 
Tris base (6.1 g), NaCl (17.5 g), and imidazole (17.0 g) were added to 950 mL of 
deionised water. The pH was adjusted to 8.0 using 6 M HCl and the total volume 
taken to 1 L with deionised water to give a final concentration of 50 mM Tris base, 
300 mM NaCl and 250 mM imidazole. The solution was filtered and degassed via 
vacuum pump (Vacuubrand GmbH +CO KG, MD4C, Werthein, Germany) and stored 
at room temperature. 
 
7.5.2.3 Purification buffer C 
HEPES (11.9 g), NaCl (17.5 g), imidazole (1.4 g) and βME (2 mL) were added to 950 
mL of deionised water. The pH was adjusted to 8.0 using 6 M HCl and the total 
volume taken to 1 L with deionised water to give a final concentration of 50 mM 
HEPES, 300 mM NaCl, 20 mM imidazole and 0.2% v/v βME. The solution was 
filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, 
Werthein, Germany) and used immediately. 
 
7.5.2.4 Purification buffer D 
HEPES (11.9 g), NaCl (17.5 g), imidazole (17.0 g) and βME (2 mL) were added to 950 
mL of deionised water. The pH was adjusted to 8.0 using 6 M HCl and the total 
volume taken to 1 L with deionised water to give a final concentration of 50 mM 
HEPES, 300 mM NaCl, 250 mM imidazole and 0.2% v/v βME. The solution was 
filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, 
Werthein, Germany) and used immediately. 
 
7.5.2.5 Purification buffer E 
HEPES (11.9 g), NaCl (1.4 g), imidazole (17.0 g) and βME (700 μL) were added to 950 
mL of deionised water. The pH was adjusted to 8.0 using 6 M HCl and the total 
volume taken to 1 L with deionised water to give a final concentration of 50 mM 
HEPES, 300 mM NaCl, 20 mM imidazole and 10 mM βME. The solution was filtered 
and degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, Werthein, 
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Germany) before bubbling with N2 for 30 minutes and placed in a glove box with 
the cap removed for 24 hr.  
 
7.5.2.6 Purification buffer F 
HEPES (11.9 g), NaCl (17.5 g), imidazole (17.0 g) and βME (700 μL) were added to 
950 mL of deionised water. The pH was adjusted to 8.0 using 6 M HCl and the total 
volume taken to 1 L with deionised water to give a final concentration of 50 mM 
HEPES, 300 mM NaCl, 250 mM imidazole and 10 mM βME. The solution was filtered 
and degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, Werthein, 
Germany) before bubbling with N2 for 30 minutes and placed in a glove box with 
the cap removed for 24 hr.  
 
7.5.2.7 Purification buffer G 
Tris base (6.1 g) and βME (350 μL) were added to 950 mL of deionised water. The 
pH was adjusted to 8.0 using 6 M HCl and the total volume taken to 1 L with 
deionised water to give a final concentration of 50 mM Tris base and 10 mM βME. 
The solution was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO 
KG, MD4C, Werthein, Germany) and stored at room temperature. 
 
7.5.2.8 Purification buffer H 
Tris base (6.1 g), NaCl (58.4 g) and βME (350 μL) were added to 950 mL of deionised 
water. The pH was adjusted to 8.0 using 6 M HCl and the total volume taken to 1 L 
with deionised water to give a final concentration of 50 mM Tris base, 1 M NaCl and 
5 mM βME. The solution was filtered and degassed via vacuum pump (Vacuubrand 
GmbH +CO KG, MD4C, Werthein, Germany) and stored at room temperature. 
 
7.5.2.9 Purification buffer I 
1 M K2HPO4 (30.5 mL, section 7.5.1.2), 1 M KH2PO4 (19.5 mL, section 7.5.1.1) and 
βME (350 μL) were added to 900 mL deionised water. The pH was adjusted to 7.0 
using 1 M HCl and the total volume taken to 1 L with deionised water to give a final 
concentration of 50 mM KiPO4 and 5 mM βME. The solution was filtered and 
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degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, Werthein, 
Germany) and stored at room temperature. 
 
7.5.2.10 Purification buffer J 
1 M K2HPO4 (30.5 mL, section 7.5.1.2), 1 M KH2PO4 (19.5 mL, section 7.5.1.1), NaCl 
(58.4 g) and βME (350 μL) were added to 900 mL deionised water. The pH was 
adjusted to 7.0 and the total volume taken to 1 L with deionised water to give a 
final concentration of 50 mM KiPO4, 1 M NaCl and 5 mM βME. The solution was 
filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, 
Werthein, Germany) and stored at room temperature. 
 
7.5.2.11 Purification buffer K 
Tris base (6.1 g) and βME (350 μL) were added to 950 mL of deionised water. The 
pH was adjusted to 9.0 using 6 M HCl and the total volume taken to 1 L with 
deionised water to give a final concentration of 50 mM Tris base and 5 mM βME. 
The solution was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO 
KG, MD4C, Werthein, Germany) and stored at room temperature. 
 
7.5.2.12 Purification buffer L 
Tris base (6.1 g), NaCl (58.4 g) and βME (350 μL) were added to 950 mL of deionised 
water. The pH was adjusted to 9.0 using 6 M HCl and the total volume taken to 1 L 
with deionised water to give a final concentration of 50 mM Tris base, 1 M NaCl and 
5 mM βME. The solution was filtered and degassed via vacuum pump (Vacuubrand 
GmbH +CO KG, MD4C, Werthein, Germany) and stored at room temperature. 
 
7.5.3 Purification Methods 
Each protein was purified using the method shown (Table 7.13) 
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Table 7.13 Purification methods used for each protein 
Purification Methods Protein 
Method 1 
L-Aspartate oxidase, quinolinate 
phosphoribosyltransferase, nicotinic acid mononucleotide 
adenylyltransferase, NAD synthetase, NAD kinase, 
xanthine-guanine phosphoribosyltransferase, 
dihydroneopterin aldolase, hydroxymethylpterin 
pyrophosphokinase 
Method 2 Quinolinate synthetase (aerobic purification) 
Method 3 Quinolinate synthetase (anaerobic purification) 
Method 4 
GTP cyclohydrolase I, dihydropteroate synthetase, 
dihydrofolate synthase 
Method 5 E. coli DHFR, M. profunda DHFR 
Method 6 G. stearothermophilus DHFR 
 
7.5.3.1 Method 1 
Induced cells harvested after expression (Section 7.4) were resuspended in 
purification buffer A (Section 7.5.2.1) and lysed by sonication (5 second sonication 
period followed by 10 second rest period for a total of 15 minutes). The solution 
was clarified by centrifugation at 4 °C, 24300 g for 30 minutes. The supernatant was 
then applied to a Ni-NTA column pre-equilibrated with 5 CV binding buffer. The 
flow through was collected and the column was washed with 10 CV binding buffer 
before elution with 5 CV purification buffer B (Section 7.5.2.2). All fractions were 
analysed by SDS-PAGE and fractions containing the target protein were dialysed 
against 5 mM KiPO4, 5 mM βME. 
 
7.5.3.2 Method 2 
Induced cells harvested after expression (Section 7.4) were resuspended in 
purification buffer C (Section 7.5.2.3) and argon bubbled through the solution for 
15 minutes before the cells were lysed by sonication (5 second sonication period 
followed by 5 second rest period for a total of 6 minutes). The solution was bubbled 
with argon for 3 minutes then clarified by centrifugation at 4 °C, 24300 g for 30 
minutes. The supernatant was then applied to a Ni2+-NTA column pre-equilibrated 
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with 5 CV binding buffer with a nitrogen line in the column. The flow through was 
collected and the column was washed with 10 CV binding buffer before elution with 
5 CV purification buffer D (Section 7.5.2.4) under nitrogen. The elution was 
collected in 5 mL fractions and the most 3 most concentrated (by colour) were 
immediately passed through a Sephadex-G25 column, pre-equilibrated in 
purification buffer C, whilst under nitrogen.  
 
7.5.3.3 Method 3 
Induced cells harvested after expression (Section 7.4) were frozen in liquid nitrogen 
and transferred to a glove box.  Cells were then defrosted and resuspended in 
purification buffer E (Section 7.5.2.5) lysed by sonication (5 second sonication 
period followed by 10 second rest period for a total of 15 minutes). The solution 
was sealed in air-tight centrifuge tubes before being transferred out of the glove 
box and then clarified by centrifugation at 4 °C, 24300 g for 30 minutes. The sealed 
tubes were transferred back into the glove box and the supernatant was then 
applied to a Ni2+-NTA column pre-equilibrated with 5 CV binding buffer. The flow 
through was collected and the column was washed with 10 CV binding buffer 
before elution with 5 CV purification buffer F (Section 7.5.2.6). The elution was 
collected in 5 mL fractions and the 3 most concentrated (by colour) were 
immediately passed through a CentriPure P25 desalting column, pre-equilibrated in 
purification buffer E. 
 
7.5.3.4 Method 4 
Induced cells harvested after expression (Section 7.4) were resuspended in 
purification buffer G (Section 7.5.2.7) and lysed by sonication (5 second sonication 
period followed by 10 second rest period for a total of 15 minutes). The solution 
was clarified by centrifugation at 4 °C, 24300 g for 30 minutes and the supernatant 
loaded onto a Q-sepharose anion exchange column (~60 mL CV). Flow through was 
collected and the column washed with purification buffer G for 4 CV until baseline 
absorbance was reached. An NaCl gradient was applied in 2 stages from 0.0-0.5 M 
NaCl (50% purification buffer H, Section 7.5.2.8) over 4 CV followed by 0.5-1.0 M 
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NaCl (100% buffer H) over 0.1 CV. Fractions were collected (10 mL) and the 
absorbance was monitored at 280 nm. All fractions were analysed by SDS-PAGE and 
fractions containing the target protein were dialysed against 5 mM KiPO4, 5 mM 
βME. 
 
7.5.3.5 Method 5 
Protein was purified as in method 4 (section 7.5.3.4) with the exception that 
purification buffers I and J (section 7.5.2.9 and 7.5.2.10) were used in place of 
purification buffers G and H respectively. Fractions containing the desired protein 
from the Q-sepharose column were concentrated to a volume of ~10 mL using an 
Amicon ultrafiltration device. The concentrated solution was loaded onto a 
Superdex75 size exclusion column (320 mL CV) equilibrated with purification buffer 
M. The sample was eluted using buffer I (1.5 CV) and fractions collected (10 mL). 
The point of elution of the desired protein was determined using a DHFR activity 
assay and SDS-PAGE was used to determine the purity of the protein. 
 
7.5.3.6 Method 6 
Induced cells harvested after expression were resuspended in purification buffer A 
and lysed by sonication (5 second sonication period followed by 10 second rest 
period for a total of 15 minutes). The solution was heat shocked at 55 °C for 10 
minutes before clarification by centrifugation at 4 °C, 24300 g for 30 minutes. The 
supernatant was loaded onto a DEAE anion exchange column (~60 mL CV). Flow 
through was collected and the column washed with purification buffer K (section 
7.5.2.11) for 2 CV until baseline absorbance was reached. An NaCl gradient was 
applied in 2 stages from 0.0-0.5 M NaCl (50% purification buffer L, section 7.5.2.12) 
over 4 CV followed by 0.5-1.0 M NaCl (100% buffer L) over 0.1 CV. Fractions were 
collected (12 mL) and the absorbance was monitored at 280 nm. The point of 
elution of the desired protein was determined using a DHFR activity assay and SDS-
PAGE was used to determine the purity of the protein. 
Fractions containing the desired protein were concentrated to a volume of ~10 mL 
using an Amicon ultrafiltration device. The concentrated solution was loaded onto a 
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Superdex75 size exclusion column (320 mL CV) equilibrated with purification buffer 
M. The sample was eluted using buffer I (1.5 CV) and fractions collected (10 mL). 
The point of elution of the desired protein was determined using a DHFR activity 
assay and SDS-PAGE was used to determine the purity of the protein. 
 
7.6 SDS-PAGE 
7.6.1 Resolving gel (10%) 
30% acrylamide/bis-acrylamide (3.3 mL), resolving buffer (2.5 mL, Section 7.6.4), 
10% (w/v) SDS (0.1 mL) and deionised water (4.1 mL) were mixed together. 
Immediately prior to pouring, freshly made 10% ammonium persulfate (APS, 50 μL) 
and N,N,N',N'-tetramethylenediamine (TEMED, 20 μL) were added and the solution 
gently mixed to initiate polymerisation. 
  
7.6.2 Stacking gel (4%) 
30% acrylamide/bis-acrylamide (1.3 mL), stacking buffer (2.5 mL, Section 7.6.3), 
10% (w/v) SDS (0.1 mL) and deionised water (6.1 mL) were mixed together. 
Immediately prior to pouring, freshly made 10% ammonium persulfate (APS, 50 μL) 
and N,N,N',N'-tetramethylenediamine (TEMED, 20 μL) were added and the solution 
gently mixed to initiate polymerisation. 
 
7.6.3 SDS stacking buffer 
Tris base (6 g) was added to 60 mL deionised water and the pH adjusted to 6.8. The 
final volume was taken up to 100 mL. 
 
7.6.4 SDS resolving buffer 
Tris base (27.23 g) was dissolved in 80 mL deionised water and the pH adjusted to 
8.8. The final volume was taken to 150 mL. 
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7.6.5 Running buffer 
Tris base (30.3 g), glycine (144.0 g) and SDS (10.0 g) was added to 900 mL deionised 
water. The final volume was taken up to 1 L with deionised water. Buffer was 
diluted 1:9 with deionised water immediately prior to use. 
7.6.6 SDS-PAGE protocol 
Monomer solutions were prepared (Section 7.6.1 and 7.6.2). When the resolving gel 
had been poured it was covered with a layer of isopropanol and allowed to 
polymerise. Isopropanol was then removed and the stacking gel poured and a comb 
inserted to create loading wells. Fraction samples (10 μL) were incubated with 
protein marker (10 μL) for 10 minutes at 85 °C and loaded into the gel. Running 
buffer (section 7.6.5) was added and the gel allowed to run at 150 V for 45 minutes. 
 
7.7 Enzyme storage 
QAPRT, NAMNT, NAD kinase, GTP cyclohydrolase I, PRPP synthetase and XGPRT 
were stored by lyophilising the enzymes. After purification and dialysis into 5 mM 
KiPO4, 5 mM βME the enzyme solutions were frozen in liquid nitrogen, lyophilised 
and stored in aliquots at -20 °C. 
 
7.8 Enzyme activity assays 
7.8.1 Assay buffers 
7.8.1.1 Assay buffer 1 
HEPES (2.4 g) and NaCl (0.6 g) were added to 150 mL of deionised water. The pH 
was adjusted to 8.0 using 6 M HCl and the total volume taken to 200 mL with 
deionised water to give a final concentration of 50 mM HEPES and 50 mM NaCl. The 
solution was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, 
MD4C, Werthein, Germany) and used immediately. 
 
7.8.1.2 Assay buffer 2 
1 M K2HPO4 (12.3 mL, section 7.5.1.2), 1 M KH2PO4 (7.7 mL, section 7.5.1.1), NaCl 
(1.17 g) and 1 M MgCl2 (2 mL) were added to 150 mL deionised water. The pH was 
adjusted to 7.0 and the total volume taken to 200 mL with deionised water to give a 
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final concentration of 50 mM KiPO4, 100 mM NaCl and 10 mM MgCl2. The solution 
was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, 
Werthein, Germany). 
 
7.8.2 L-Aspartate oxidase 
LAO activity was assayed either via UV-Vis by coupling the reaction to horseradish 
peroxidase (HRP) and monitoring at 436 nm or by directly through the absorption of 
FAD and FADH2 at 450 nm. For the coupled assay stock solutions of FAD (4 mg/mL), 
σ-dianisidine (5 mg/mL it EtOH) 3 mg HRP and aspartate (13 mg/mL) were made up 
in assay buffer 1 (section 7.8.1.1). 4 μL FAD stock solution, 20 μL σ-dianisidine stock 
solution and 100 μL aspartate stock solution were added to a cuvette to give final 
concentrations of 20 μM FAD, 0.01% v/v σ-dianisidine, and 10 mM aspartate. The 
volume was brought to 850 μL with assay buffer 1, before the addition of 50 μL HRP 
stock solution and 100 μL LAO (approx. 100 μM stock solution) to initiate the 
reaction. The absorption change at 436 nm was followed. 
For the direct assay 100 μL aspartate stock solution and 4 μL FAD stock solution 
were added to a cuvette and the volume taken to 900 μL with assay buffer 1 
(section 7.8.1.1) to give final concentrations of 100 mM aspartate and 20 μM FAD. 
100 μL LAO (approx. 100 μM stock solution) was added to start the reaction and the 
absorption at 450 nm was measured. 
 
7.8.3 NAD kinase 
NAD kinase activity was assayed via UV-Vis by coupling the reaction to TbADH 
activity. Stock solution of NAD and ATP was made up (5 mg in 1 mL assay buffer 2 
(section 7.8.1.2)) and 100 μL of each added to a cuvette. 10 L TbADH (2 mg/mL) 
and 100 L isopropanol was added and the volume taken up to 900 L with assay 
buffer 2. 100 L NAD kinase was added (typically 10 M final concentration) and 
the increase in absorption at 340 nm monitored over 15 minutes. 
 
7.8.4 GTP cyclohydrolase I 
GTP cyclohydrolase I was assayed via UV-Vis spectroscopy. 0.2 μL GTP (100 mM) 
was added to 900 μL assay buffer 2 (section 7.8.1.2). 100 μL GTP cyclohydrolase 
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was added (typically 10 μM final concentration) and the increase in absorption at 
330 nm was monitored. 
 
7.8.5 PRPP synthetase 
PRPP synthetase was assayed via UV-Vis spectroscopy by coupling the reaction to 
myokinase (MK), pyruvate kinase (PK) and lactose dehydrogenase activity. Stock 
solutions of ATP, ribose 5-phosphate, phosphoenolpyruvate (PEP) and NADH were 
made up (5 mg in 1 mL assay buffer 2 (section 7.8.1.2)) and 100 L of each added to 
a cuvette. 5 L PK (5 mg/mL), 2 μL MK ((NH4)2SO4 suspension) 5 L LDH (5 mg/mL) 
were added and the volume taken up to 900 L with assay buffer 2.  100 L of PRPP 
synthetase (typically 10 M final concentration in cuvette) was added and the 
decrease in absorption at 340 nm monitored over 15-20 minutes. 
 
7.8.6 DHFR  
Steady state kinetics were performed on a Jasco V-660 spectrometer. The cuvettes 
used all have a pathlength of 10 mm. Assay buffer 2 (section 7.8.1.2) was incubated 
with the sample fraction (0.5-10 μL) and NADPH (100 μM). The reaction was started 
by the addition of DHF (100 μM). The oxidation of NADPH was monitored at 340 nm 
and a linear decrease in the absorbance was recorded over time. A linear fit was 
applied to the decrease in absorbance signal using the software provided (Spectra 
Analysis, Spectra Manager Version 203.02© JASCO corporation). Initial velocities 
were recorded up to 40 seconds and any fractions with an absorbance change >0.5 
AU were pooled and concentrated to ~15 mL. 
 
7.9 Enzyme concentration determination 
7.9.1 Bradford Assay 
7.9.1.1 Bradford reagent  
Brilliant blue G250 (20 mg) was dissolved in 2 mL of ethanol and H3PO4 added (80%, 
20 mL). The final volume was brought up to 200 mL with dH2O and stored in the 
dark at 4 °C. 
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7.9.1.2 Bradford assay 
A 1 mg mL-1 sample of bovine serum albumin (BSA) in dH2O was used to prepare a 
range of concentrations from 0 to 100 µg mL-1 in 200 µL deionised water. Bradford 
reagent (1 mL, section 7.9.1.1)) was added and the absorbance measured from 400 
to 600 nm using a Jasco V-660 spectrophotometer. The ratio of absorbances at 590 
nm and 450 nm was calculated and used to plot a standard curve. The procedure 
was repeated for the purified proteins and the ratio of absorbances compared to 
the BSA standard to calculate the concentration of each sample. 
 
7.9.1.3 UV-Vis assay 
Filtered and degassed potassium phosphate (100 mM, pH 7) was used. The Beer-
Lambert law was used to calculate the concentration (mg mL-1) of all the protein 
solutions using a Jasco V-660 spectrophotometer: 
 
A = ε.c.l 
 
where A = absorbance at the given wavelength, ε = the extinction coefficient, c = 
concentration of the sample and l = the pathlength of the cuvette (cm). Average 
extinction coefficients for proteins at 205, 210, 215 and 220 nm (ε = 31, 20, 15 and 
11 mL mg-1 cm-1 respectively) were used, and the concentration in mg mL-1 was 
divided by the molecular weight of the protein (~18000 g mol-1) to give a molar 
concentration. 
 
 
7.10 NADPH biosynthesis 
7.10.1 Purification buffers 
7.10.1.1 Purification buffer M 
1 M K2HPO4 (9.6 mL, section 7.5.1.2) and 1 M KH2PO4 (0.6 mL, section 7.5.1.1) were 
added to 900 mL deionised water. The pH was adjusted to 7.0 and the total volume 
taken to 1 L with deionised water to give a final concentration of 10 mM KiPO4. The 
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solution was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, 
MD4C, Werthein, Germany) and stored at 4 °C. 
7.10.1.2 Purification buffer N 
1 M K2HPO4 (9.4 mL, section 7.5.1.2), 1 M KH2PO4 (0.6 mL, section 7.5.1.1) and NaCl 
(58.4 g) were added to 900 mL deionised water. The pH was adjusted to 7.0 and the 
total volume taken to 1 L with deionised water to give a final concentration of 10 
mM KiPO4 and 1 M NaCl. The solution was filtered and degassed via vacuum pump 
(Vacuubrand GmbH +CO KG, MD4C, Werthein, Germany) and stored at 4 °C. 
 
7.10.1.3 Purification buffer P 
Tris base (2.4 g) was added to 900 mL deionised water. The pH was adjusted to pH 9 
with 1 M NaOH and the final volume taken to 1 L to give 20 mM Tris. The solution 
was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, 
Werthein, Germany) and stored at 4 °C. 
7.10.1.4 Purification buffer Q 
Tris base (2.4 g) and NaCl (58.4 g) were added to 900 mL deionised water. The pH 
was adjusted to pH 9 with 1 M NaOH and the final volume taken to 1 L to give 20 
mM Tris and 1 M NaCl. The solution was filtered and degassed via vacuum pump 
(Vacuubrand GmbH +CO KG, MD4C, Werthein, Germany) and stored at 4 °C. 
 
7.10.2 [4-13C]-NADP+ biosynthesis 
7.10.2.1 [4-13C]-Quinolinic acid 
[1,6-13C2]-glucose (30 mg), ATP (10 mg) and PEP (100 mg) were dissolved in 2 mL of 
reaction buffer (50 mM HEPES, 0.2% v/v βME and 50 mM NaCl, pH 8). The pH was 
adjusted to pH 8 before the addition of hexokinase (3 mg), phosphoglucoisomerase 
(10 μL (NH4)2SO4 suspension), phosphofructokinase (10 μL (NH4)2SO4 suspension), 
aldolase (30 μL, (NH4)2SO4 suspension), TIM (5 μL, (NH4)2SO4 suspension) and PK (3 
mg). The reaction was left at 37 °C for 6-12 h. Aspartate (30 mg) and FAD (5 mg) 
were added to 2 mL of reaction buffer and the pH adjusted to 8 before addition to 
the glucose reaction. The reaction solution was bubbled with argon for 1 h. 
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Immediately, freshly prepared QS was added (typically 12 mL of approx. 100 μM 
stock solution) and LAO (3 mL, approx. 100 μM stock solution), the reaction sealed 
and left at 30 °C for 24-48 h. The reaction was quenched by lowering the pH to 3, 
before the pH was readjusted to approx. 7. The solution was centrifuged to remove 
precipitate and passed through a 10000 MW spin column to remove any residual 
enzymes in solution before loading onto a C18 Gemini Semi-prep column 
equilibrated with 0.15 v/v trifluoroacetic acid (TFA) and eluted with MeCN, 0.1% v/v 
TFA. QA was eluted using the following gradient at 5 mL/min: 0-5 min 0% MeCN, 5-
20 min 0-20% MeCN, 20-25 min 20-100% MeCN and 25-27 min 100% MeCN. ATP 
eluted at 7.5 min and QA eluted at 8.8 min. Yield: 1%. δH (600 MHz, D2O): 8.61 (1H, 
s, broad), 7.98 (1H, dd, J1 = 9.0, J13C-1H = 165.0), 7.62 (1H, s, broad). δC (125 MHz, 
D2O): 137.2. 
 
7.10.2.2 [4-13C]-Nicotinic acid adenine dinucleotide 
Quinolinic acid (section 7.10.2.1), ribose-5-phosphate (60 mg), ATP (5 mg) and 
phosphoenolpyruvate (50 mg) were added to 1 mL buffer containing 50 mM K iPO4, 
50 mM KCl and 10 mM MgCl2. The pH was adjusted to pH 7 before the addition of 
pyruvate kinase (2 mg), myokinase (1 μL, (NH4)2SO4 suspension), PRPP synthetase (1 
mg) and QAPRT (5 mg) giving a total volume of 1.5 mL. The reaction was incubated 
at 37 °C whilst shaking for 3 hours. The reaction was quenched via heat shocking at 
120 °C for 90 s and centrifuged at 16100 g for 15 minutes to remove precipitate. 
The supernatant was loaded onto a SAX10 (9 x 250 mm) anion exchange column 
equilibrated with purification buffer M (section 7.10.1.1) and eluted with 
purification buffer N (section 7.10.1.2). The following gradient was used to elute the 
product at a flow rate of 2 mL/min: 0-11 min 0% buffer N, 11-28 min 0-10% buffer 
N, 28-38 min 10-30% buffer N and 38-43 min 30-100% buffer N. NAMN eluted at 5 
min, QA at 21.5 min and ATP at 37 min.  
The eluted NAMN peak was readjusted to pH 7 before the addition of 1 M MgCl2 
and KCl to give a final concentration of 10 mM KiPO4, 10 mM MgCl2 and 50 mM KCl. 
ATP (50 mg) was dissolved in 2 mL of 50 mM KiPO4, 50 mM KCl and 10 mM MgCl2 
and the pH readjusted to 7 before addition of NAMN solution. NAMNT (10 mg) was 
added and the reaction incubated at 37 °C for 3 h. The reaction was quenched via 
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heat shocking at 120 °C for 90 s and centrifuged at 16100 g for 15 minutes to 
remove precipitate. The supernatant was reloaded on the SAX10 column to remove 
excess ATP and the corresponding NAMN/NAAD peak immediately loaded onto a 
C18 Gemini Semiprep column equilibrated with 20 mM NH4HCO3 and eluted with 
MeCN. NAAD was eluted using the following gradient at 5 mL/min: 0-5 min 0% 
MeCN, 5-20 min 0-20% MeCN, 20-25 min 20-100% MeCN and 25-27 min 100% 
MeCN. NAMN eluted at ~3.5 min and NAAD eluted at 11.5 min. δH (500 MHz, D2O): 
9.03 (1H, s, broad), 8.89 (1H, t, J = 5.0), 8.63 (1H, dd, J1 = 7.5, J13C-1H = 172.5), 8.32 
(1H, s), 8.03 (1H, s), 7.94 (1H, t, J1 = 10.0, J2 = 5.0), 5.93 (2H, m), 4.41 (2H, s, broad), 
4.30-4.13 (8H, m). 
 
7.10.2.3 [4-13C]-NAD+ 
ATP (50 mg) and NH4Cl (27 mg) were dissolved in 1 mL buffer containing 50 mM 
KiPO4, 50 mM KCl and 10 mM MgCl2. The pH was adjusted to pH 7 before the 
addition of NAAD (section 7.10.2.2) and 0.5 mL NAD synthetase (approx. 100 mM 
stock). The reaction was incubated at 37 °C for 3 hours before being quenched by 
heat shock at 120 °C for 90 s. The precipitate was removed via centrifugation and 
the supernatant loaded onto a C18 Gemini Semiprep column equilibrated with 20 
mM NH4HCO3 and eluted with MeCN. NAD
+ was eluted using the following gradient 
at 5 mL/min: 0-5 min 0% MeCN, 5-20 min 0-20% MeCN, 20-25 min 20-100% MeCN 
and 25-27 min 100% MeCN. NAD+ eluted at 13.6 min. Yield: 41% from quinolinic 
acid. δH (500 MHz, D2O): 9.21 (1H, s, broad), 9.02 (1H, t, J = 7.5), 8.71 (1H, dd, J1 = 
10.0, J13C-1H = 175.0), 8.31 (1H, s), 8.07 (1H, t, J1 = 5.0, J2 = 10), 8.05 (1H, s), 5.96 (1H, 
d, J = 5.0), 5.91 (1H, d, J = 5.0), 4.42-4.10 (10 H, m) 
 
7.10.2.4 [4-13C]-NADP+ 
ATP (25 mg) was dissolved in 1 mL buffer containing 50 mM KiPO4, 50 mM KCl and 
10 mM MgCl2. The pH was adjusted to pH 7 before the addition of NAD
+ (section 
7.10.2.3) and NAD kinase (approx. 5 mg). The reaction was incubated at 37 °C for 3 
hours before being quenched by heat shock at 120 °C for 90 s. The supernatant was 
loaded onto a SAX10 (9 x 250 mm) anion exchange column equilibrated with 
purification buffer M (section 7.10.1.1) and eluted with purification buffer N 
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(section 7.10.1.2). The following gradient was used to elute the product at a flow 
rate of 2 mL/min: 0-11 min 0% buffer N, 11-28 min 0-10% buffer N, 28-38 min 10-
30% buffer N and 38-43 min 30-100% buffer N. NADP+ eluted at and ATP at . Yield: 
40%. δH (600 MHz, D2O): 9.31 (1H, s, broad), 9.08 (1H, t, J = 6.0), 8.87 (1H, dd, J1 = 
6.0, J13C-1H = 174.0), 8.45 (1H, s), 8.21 (1H, t, J = 6.0), 8.19 (1H, s), 6.12 (2H, J = 6.0), 
5.01 (1H, m), 4.54-4.24 (9H, m). 
7.10.3 (R)-[4-2H]-NADPH 
Thermoanaerobacter brockii ADH (1 mg) and NADP+ (7 mg) were dissolved in 
purification buffer P (2 mL, Section 7.10.1.3) and d8-
2H-isopropanol (0.2 mL) was 
added. The reaction mixture was incubated at 40 °C for 10 minutes and loaded onto 
a SAX10 (4 x 250 mm) anion exchange column equilibrated with purification buffer 
P (section 7.10.1.3). An NaCl gradient was applied from 0.0-1.0 M (100% 
purification buffer Q, section 7.10.1.4) over 30 minutes. Absorbance at 260 and 340 
nm was monitored and fractions collected when absorbance at 340 nm increased. A 
control run with NADP+ was performed first to enable a comparison showing that 
reduction of the substrate had occurred and the product had eluted.  
 
7.10.4 (S)-[4-2H]-NADPH 
(S)-[4-2H]-NADPH was produced and purified as (R)-[4-2H]-NADPH but glucose-1-D 
was used as the source of the deuterium label with glucose dehydrogenase rather 
than alcohol dehydrogenase as the enzyme. 
 
 
7.10.5 [4-13C]-NADPH and (R)-[4-2H,13C]-NADPH 
[4-13C]-NADPH and (R)-[4-2H,13C]-NADPH were produced and purified as (R)-[4-2H]-
NADPH with the exception that [4-13C]-NADP+ (section 7.10.2.4) was the starting 
material and unlabelled isopropanol was used as the hydride source for [4-13C]-
NADPH. 
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7.11 DHF synthesis and purification 
7.11.1 Dihydrofolate 
Folic acid (400 mg) was dissolved in a minimal volume of 5 M NaOH and added to 
80 mL 10% aqueous ascorbic acid (pH 6.0). The pH was readjusted to 6 if any 
change was seen after the folic acid was added. The mixture was stirred under N2 
and the sodium dithionite (4.4 g) added. The reaction was cooled on ice for 5 
minutes and the pH slowly lowered to 2.8 by the addition of 1 M HCl. The mixture 
was centrifuged at 4 °C, 24300 g for 10 minutes and the pellet re-suspended in ~20 
mL of acetone, purged with N2 and re-centrifuged. The washing step and 
centrifugation was repeated once more with acetone and then with diethyl ether. 
The product was dried with N2 and stored at -20 °C in an N2-purged, foil-wrapped 
container. 
 
7.11.2 GMP biosynthesis 
Ribose-5-phosphate (20 mg), ATP (5 mg) and phosphoenolpyruvate (50 mg) were 
added to 1 mL buffer containing 50 mM KiPO4, 50 mM KCl and 10 mM MgCl2. The 
pH was adjusted to pH 7 before the addition of pyruvate kinase (2 mg), myokinase 
(1 μL ,(NH4)2SO4 suspension), PRPP synthetase (1 mg) and XGPRT (5 mg) giving a 
total volume of 1.5 mL. The reaction was incubated at 37 °C whilst shaking for 3 
hours. Guanine (15 mg) was dissolved in 1 M NaOH and added in 10 μL aliquots 
every 5 minutes until saturation occurred. The reaction was quenched via heat 
shocking at 120 °C for 90 s and centrifuged at 16100 g for 15 minutes to remove 
precipitate. The supernatant was loaded onto a SAX10 (9 x 250 mm) anion 
exchange column equilibrated with purification buffer M (Section 7.10.1.1) and 
eluted with purification buffer N (Section 7.10.1.2). The following gradient was used 
to elute the product at a flow rate of 2 mL/min: 0-11 min 0% buffer N, 11-28 min 0-
10% buffer N, 28-38 min 10-30% buffer N and 38-43 min 30-100% buffer N. GMP 
eluted at 34 min and ATP at 37 min. 
 
7.11.3 7,8-Dihydroneopterin triphosphate biosynthesis 
GTP cyclohydrolase I (10 mg) and GTP (10 mg) were dissolved in 3 mL of 50 mM 
KiPO4, 50 mM KCl and 1 mM ZnCl2 pH 7.5. The reaction was left for 6 hours at 37 °C 
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before the solution was put through a 10,000 MW filter to remove the enzyme. The 
supernatant was loaded onto a SAX10 (9 x 250 mm) anion exchange column 
equilibrated with purification buffer M (Section 7.10.1.1) and eluted with 
purification buffer N (Section 7.10.1.2). The following gradient was used to elute 
the product at a flow rate of 2 mL/min: 0-2 min 0% buffer N, 2-11 min 0-10% buffer 
N, 11-20 min 10-30% buffer N and 20-22 min 30-100% buffer N. 7,8-
dihydroneopterin triphosphate eluted at 18 min and the oxidised product at 20 
min. 
7.11.4 6-Hydroxymethyl-7,8-dihydroneopterin biosynthesis 
Dihydroneopterin triphosphate was dissolved in 3 mL of 50 mM KiPO4, 50 mM KCl 
and 1 mM ZnCl2 pH 7.5. Bovine alkaline phosphatase (3 mg) and DHNA (1 mL) were 
added and the reaction incubated for 3 h at 37 °C. The solution was passed through 
a 10000 MW spin column to remove any enzyme before loading onto a C18 Gemini 
Semi-prep column equilibrated with 0.15 v/v trifluoroacetic acid (TFA) and eluted 
with MeCN, 0.1% v/v TFA. The oxidised products were eluted using the following 
gradient at 5 mL/min: 0-5 min 0% MeCN, 5-20 min 0-20% MeCN, 20-25 min 20-
100% MeCN and 25-27 min 100% MeCN. Neopterin eluted at 12.6 min and 6-
hydroxymethyl-7,8-neopterin eluted at 13.2 min. 
 
7.12 Enzyme kinetics 
7.12.1 Buffers 
7.12.1.1 Phosphate buffer 
1 M K2HPO4 (12.3 mL, section 7.5.1.2), 1 M KH2PO4 (7.7 mL, section 7.5.1.1), NaCl 
(1.17 g) and βME (140 μL) were added to 150 mL deionised water. The pH was 
adjusted to 7.0 and the total volume taken to 200 mL with deionised water to give a 
final concentration of 50 mM KiPO4, 100 mM NaCl and 10 mM βME. The solution 
was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, MD4C, 
Werthein, Germany) and stored at room temperature. 
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7.12.1.2 Deuterated phosphate buffer 
1 M K2HPO4 (12.3 mL, section 7.5.1.2), 1 M KH2PO4 (7.7 mL, section 7.5.1.1) and 
NaCl (1.17 g) were added to 50 mL  [2H2, 99.9%] H2O. The solution was lyophilised 
and resuspended in 150 mL  [2H2, 99.9%] H2O and βME (70 μL) added. The pD was 
adjusted to 7.0 and the total volume taken to 200 mL with [2H2, 99.9%] H2O to give 
a final concentration of 50 mM KiPO4, 100 mM NaCl and 10 mM βME. The buffer 
was filtered and degassed immediately prior to use via vacuum pump (Vacuubrand 
GmbH +CO KG, MD4C, Werthein, Germany) and stored at 4 C. 
 
7.12.1.3 MTEN buffer 
Morpholinoethanesulfonic acid (MES, 1.952 g), Tris (0.6057 g), ethanolamine (1.5 
mL), NaCl  (1.168 g) and 10 mM βME (140 μL) were added to 150 mL deionised 
water. The pH was adjusted to the required pH (5-9) at the temperature of use and 
the total volume taken to 200 mL with deionised water to give a final concentration 
of 50 mM MES, 25 mM Tris, 25 mM ethanolamine, 100 mM NaCl and 10 mM βME. 
The solution was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO 
KG, MD4C, Werthein, Germany) and stored at room temperature. 
 
7.12.1.4 Deuterated MTEN buffer 
Morpholinoethanesulfonic acid (MES, 1.952 g), Tris (0.6057 g), ethanolamine (1.5 
mL), NaCl  (1.168 g) and 10 mM βME (140 μL) were added to 50 mL  [2H2, 99.9%] 
H2O.  The solution was lyophilised and resuspended in 150 mL [
2H2, 99.9%] H2O. The 
pD was adjusted to the required pD (5-9) at the temperature of use and the total 
volume taken to 200 mL with [2H2, 99.9%] H2O to give a final concentration of 50 
mM MES, 25 mM Tris, 25 mM ethanolamine, 100 mM NaCl and 10 mM βME. The 
solution was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, 
MD4C, Werthein, Germany) and stored at 4 C. 
 
7.12.2 Steady state kinetics 
Steady state kinetics were performed on a Jasco V-660 spectrophotometer (Essex, 
UK) and the temperature was monitored in the cuvette using a Traceable® RTD 
Platinum Thermometer (Control Company, TX, USA) immediately before the 
Materials & Methods 
 
203 
 
reaction was started. The reaction was monitored by following the oxidation of 
NADPH at 340 nm (ε340 (cofactor + substrate) = 11,800 M-1 cm-1 (84)) over a 40 s 
time period. 
 
7.12.2.1 KM measurements 
Typically, for KM NADPH, enzyme (0.01-0.03 μM) was incubated with NADPH (5-300 
μM) for 5 minutes at the required temperature before the addition of DHF (100 
μM) to start the reaction. For KM DHF measurements, enzyme (0.01-0.03 μM) was 
incubated with NADPH (100 or 250 μM) for 5 minutes at the required temperature 
before the addition of DHF (0.5-100 μM) to start the reaction. Measurements were 
performed at 10, 20 and 35 °C using phosphate buffer (section 7.12.1.1). 
 
7.12.3 Pre-steady state enzyme kinetics 
Pre-steady state kinetics were performed on an Applied Photophysics stopped-flow 
spectrophotometer (Surrey, UK). The reaction was monitored via fluorescence 
resonance energy transfer (FRET) for EcDHFR and MpDHFR measurements. 
Tryptophan residues were excited at 292 nm, in turn exciting the NADPH at 340 nm 
and measuring the subsequent emission at 450 nm. Measurements involving 
BsDHFR were monitored via FRET or by following the oxidation of NADPH by 
absorbance at 340 nm.  
 
7.12.3.1 Hydride transfer/primary and secondary KIE measurements 
Enzyme and cofactors were incubated in separate syringes with enzyme (20 μM) 
and NADPH (8 μM) in one syringe and only DHF (200 μM) in the other syringe. The 
syringes were incubated at the required temperature for 10 minutes before starting 
the reaction by rapid mixing of the solutions in syringes. Measurements were 
performed between 5 and 40 °C using phosphate buffer (section 7.12.1.1) or MTEN 
buffer (section 7.12.1.3) for pH rate profiles. Primary KIE measurements were 
performed by repeating the experiment using (R)-[4-2H]-NADPH instead of NADPH 
and comparing rates. α-secondary KIEs measurements were performed by 
repeating the experiment using (S)-[4-2H]-NADPH and comparing rates. 
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7.12.3.2 Solvent isotope effect measurements 
The reaction was set up as for hydride transfer measurements (section 7.12.3.1). 
Measurements were performed between 5 and 40 °C using phosphate buffer 
(section 7.12.1.1) and deuterated phosphate buffer (section 7.12.1.2) or MTEN 
buffer (section 7.12.1.3) and deuterated MTEN buffer (section 7.12.1.4) for pH rate 
profiles. 
 
7.12.3.3 Heavy atom KIE measurements 
Heavy atom KIE measurements were performed as for hydride transfer 
measurements (section 7.12.3.1) with the exception that [4-13C]-labelled cofactors 
were used. Measurements were performed between 5 and 35 °C using phosphate 
buffer (section 7.12.1.1). 
 
7.12.4 Heavy enzyme kinetic measurements 
Heavy enzyme kinetic experiments were performed in an identical manner to 
previous steady state (section 7.12.2) and pre-steady state kinetics (section 7.12.3) 
with the exception that 13C,15N,2H-isotopically labelled enzyme was used. 
 
7.13 Circular dichroism spectroscopy 
7.13.1 CD Buffer 
1 M K2HPO4 (9.4 mL, section 7.5.1.2), and 1 M KH2PO4 (0.6 mL, section 7.5.1.1) were 
added to 900 mL deionised water. The pH was adjusted to 7.0 and the total volume 
taken to 1 L with deionised water to give a final concentration of 10 mM KiPO4. The 
solution was filtered and degassed via vacuum pump (Vacuubrand GmbH +CO KG, 
MD4C, Werthein, Germany) immediately prior to use. 
 
7.13.2 CD measurements 
Circular dichroism experiments were performed on an Applied PhotoPhysics 
Chirascan spectrometer. Spectra of 10-20 µM protein in CD buffer (Section 7.13.1) 
were measured between 190 nm and 400 nm in 10 mm quartz cuvettes under N2 
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with a 50 nm/min scan speed, 0.5 nm data pitch, 1 nm bandwidth and 0.5 s 
response time.  
  
7.13.3 Mean residue ellipticity (MRE) 
The spectra obtained from the CD spectrometer was converted to MRE using the 
following equation: 
ΘMRE=Θ/10.c.n.l 
 
where Θ = CD signal in millidegrees, c = molar concentration of sample, n = number 
of peptide bonds and l = pathlength of the cuvette in cm. 
 
7.14 Error calculations 
7.14.1 Standard error of the mean 
All errors are reported as the standard error of the mean (σM), which is defined as: 
    
 
  
 
where n is the number of samples and σ is the standard deviation, defined as: 
    
      
 
      
 
where X is each value measured in the sample and M is the mean of the sample. 
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9.1 Appendix 1 - Sequencing data 
Sequencing was performed by Eurofins (Germany). Sequencing results are shown 
below for each gene (FASTA sequence), and the alignment score from a BLAST 
alignment to confirm the correct gene sequence (or corresponding amino acid 
sequence) had been correctly cloned. Where genes were significantly longer than 
the reliable trace from N-terminus sequencing, typically above 900 bp, sequencing 
was repeated from the C-terminus to confirm the correct sequence of the gene. 
9.1.1 nad gene family sequencing data 
9.1.1.1 nadA 
>113590_pET28anadA1_T7 
CACAAACCGTGCGTCTTCCCTCTAGAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCCAT
CATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGAGCGTAATGTTTGATCCAGACACGGCG
ATTTATCCTTTCCCCCCGAAGCCGACGCCGTTAAGCATTGATGAAAAAGCGTATTACCGCGAGAAGATAAAACGT
CTGCTAAAAGAACGTAATGCGGTGATGGTTGCCCACTACTATACCGATCCCGAAATTCAACAACTGGCAGAAGAA
ACCGGTGGCTGTATTTCTGATTCTCTGGAAATGGCGCGCTTCGGTGCAAAGCATCCCGCTTCTACTTTGTTAGTC
GCTGGGGTGAGATTTATGGGAGAAACCGCCAAAATTCTCAGTCCGGAAAAAACAATTCTGATGCCGACACTTCAG
GCTGAATGTTCACTGGATCTCGGCTGCCCTGTTGAAGAATTTAACGCATTTTGCGATGCCCATCCCGATCGTACT
GTCGTCGTCTACGCCAACACTTCTGCTGCGGTAAAAGCGCGCGCAGATTGGGTGGTAACTTCAAGCATTGCCGTC
GAACTTATTGATCATCTTGATAGTTTGGGTGAAAAAATCATCTGGGCACCCGACAAACATCTGGGGCGTTACGTG
CAAAAACAGACGGGTGGAGACATTCTATGCTGGCAGGGTGCCTGTATTGTGCATGATGAATTTAAGACTCAGGCG
TTAACCCGCTTGCAAGAAGAATACCCGGATGCTGCCATACTGGTGCATCCAGAATCACCACAAGCTATTGTCGAT
ATGGCGGATGCGGTCGGTTCCACCAGTCAACTGATCGCTGCTGCGAAAACATTGCCACATCAGAGGCTTATTGTG
GCAACCGATCGGGGTATTTTCTACAAAATGCAGCAGCGGTGCCAGATAAAGAGTTACTGGAAGCACCAACCGCAG
TGAGGGTGCAACCTGCCGCAGCTGCGCGCATTGTCCGTGGATGGCCATGAATGGTCTTCAGGCCATCGCAGAGGC
ATTAGAACAGGAAGGAAGCAATCACGAGGTTCATGTTGATGAAA 
 
 
Query  121     ATGAGCGTAATGTTTGATCCAGACACGGCGATTTATCCTTTCCCCCCGAAGCCGACGCCG  180 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  745868  ATGAGCGTAATGTTTGATCCAGACACGGCGATTTATCCTTTCCCCCCGAAGCCGACGCCG  745927 
 
Query  181     TTAAGCATTGATGAAAAAGCGTATTACCGCGAGAAGATAAAACGTCTGCTAAAAGAACGT  240 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  745928  TTAAGCATTGATGAAAAAGCGTATTACCGCGAGAAGATAAAACGTCTGCTAAAAGAACGT  745987 
 
Query  241     AATGCGGTGATGGTTGCCCACTACTATACCGATCCCGAAATTCAACAACTGGCAGAAGAA  300 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  745988  AATGCGGTGATGGTTGCCCACTACTATACCGATCCCGAAATTCAACAACTGGCAGAAGAA  746047 
 
Query  301     ACCGGTGGCTGTATTTCTGATTCTCTGGAAATGGCGCGCTTCGGTGCAAAGCATCCCGCT  360 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746048  ACCGGTGGCTGTATTTCTGATTCTCTGGAAATGGCGCGCTTCGGTGCAAAGCATCCCGCT  746107 
 
Query  361     TCTACTTTGTTAGTCGCTGGGGTGAGATTTATGGGAGAAACCGCCAAAATTCTCAGTCCG  420 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746108  TCTACTTTGTTAGTCGCTGGGGTGAGATTTATGGGAGAAACCGCCAAAATTCTCAGTCCG  746167 
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Query  421     GAAAAAACAATTCTGATGCCGACACTTCAGGCTGAATGTTCACTGGATCTCGGCTGCCCT  480 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746168  GAAAAAACAATTCTGATGCCGACACTTCAGGCTGAATGTTCACTGGATCTCGGCTGCCCT  746227 
 
Query  481     GTTGAAGAATTTAACGCATTTTGCGATGCCCATCCCGATCGTACTGTCGTCGTCTACGCC  540 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746228  GTTGAAGAATTTAACGCATTTTGCGATGCCCATCCCGATCGTACTGTCGTCGTCTACGCC  746287 
 
Query  541     AACACTTCTGCTGCGGTAAAAGCGCGCGCAGATTGGGTGGTAACTTCAAGCATTGCCGTC  600 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746288  AACACTTCTGCTGCGGTAAAAGCGCGCGCAGATTGGGTGGTAACTTCAAGCATTGCCGTC  746347 
 
Query  601     GAACTTATTGATCATCTTGATAGTTTGGGTGAAAAAATCATCTGGGCACCCGACAAACAT  660 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746348  GAACTTATTGATCATCTTGATAGTTTGGGTGAAAAAATCATCTGGGCACCCGACAAACAT  746407 
 
Query  661     CTGGGGCGTTACGTGCAAAAACAGACGGGTGGAGACATTCTATGCTGGCAGGGTGCCTGT  720 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746408  CTGGGGCGTTACGTGCAAAAACAGACGGGTGGAGACATTCTATGCTGGCAGGGTGCCTGT  746467 
 
Query  721     ATTGTGCATGATGAATTTAAGACTCAGGCGTTAACCCGCTTGCAAGAAGAATACCCGGAT  780 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746468  ATTGTGCATGATGAATTTAAGACTCAGGCGTTAACCCGCTTGCAAGAAGAATACCCGGAT  746527 
 
Query  781     GCTGCCATACTGGTGCATCCAGAATCACCACAAGCTATTGTCGATATGGCGGATGCGGTC  840 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746528  GCTGCCATACTGGTGCATCCAGAATCACCACAAGCTATTGTCGATATGGCGGATGCGGTC  746587 
 
Query  841     GGTTCCACCAGTCAACTGATCGCTGCTGCGAAAACATTGCCACATCAGAGGCTTATTGTG  900 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746588  GGTTCCACCAGTCAACTGATCGCTGCTGCGAAAACATTGCCACATCAGAGGCTTATTGTG  746647 
 
Query  901     GCAACCGATCGGGGTATTTTCTACAAAATGCAGCA-GCGGTGCCAGATAAAGAGTTACTG  959 
               ||||||||||||||||||||||||||||||||||| |||||||||||||||||||||||| 
Sbjct  746648  GCAACCGATCGGGGTATTTTCTACAAAATGCAGCAGGCGGTGCCAGATAAAGAGTTACTG  746707 
 
Query  960     GAAGCACCAACCGCA-GTGAGGGTGCAACCTGCCGCAGCTGCGCGCATTGTCCGTGGATG  1018 
               ||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746708  GAAGCACCAACCGCAGGTGAGGGTGCAACCTGCCGCAGCTGCGCGCATTGTCCGTGGATG  746767 
 
Query  1019    GCCATGAATGGTCTTCAGGCCATCGCAGAGGCATTAGAACAGGAAGGAAGCAATCACGAG  1078 
               ||||||||||| |||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746768  GCCATGAATGGCCTTCAGGCCATCGCAGAGGCATTAGAACAGGAAGGAAGCAATCACGAG  746827 
 
Query  1079    GTTCATGTTGATGAAA  1094 
               |||||||||||||||| 
Sbjct  746828  GTTCATGTTGATGAAA  746843 
 
 
>113781_pET28anadA1_T7term 
AAGGTAGCTAGCTTCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTGCGGCC
GCAAGCTTATTATCCACGTAGTGTAGCCGCAAAATCCAGCATACGATTGAGCGGCACCAGCGCCCTCTCTCGCAG
CCTTTCATCAACATGAACCTCGTGATTGCTTCCTTCCTGTTCTAATGCCTCTGCGATGGCCTGAAGGCCATTCAT
GGCCATCCACGGACAATGCGCGCAGCTGCGGCAGGTTGCACCCTCACCTGCGGTTGGTGCTTCCAGTAACTCTTT
ATCTGGCACCGCCTGCTGCATTTTGTAGAAAATACCCCGATCGGTTGCCACAATAAGCCTCTGATGTGGCAATGT
TTTCGCAGCAGCGATCAGTTGACTGGTGGAACCGACCGCATCCGCCATATCGACAATAGCTTGTGGTGATTCTGG
ATGCACCAGTATGGCAGCATCCGGGTATTCTTCTTGCAAGCGGGTTAACGCCTGAGTCTTAAATTCATCATGCAC
AATACAGGCACCCTGCCAGCATAGAATGTCTCCACCCGTCTGTTTTTGCACGTAACGCCCCAGATGTTTGTCGGG
TGCCCAGATGATTTTTTCACCCAAACTATCAAGATGATCAATAAGTTCGACGGCAATGCTTGAAGTTACCACCCA
ATCTGCGCGCGCTTTTACCGCAGCAGAAGTGTTGGCGTAGACGACGACAGTACGATCGGGATGGGCATCGCAAAA
TGCGTTAAATTCTTCAACAGGGCAGCCGAGATCCAGTGAACATTCAGCCTGAAGTGTCGGCATCAGAATTGTTTT
TTCCGGACTGAGAATTTTGGCGGTTTCTCCCATAAATCTCACCCCAGCGACTAACAAAGTAGAAGCGGGATGCTT
TGCACCGAAGCGCGCCATTTCCAGAGAATCAGAAATACAGCCACCGGTTTCTTCTGCCAGTTGTTGAATTTCGGG
ATCGGTATAGTAGTGGGCAACCATCACCGCATTACGTTCTTTAGCAGACGTTTTATCTCTCGCGGTAATACGCTT
TTTCATCATGCTTAACGGCGTCGCTTCGGGGGGAAAGGATAAAATCGGCCGGTGTC 
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Query  85      TTATCCACGTAGTGTAGCCGCAAAATCCAGCATACGATTGAGCGGCACCAGCGCCCTCTC  144 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746911  TTATCCACGTAGTGTAGCCGCAAAATCCAGCATACGATTGAGCGGCACCAGCGCCCTCTC  746852 
 
Query  145     TCGCAGCCTTTCATCAACATGAACCTCGTGATTGCTTCCTTCCTGTTCTAATGCCTCTGC  204 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746851  TCGCAGCCTTTCATCAACATGAACCTCGTGATTGCTTCCTTCCTGTTCTAATGCCTCTGC  746792 
 
Query  205     GATGGCCTGAAGGCCATTCATGGCCATCCACGGACAATGCGCGCAGCTGCGGCAGGTTGC  264 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746791  GATGGCCTGAAGGCCATTCATGGCCATCCACGGACAATGCGCGCAGCTGCGGCAGGTTGC  746732 
 
Query  265     ACCCTCACCTGCGGTTGGTGCTTCCAGTAACTCTTTATCTGGCACCGCCTGCTGCATTTT  324 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746731  ACCCTCACCTGCGGTTGGTGCTTCCAGTAACTCTTTATCTGGCACCGCCTGCTGCATTTT  746672 
 
Query  325     GTAGAAAATACCCCGATCGGTTGCCACAATAAGCCTCTGATGTGGCAATGTTTTCGCAGC  384 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746671  GTAGAAAATACCCCGATCGGTTGCCACAATAAGCCTCTGATGTGGCAATGTTTTCGCAGC  746612 
 
Query  385     AGCGATCAGTTGACTGGTGGAACCGACCGCATCCGCCATATCGACAATAGCTTGTGGTGA  444 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746611  AGCGATCAGTTGACTGGTGGAACCGACCGCATCCGCCATATCGACAATAGCTTGTGGTGA  746552 
 
Query  445     TTCTGGATGCACCAGTATGGCAGCATCCGGGTATTCTTCTTGCAAGCGGGTTAACGCCTG  504 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746551  TTCTGGATGCACCAGTATGGCAGCATCCGGGTATTCTTCTTGCAAGCGGGTTAACGCCTG  746492 
 
Query  505     AGTCTTAAATTCATCATGCACAATACAGGCACCCTGCCAGCATAGAATGTCTCCACCCGT  564 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746491  AGTCTTAAATTCATCATGCACAATACAGGCACCCTGCCAGCATAGAATGTCTCCACCCGT  746432 
 
Query  565     CTGTTTTTGCACGTAACGCCCCAGATGTTTGTCGGGTGCCCAGATGATTTTTTCACCCAA  624 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746431  CTGTTTTTGCACGTAACGCCCCAGATGTTTGTCGGGTGCCCAGATGATTTTTTCACCCAA  746372 
 
Query  625     ACTATCAAGATGATCAATAAGTTCGACGGCAATGCTTGAAGTTACCACCCAATCTGCGCG  684 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746371  ACTATCAAGATGATCAATAAGTTCGACGGCAATGCTTGAAGTTACCACCCAATCTGCGCG  746312 
 
Query  685     CGCTTTTACCGCAGCAGAAGTGTTGGCGTAGACGACGACAGTACGATCGGGATGGGCATC  744 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746311  CGCTTTTACCGCAGCAGAAGTGTTGGCGTAGACGACGACAGTACGATCGGGATGGGCATC  746252 
 
Query  745     GCAAAATGCGTTAAATTCTTCAACAGGGCAGCCGAGATCCAGTGAACATTCAGCCTGAAG  804 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746251  GCAAAATGCGTTAAATTCTTCAACAGGGCAGCCGAGATCCAGTGAACATTCAGCCTGAAG  746192 
 
Query  805     TGTCGGCATCAGAATTGTTTTTTCCGGACTGAGAATTTTGGCGGTTTCTCCCATAAATCT  864 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746191  TGTCGGCATCAGAATTGTTTTTTCCGGACTGAGAATTTTGGCGGTTTCTCCCATAAATCT  746132 
 
Query  865     CACCCCAGCGACTAACAAAGTAGAAGCGGGATGCTTTGCACCGAAGCGCGCCATTTCCAG  924 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746131  CACCCCAGCGACTAACAAAGTAGAAGCGGGATGCTTTGCACCGAAGCGCGCCATTTCCAG  746072 
 
Query  925     AGAATCAGAAATACAGCCACCGGTTTCTTCTGCCAGTTGTTGAATTTCGGGATCGGTATA  984 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  746071  AGAATCAGAAATACAGCCACCGGTTTCTTCTGCCAGTTGTTGAATTTCGGGATCGGTATA  746012 
 
Query  985     GTAGTGGGCAACCATCACCGCATTACGTTC-TTTAGCAGACGTTTTATC-TCTCGCGGTA  1042 
               |||||||||||||||||||||||||||||| |||||||||||||||||| |||||||||| 
Sbjct  746011  GTAGTGGGCAACCATCACCGCATTACGTTCTTTTAGCAGACGTTTTATCTTCTCGCGGTA  745952 
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Query  1043    ATACGCTTTTTCATC-ATGCTTAACGGCGTC-GCTTCGGGGGGAAAGGATAAA  1093 
               ||||||||||||||| ||||||||||||||| ||||||||||||||||||||| 
Sbjct  745951  ATACGCTTTTTCATCAATGCTTAACGGCGTCGGCTTCGGGGGGAAAGGATAAA  745899 
 
9.1.1.2 nadB 
>113593_pET28anadB1_T7 
CCCTTTAATACCTTCTTCCCTCTAGAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCCAT
CATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGAATACTCTCCCTGAACATTCATGTGAC
GTGTTGATTATCGGTAGCGGCGCAGCCGGACTTTCACTGGCGCTACGCCTGGCTGACCAGCATCAGGTCATCGTT
CTAAGTAAAGGCCCGGTAACGGAAGGTTCAACATTTTATGCCCAGGGCGGTATTGCCGCCGTGTTTGATGAAACT
GACAGCATTGACTCGCATGTGGAAGACACATTGATTGCCGGGGCTGGTATTTGCGATCGCCATGCAGTTGAATTT
GTCGCCAGCAATGCACGATCCTGTGTGCAATGCCTAATCGACCAGGGGGTGTTATTTGATACCCACATTCAGCCG
AATGGCGAAGAAAGCTACCATCTGACCCGTGAAGGTGGACATAGTCACCGTCGTATTCTTCATGCCGCCGACGCA
ACTGGTAGAGAAGTAGAAACCACGCTGGTGAGCAAGGCGCTGAACCATCCGAATATTCGCGTGCTGGAGCGCAGC
AACGCGGTTGATCTGATTATTTCTGACAAAATTGGCCTGCCGGGCACGCGACGGGTTGTTGGCGCGTGGGTATGG
AACCGAAATAAAGAAAAGGTGGAAACCTGCCACGCAAAAGCGGTGGTGCTGGCAACCGGCGGTGCGTCGAAGGTT
TATCAGTACACCACCAATCCGGATATTTCTTCTGGCGATGGCATTGCTATGGCGTGCGCGCAGCTGCCGGGTTGC
CAATCTCGAATTTAATCAGTTCCACCCTACCGCGCTGTATCACCCCCAGGCACGCAATTTCCTGTTAACGGAAGC
ACTGCGCGGCGAAGCGCTTATCTCAAGCGCCCGGATGGCACGCGTTTTATGCCCGATTTTGATGTGCGCGGCGAA
CTGGGCCCGCGCGATATGTCGCCCGCGCATTGACCATGAATGAAACGCCTCGGCGCGGATTGTATGTCTGATATC
AGCATAAGCCGCTGATTTATCGCAGCATTTCCCGATGATTATGAAAATGCTCGGCTGGGGATGATCTCACACAGA
CGGTAC 
 
 
Query  121      ATGAATACTCTCCCTGAACATTCATGTGACGTGTTGATTATCGGTAGCGGCGCAGCCGGA  180 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1273132  ATGAATACTCTCCCTGAACATTCATGTGACGTGTTGATTATCGGTAGCGGCGCAGCCGGA  1273073 
 
Query  181      CTTTCACTGGCGCTACGCCTGGCTGACCAGCATCAGGTCATCGTTCTAAGTAAAGGCCCG  240 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1273072  CTTTCACTGGCGCTACGCCTGGCTGACCAGCATCAGGTCATCGTTCTAAGTAAAGGCCCG  1273013 
 
Query  241      GTAACGGAAGGTTCAACATTTTATGCCCAGGGCGGTATTGCCGCCGTGTTTGATGAAACT  300 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1273012  GTAACGGAAGGTTCAACATTTTATGCCCAGGGCGGTATTGCCGCCGTGTTTGATGAAACT  1272953 
 
Query  301      GACAGCATTGACTCGCATGTGGAAGACACATTGATTGCCGGGGCTGGTATTTGCGATCGC  360 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272952  GACAGCATTGACTCGCATGTGGAAGACACATTGATTGCCGGGGCTGGTATTTGCGATCGC  1272893 
 
Query  361      CATGCAGTTGAATTTGTCGCCAGCAATGCACGATCCTGTGTGCAATGCCTAATCGACCAG  420 
                ||||||||||||||||||||||||||||||||||||||||||||||| |||||||||||| 
Sbjct  1272892  CATGCAGTTGAATTTGTCGCCAGCAATGCACGATCCTGTGTGCAATGGCTAATCGACCAG  1272833 
 
Query  421      GGGGTGTTATTTGATACCCACATTCAGCCGAATGGCGAAGAAAGCTACCATCTGACCCGT  480 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272832  GGGGTGTTATTTGATACCCACATTCAGCCGAATGGCGAAGAAAGCTACCATCTGACCCGT  1272773 
 
Query  481      GAAGGTGGACATAGTCACCGTCGTATTCTTCATGCCGCCGACGCAACTGGTAGAGAAGTA  540 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272772  GAAGGTGGACATAGTCACCGTCGTATTCTTCATGCCGCCGACGCAACTGGTAGAGAAGTA  1272713 
 
Query  541      GAAACCACGCTGGTGAGCAAGGCGCTGAACCATCCGAATATTCGCGTGCTGGAGCGCAGC  600 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272712  GAAACCACGCTGGTGAGCAAGGCGCTGAACCATCCGAATATTCGCGTGCTGGAGCGCAGC  1272653 
 
Query  601      AACGCGGTTGATCTGATTATTTCTGACAAAATTGGCCTGCCGGGCACGCGACGGGTTGTT  660 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
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Sbjct  1272652  AACGCGGTTGATCTGATTATTTCTGACAAAATTGGCCTGCCGGGCACGCGACGGGTTGTT  1272593 
Query  661      GGCGCGTGGGTATGGAACCGAAATAAAGAAAAGGTGGAAACCTGCCACGCAAAAGCGGTG  720 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272592  GGCGCGTGGGTATGGAACCGAAATAAAGAAAAGGTGGAAACCTGCCACGCAAAAGCGGTG  1272533 
 
Query  721      GTGCTGGCAACCGGCGGTGCGTCGAAGGTTTATCAGTACACCACCAATCCGGATATTTCT  780 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272532  GTGCTGGCAACCGGCGGTGCGTCGAAGGTTTATCAGTACACCACCAATCCGGATATTTCT  1272473 
 
Query  781      TCTGGCGATGGCATTGCTATGGCGT-GCGCGCA-GCTGCCGGGTTGCCAATCTCGAATTT  838 
                ||||||||||||||||||||||||| ||||||| |||||||||||||||||||||||||| 
Sbjct  1272472  TCTGGCGATGGCATTGCTATGGCGTGGCGCGCAGGCTGCCGGGTTGCCAATCTCGAATTT  1272413 
 
Query  839      AATCAGTTCCACCCTACCGCGCTGTATCACCCCCAGGCACGCAATTTCCTGTTAACGGAA  898 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272412  AATCAGTTCCACCCTACCGCGCTGTATCACCCCCAGGCACGCAATTTCCTGTTAACGGAA  1272353 
 
Query  899      GCACTGCGCGGCGAA-GCGCTTATCTCAAGCGCCCGGATGGCACGCGTTTTATGCCCGAT  957 
                ||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272352  GCACTGCGCGGCGAAGGCGCTTATCTCAAGCGCCCGGATGGCACGCGTTTTATGCCCGAT  1272293 
 
Query  958      TTTGATGTGCGCGGCGAACTGGGCCCGCGCGATA-TGTCGCCCGCG-CATTGACCATG-A  1014 
                |||||||||||||||||||||| ||||||||||| ||||||||||| ||||||||||| | 
Sbjct  1272292  TTTGATGTGCGCGGCGAACTGGCCCCGCGCGATATTGTCGCCCGCGCCATTGACCATGAA  1272233 
 
Query  1015     ATGAAACGCCTCGGCGCGGATTGTATGT---CTGATATCAG-CATAAG-CCGCTGATTT-  1068 
                ||||||||||||||||||||||||||||    ||||||||| |||||| ||||||||||  
Sbjct  1272232  ATGAAACGCCTCGGCGCGGATTGTATGTTCCTTGATATCAGCCATAAGCCCGCTGATTTT  1272173 
 
Query  1069     -ATCG-CAGCATTTCCCGATGA-TTATGAAAA--TGCTC-GGCTGGGGA-TGATCTCACA  1121 
                  ||| |||||||||||||||| |||||||||  ||||| ||||||||| |||||||||| 
Sbjct  1272172  ATTCGCCAGCATTTCCCGATGATTTATGAAAAATTGCTCGGGCTGGGGATTGATCTCACA  1272113 
 
Query  1122     CA  1123 
                || 
Sbjct  1272112  CA  1272111 
 
>113782_pET28anadB1_T7term 
AAAAGCCTAGCTTCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTGCGGCCG
CAAGCTTATTATCTGTTTATGTAATGATTGCCGGGAGAAAGGATCGATGGACCGGAATGCGTGAGCAGTTCCGGG
TAATCCAGCGTAAAATGCAGGCCACGACTCTCCTTGCGCATCATCGCACAGCGAACAATCAACTCGGCAACCTGT
ACCAGATTACGCAGCTCCAGCAAATTATTTGAGACGCGGAAATGGGCGTAATATTCGTCTATTTCTTGTTGGAGC
ATGGTTATCCGCCGCAGGGCGCGTTCCAGGCGCTTCGTTGTGCGCACAATGCCAACGTAATCCCACATAAACAGA
CGTAGCTCGTGCCAGTTATGCTGAATTACTACCCGTTCGTCAGGGTTCTCAACGCGGCTTTCATCCCACGGCGGT
AACGTACTGATGTCGTGGGCATAAGGCATACGTCTGGTGATATCTTCCGCCGCCGACCAGCCATAGACCAGACAC
TCCAGCAATGAATTCGAGGCCATGCGGTTAGCGCCGTGTAAGCCGGTATAACTCACCTCGCCAATGGCATACAAG
CCCTCGACGTCCGTACGCCCATGATCATCAACCATTACACCACCGCAGGTATAGTGTGCAGCAGGCACAATCCGC
ACCGGTTCTTGTGTGAGATCAATCCCCAGCCCGAGCAATTTTTCATAAATCATCGGGAAACGCTGGCGAATAAAA
TCAGCGGGCTTATGGCTGATATCAAGGAACATACGATCCCGCGCCGAGGCGTTTCATTTTATTGGTCAATGGCGC
GGGCTACAATATCGCGCGGGTCCAATTCTGTCTCCCCGCATCAAAATCGTTTCTAAAA 
 
 
Query  76       CAAGCTTATTATCTGTTTATGTAATGATTGCCGGGAGAAAGGATCGATGGACCGGAATGC  135 
                || |||| |||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271502  CAGGCTTTTTATCTGTTTATGTAATGATTGCCGGGAGAAAGGATCGATGGACCGGAATGC  1271561 
 
Query  136      GTGAGCAGTTCCGGGTAATCCAGCGTAAAATGCAGGCCACGACTCTCCTTGCGCATCATC  195 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271562  GTGAGCAGTTCCGGGTAATCCAGCGTAAAATGCAGGCCACGACTCTCCTTGCGCATCATC  1271621 
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Query  196      GCACAGCGAACAATCAACTCGGCAACCTGTACCAGATTACGCAGCTCCAGCAAATTATTT  255 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271622  GCACAGCGAACAATCAACTCGGCAACCTGTACCAGATTACGCAGCTCCAGCAAATTATTT  1271681 
 
Query  256      GAGACGCGGAAATGGGCGTAATATTCGTCTATTTCTTGTTGGAGCATGGTTATCCGCCGC  315 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271682  GAGACGCGGAAATGGGCGTAATATTCGTCTATTTCTTGTTGGAGCATGGTTATCCGCCGC  1271741 
 
Query  316      AGGGCGCGTTCCAGGCGCTTCGTTGTGCGCACAATGCCAACGTAATCCCACATAAACAGA  375 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271742  AGGGCGCGTTCCAGGCGCTTCGTTGTGCGCACAATGCCAACGTAATCCCACATAAACAGA  1271801 
 
Query  376      CGTAGCTCGTGCCAGTTATGCTGAATTACTACCCGTTCGTCAGGGTTCTCAACGCGGCTT  435 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271802  CGTAGCTCGTGCCAGTTATGCTGAATTACTACCCGTTCGTCAGGGTTCTCAACGCGGCTT  1271861 
 
Query  436      TCATCCCACGGCGGTAACGTACTGATGTCGTGGGCATAAGGCATACGTCTGGTGATATCT  495 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271862  TCATCCCACGGCGGTAACGTACTGATGTCGTGGGCATAAGGCATACGTCTGGTGATATCT  1271921 
 
Query  496      TCCGCCGCCGACCAGCCATAGACCAGACACTCCAGCAATGAATTCGAGGCCATGCGGTTA  555 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271922  TCCGCCGCCGACCAGCCATAGACCAGACACTCCAGCAATGAATTCGAGGCCATGCGGTTA  1271981 
 
Query  556      GCGCCGTGTAAGCCGGTATAACTCACCTCGCCAATGGCATACAAGCCCTCGACGTCCGTA  615 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271982  GCGCCGTGTAAGCCGGTATAACTCACCTCGCCAATGGCATACAAGCCCTCGACGTCCGTA  1272041 
 
Query  616      CGCCCATGATCATCAACCATTACACCACCGCAGGTATAGTGTGCAGCAGGCACAATCCGC  675 
                ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |  
Sbjct  1272042  CGCCCATGATCATCAACCATTACACCACCGCAGGTATAGTGTGCAGCAGGCACAATCGGT  1272101 
 
Query  676      ACCGGTTCTTGTGTGAGATCAATCCCCAGCCCGAGCAATTTTTCATAAATCATCGGGAAA  735 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1272102  ACCGGTTCTTGTGTGAGATCAATCCCCAGCCCGAGCAATTTTTCATAAATCATCGGGAAA  1272161 
 
Query  736      CGCTGGCGAATAAAATCAGCGGGCTTATGGCTGATATCAAGGAACATACGATCCCGCGCC  795 
                 |||||||||||||||||||||||||||||||||||||||||||||||| || ||||||| 
Sbjct  1272162  TGCTGGCGAATAAAATCAGCGGGCTTATGGCTGATATCAAGGAACATACAAT-CCGCGCC  1272220 
 
Query  796      GAGGCGTTTCATTTTATTGGTCAATGGCGCGGGCTACAATATCGCGCGGGTCCAATTCTG  855 
                |||||||||||||| | ||||||||||||||||| ||||||||||||||| ||| |||   
Sbjct  1272221  GAGGCGTTTCATTTCA-TGGTCAATGGCGCGGGCGACAATATCGCGCGGGGCCAGTTC--  1272277 
 
Query  856      TCTCCCCGCATCAAAATCG  874 
                 |  | | ||||||||||| 
Sbjct  1272278  GCCGCGCACATCAAAATCG  1272296 
 
 
9.1.1.3 nadC 
>113597_pET28anadC2_T7 
AGGTTAACCGGTACATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCC
ATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGCCGCCTCGCCGCTATAACCCTGACA
CCCGACGTGACGAGCTGCTGGAACGCATTAATCTCGATATCCCCGGCGCGGTGGCCCAGGCGCTGCGGGAAGATT
TAGGCGGAACAGTCGATGCCAACAATGATATTACGGCAAAACTTTTACCGGAAAATTCTCGCTCTCATGCCACGG
TGATCACCCGCGAGAATGGCGTCTTTTGCGGCAAACGCTGGGTTGAAGAGGTGTTTATTCAACTGGCAGGCGACG
ATGTCACCATAATCTGGCATGTGGATGACGGCGATGTCATCAATGCCAATCAATCCTTGTTCGAACTTGAAGGCC
CATCCCGCGTGCTGTTAACGGGCGAACGCACTGCGCTTAATTTTGTGCAAACCCTTTCAGGAGTTGCCAGTAAGG
TACGCCACTATGTCGAATTGCTGGAAGGCACCAACACGCAGTTGTTGGATACGCGCAAAACCTTACCCGGCCTGC
GTTCAGCTCTGAAATACGCGGTACTTTGCGGCGGCGGAGCGAATCACCGTCTGGGGCTTTCTGATGCCTTCCTGA
TCAAAGAAAACCATATTATTGCCTCCGGCTCAGTGCGCCAGGCGGTCGAAAAAGCGTCCTGGCTGCACCCGGATG
CGCCAGTAGAAGTCGAAGTAGAGAATCTGGAAGAACTTGATGAAGCCCTGAAAGCAGGAGCCGATATCATCATGC
TGGATAACTTCGAAACAGAACAGATGCGCGAAGCCGTCAAACGCACCAACGGCAAGGCGCTACTGGAAGTGTCTG
GCAACGTCACTGACAAAACACTGCGTGAATTTGCCGAAACGGGCGTGGACTTTATCTCCGTCGTGCGCTAACTAA
ACACGTACAAGCACTCGACCTTTCAATGCGTTTCGCTAATAAGCTTGCGGCCGCACCTCGAGCACACACACACAC
TGAGATCCGGCTGCTAACAAAGCCCGAAAGAGCTGAGTGCTGCTGCCACCGCTGAGCATACTAGCATAACCCTTT
GGGGCCTCTAACGGTCTTGGAGGG 
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Query  123     ATGCCGCCTCGCCGCTATAACCCTGACACCCGACGTGACGAGCTGCTGGAACGCATTAAT  182 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118645  ATGCCGCCTCGCCGCTATAACCCTGACACCCGACGTGACGAGCTGCTGGAACGCATTAAT  118586 
 
Query  183     CTCGATATCCCCGGCGCGGTGGCCCAGGCGCTGCGGGAAGATTTAGGCGGAACAGTCGAT  242 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118585  CTCGATATCCCCGGCGCGGTGGCCCAGGCGCTGCGGGAAGATTTAGGCGGAACAGTCGAT  118526 
 
Query  243     GCCAACAATGATATTACGGCAAAACTTTTACCGGAAAATTCTCGCTCTCATGCCACGGTG  302 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118525  GCCAACAATGATATTACGGCAAAACTTTTACCGGAAAATTCTCGCTCTCATGCCACGGTG  118466 
 
Query  303     ATCACCCGCGAGAATGGCGTCTTTTGCGGCAAACGCTGGGTTGAAGAGGTGTTTATTCAA  362 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118465  ATCACCCGCGAGAATGGCGTCTTTTGCGGCAAACGCTGGGTTGAAGAGGTGTTTATTCAA  118406 
 
Query  363     CTGGCAGGCGACGATGTCACCATAATCTGGCATGTGGATGACGGCGATGTCATCAATGCC  422 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118405  CTGGCAGGCGACGATGTCACCATAATCTGGCATGTGGATGACGGCGATGTCATCAATGCC  118346 
 
Query  423     AATCAATCCTTGTTCGAACTTGAAGGCCCATCCCGCGTGCTGTTAACGGGCGAACGCACT  482 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118345  AATCAATCCTTGTTCGAACTTGAAGGCCCATCCCGCGTGCTGTTAACGGGCGAACGCACT  118286 
 
Query  483     GCGCTTAATTTTGTGCAAACCCTTTCAGGAGTTGCCAGTAAGGTACGCCACTATGTCGAA  542 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118285  GCGCTTAATTTTGTGCAAACCCTTTCAGGAGTTGCCAGTAAGGTACGCCACTATGTCGAA  118226 
 
Query  543     TTGCTGGAAGGCACCAACACGCAGTTGTTGGATACGCGCAAAACCTTACCCGGCCTGCGT  602 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118225  TTGCTGGAAGGCACCAACACGCAGTTGTTGGATACGCGCAAAACCTTACCCGGCCTGCGT  118166 
 
Query  603     TCAGCTCTGAAATACGCGGTACTTTGCGGCGGCGGAGCGAATCACCGTCTGGGGCTTTCT  662 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118165  TCAGCTCTGAAATACGCGGTACTTTGCGGCGGCGGAGCGAATCACCGTCTGGGGCTTTCT  118106 
 
Query  663     GATGCCTTCCTGATCAAAGAAAACCATATTATTGCCTCCGGCTCAGTGCGCCAGGCGGTC  722 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118105  GATGCCTTCCTGATCAAAGAAAACCATATTATTGCCTCCGGCTCAGTGCGCCAGGCGGTC  118046 
 
Query  723     GAAAAAGCGTCCTGGCTGCACCCGGATGCGCCAGTAGAAGTCGAAGTAGAGAATCTGGAA  782 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118045  GAAAAAGCGTCCTGGCTGCACCCGGATGCGCCAGTAGAAGTCGAAGTAGAGAATCTGGAA  117986 
 
Query  783     GAACTTGATGAAGCCCTGAAAGCAGGAGCCGATATCATCATGCTGGATAACTTCGAAACA  842 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117985  GAACTTGATGAAGCCCTGAAAGCAGGAGCCGATATCATCATGCTGGATAACTTCGAAACA  117926 
 
Query  843     GAACAGATGCGCGAAGCCGTCAAACGCACCAACGGCAAGGCGCTACTGGAAGTGTCTGGC  902 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117925  GAACAGATGCGCGAAGCCGTCAAACGCACCAACGGCAAGGCGCTACTGGAAGTGTCTGGC  117866 
 
Query  903     AACGTCACTGACAAAACACTGCGTGAATTTGCCGAAACGGGCGTGGACTTTATCTCCGTC  962 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117865  AACGTCACTGACAAAACACTGCGTGAATTTGCCGAAACGGGCGTGGACTTTATCTCCGTC  117806 
 
Query  963     -GTGCGCTAACTAAACACGTACAAGCACTCGACCTTTCAATGCG-TTTCGCTAATA  1016 
                ||||||||||||||||||||||||||||||||||||||||||| ||||||||||| 
Sbjct  117805  GGTGCGCTAACTAAACACGTACAAGCACTCGACCTTTCAATGCGTTTTCGCTAATA  117750 
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>113783_pET28anadC2_T7term 
TCATGCGGAGCGCTAGCTTCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTG
CGGCCGCAAGCTTATTAGCGAAAACGCATTGAAAGGTCGAGTGCTTGTACGTGTTTAGTTAGCGCACCGACGGAG
ATAAAGTCCACGCCCGTTTCGGCAAATTCACGCAGTGTTTTGTCAGTGACGTTGCCAGACACTTCCAGTAGCGCC
TTGCCGTTGGTGCGTTTGACGGCTTCGCGCATCTGTTCTGTTTCGAAGTTATCCAGCATGATGATATCGGCTCCT
GCTTTCAGGGCTTCATCAAGTTCTTCCAGATTCTCTACTTCGACTTCTACTGGCGCATCCGGGTGCAGCCAGGAC
GCTTTTTCGACCGCCTGGCGCACTGAGCCGGAGGCAATAATATGGTTTTCTTTGATCAGGAAGGCATCAGAAAGC
CCCAGACGGTGATTCGCTCCGCCGCCGCAAAGTACCGCGTATTTCAGAGCTGAACGCAGGCCGGGTAAGGTTTTG
CGCGTATCCAACAACTGCGTGTTGGTGCCTTCCAGCAATTCGACATAGTGGCGTACCTTACTGGCAACTCCTGAA
AGGGTTTGCACAAAATTAAGCGCAGTGCGTTCGCCCGTTAACAGCACGCGGGATGGGCCTTCAAGTTCGAACAAG
GATTGATTGGCATTGATGACATCGCCGTCATCCACATGCCAGATTATGGTGACATCGTCGCCTGCCAGTTGAATA
AACACCTCTTCAACCCAGCGTTTGCCGCAAAAGACGCCATTCTCGCGGGTGATCACCGTGGCATGAGAGCGAGAA
TTTTCCGGTAAAAGTTTTGCCGTAATATCATTGTTGGCATCGACTGTTCCGCCTAAATCTTCCCGCAGCGCCTGG
GCCACCGCGCCGGGGATATCGAGATTAATGCGTTCCAGCAGCTCGTCACGTCGGGTGTCAGGTTATAGCGGCGAG
GCGGCATATGGCTGCCGCGCGGCACCAGGCCGCTGCTGTGATGATGATGATGATGGCTGCTGCCCATGGTATATC
TCCTTCTTAAAGTTAAACAAAATAT 
 
 
Query  88      TATTAGCGAAAACGCATTGAAAGGTCGAGTGCTTGTACGTGTTTAGTTAGCGCACCGACG  147 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117750  TATTAGCGAAAACGCATTGAAAGGTCGAGTGCTTGTACGTGTTTAGTTAGCGCACCGACG  117809 
 
Query  148     GAGATAAAGTCCACGCCCGTTTCGGCAAATTCACGCAGTGTTTTGTCAGTGACGTTGCCA  207 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117810  GAGATAAAGTCCACGCCCGTTTCGGCAAATTCACGCAGTGTTTTGTCAGTGACGTTGCCA  117869 
 
Query  208     GACACTTCCAGTAGCGCCTTGCCGTTGGTGCGTTTGACGGCTTCGCGCATCTGTTCTGTT  267 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117870  GACACTTCCAGTAGCGCCTTGCCGTTGGTGCGTTTGACGGCTTCGCGCATCTGTTCTGTT  117929 
 
Query  268     TCGAAGTTATCCAGCATGATGATATCGGCTCCTGCTTTCAGGGCTTCATCAAGTTCTTCC  327 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117930  TCGAAGTTATCCAGCATGATGATATCGGCTCCTGCTTTCAGGGCTTCATCAAGTTCTTCC  117989 
 
Query  328     AGATTCTCTACTTCGACTTCTACTGGCGCATCCGGGTGCAGCCAGGACGCTTTTTCGACC  387 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117990  AGATTCTCTACTTCGACTTCTACTGGCGCATCCGGGTGCAGCCAGGACGCTTTTTCGACC  118049 
 
Query  388     GCCTGGCGCACTGAGCCGGAGGCAATAATATGGTTTTCTTTGATCAGGAAGGCATCAGAA  447 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118050  GCCTGGCGCACTGAGCCGGAGGCAATAATATGGTTTTCTTTGATCAGGAAGGCATCAGAA  118109 
 
Query  448     AGCCCCAGACGGTGATTCGCTCCGCCGCCGCAAAGTACCGCGTATTTCAGAGCTGAACGC  507 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118110  AGCCCCAGACGGTGATTCGCTCCGCCGCCGCAAAGTACCGCGTATTTCAGAGCTGAACGC  118169 
 
Query  508     AGGCCGGGTAAGGTTTTGCGCGTATCCAACAACTGCGTGTTGGTGCCTTCCAGCAATTCG  567 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118170  AGGCCGGGTAAGGTTTTGCGCGTATCCAACAACTGCGTGTTGGTGCCTTCCAGCAATTCG  118229 
 
Query  568     ACATAGTGGCGTACCTTACTGGCAACTCCTGAAAGGGTTTGCACAAAATTAAGCGCAGTG  627 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118230  ACATAGTGGCGTACCTTACTGGCAACTCCTGAAAGGGTTTGCACAAAATTAAGCGCAGTG  118289 
 
Query  628     CGTTCGCCCGTTAACAGCACGCGGGATGGGCCTTCAAGTTCGAACAAGGATTGATTGGCA  687 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118290  CGTTCGCCCGTTAACAGCACGCGGGATGGGCCTTCAAGTTCGAACAAGGATTGATTGGCA  118349 
 
Query  688     TTGATGACATCGCCGTCATCCACATGCCAGATTATGGTGACATCGTCGCCTGCCAGTTGA  747 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118350  TTGATGACATCGCCGTCATCCACATGCCAGATTATGGTGACATCGTCGCCTGCCAGTTGA  118409 
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Query  748     ATAAACACCTCTTCAACCCAGCGTTTGCCGCAAAAGACGCCATTCTCGCGGGTGATCACC  807 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118410  ATAAACACCTCTTCAACCCAGCGTTTGCCGCAAAAGACGCCATTCTCGCGGGTGATCACC  118469 
 
Query  808     GTGGCATGAGAGCGAGAATTTTCCGGTAAAAGTTTTGCCGTAATATCATTGTTGGCATCG  867 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118470  GTGGCATGAGAGCGAGAATTTTCCGGTAAAAGTTTTGCCGTAATATCATTGTTGGCATCG  118529 
 
Query  868     ACTGTTCCGCCTAAATCTTCCCGCAGCGCCTGGGCCACCGCGCCGGGGATATCGAGATTA  927 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118530  ACTGTTCCGCCTAAATCTTCCCGCAGCGCCTGGGCCACCGCGCCGGGGATATCGAGATTA  118589 
 
Query  928     ATGCGTTCCAGCAGCTCGTCACGTCGGGTGTCA-GGTTATAGCGGCGAGGCGGCAT  982 
               ||||||||||||||||||||||||||||||||| |||||||||||||||||||||| 
Sbjct  118590  ATGCGTTCCAGCAGCTCGTCACGTCGGGTGTCAGGGTTATAGCGGCGAGGCGGCAT  118645 
 
9.1.1.4 nadD 
>109348_pET28anaD1_T7 
CGTTGAACCGAACATTCCCTCTAGAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATC
ATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCTAGCATGACTGGTGGACAGCAAATGG
GTCGCGGATCCATGAAATCTTTACAGGCTCTGTTTGGCGGCACCTTTGATCCGGTGCACTATGGTCATCTAAAAC
CCGTGGAAACGCTGGCGAATTTGATTGGTCTGACGCGGGTCACAATCATCCCTAATAATGTTCCTCCGCATCGTC
CCCAGCCGGAAGCGAACAGCGTGCAGCGTAAACACATGCTTGAACTGGCGATTGCCGACAAGCCATTATTTACTC
TTGATGAACGCGAGCTAAAGCGCAATGCCCCCTCTTACACTGCGCAAACACTGAAAGAGTGGCGGCAGGAACAAG
GACCGGACGTGCCGCTGGCGTTTATTATTGGTCAGGATTCACTGCTGACCTTTCCGACCTGGTACGAATACGAAA
CGATACTCGACAATGCACATTTGATCGTCTGTCGGCGTCCAGGTTACCCACTTGAAATGGCGCAACCGCAATACC
AGCAATGGCTGGAAGATCATTTGACACATAACCCGGAAGATCTTCACCTTCAGCCTGCCGGTAAAATTTATCTGG
CTGAAACGCCGTGGTTTAACATCTCGGCGACCATCATCCGCGAACGTTTGCAAAACGGTGAATCATGTGAGGATT
TATTGCCGGAACCGGTACTGACTTACATTAACCAACAAGGCTTGTATCGCTGATAAGCTTGCGGCCGCACTCGAG
CACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCT
GAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATA
TCCGGATTGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGA
CCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTTCCTTTCTCGCCACGTTCGCCGGC
TTCCCGTCAGCTCTAAATCGGGGGGCTCCTTTAGGTTTCGATTAGTGCCTTACGGCACCTCGACCCCAAAACCTT
GATTAGGGTGATCTCACGTTATTGGCATCGGCCCTGGATAGAAACGGTTTTTCGCCCTTTTGAAACGTTTGTGGA
GATTTC 
 
 
Query  162     ATGAAATCTTTACAGGCTCTGTTTGGCGGCACCTTTGATCCGGTGCACTATGGTCATCTA  221 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  634355  ATGAAATCTTTACAGGCTCTGTTTGGCGGCACCTTTGATCCGGTGCACTATGGTCATCTA  634296 
 
Query  222     AAACCCGTGGAAACGCTGGCGAATTTGATTGGTCTGACGCGGGTCACAATCATCCCTAAT  281 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  634295  AAACCCGTGGAAACGCTGGCGAATTTGATTGGTCTGACGCGGGTCACAATCATCCCTAAT  634236 
 
Query  282     AATGTTCCTCCGCATCGTCCCCAGCCGGAAGCGAACAGCGTGCAGCGTAAACACATGCTT  341 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  634235  AATGTTCCTCCGCATCGTCCCCAGCCGGAAGCGAACAGCGTGCAGCGTAAACACATGCTT  634176 
 
Query  342     GAACTGGCGATTGCCGACAAGCCATTATTTACTCTTGATGAACGCGAGCTAAAGCGCAAT  401 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  634175  GAACTGGCGATTGCCGACAAGCCATTATTTACTCTTGATGAACGCGAGCTAAAGCGCAAT  634116 
 
Query  402     GCCCCCTCTTACACTGCGCAAACACTGAAAGAGTGGCGGCAGGAACAAGGACCGGACGTG  461 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  634115  GCCCCCTCTTACACTGCGCAAACACTGAAAGAGTGGCGGCAGGAACAAGGACCGGACGTG  634056 
 
Query  462     CCGCTGGCGTTTATTATTGGTCAGGATTCACTGCTGACCTTTCCGACCTGGTACGAATAC  521 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  634055  CCGCTGGCGTTTATTATTGGTCAGGATTCACTGCTGACCTTTCCGACCTGGTACGAATAC  633996 
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Query  522     GAAACGATACTCGACAATGCACATTTGATCGTCTGTCGGCGTCCAGGTTACCCACTTGAA  581 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  633995  GAAACGATACTCGACAATGCACATTTGATCGTCTGTCGGCGTCCAGGTTACCCACTTGAA  633936 
 
Query  582     ATGGCGCAACCGCAATACCAGCAATGGCTGGAAGATCATTTGACACATAACCCGGAAGAT  641 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  633935  ATGGCGCAACCGCAATACCAGCAATGGCTGGAAGATCATTTGACACATAACCCGGAAGAT  633876 
 
Query  642     CTTCACCTTCAGCCTGCCGGTAAAATTTATCTGGCTGAAACGCCGTGGTTTAACATCTCG  701 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  633875  CTTCACCTTCAGCCTGCCGGTAAAATTTATCTGGCTGAAACGCCGTGGTTTAACATCTCG  633816 
 
Query  702     GCGACCATCATCCGCGAACGTTTGCAAAACGGTGAATCATGTGAGGATTTATTGCCGGAA  761 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  633815  GCGACCATCATCCGCGAACGTTTGCAAAACGGTGAATCATGTGAGGATTTATTGCCGGAA  633756 
 
Query  762     CCGGTACTGACTTACATTAACCAACAAGGCTTGTATCGCTGATA  805 
               |||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  633755  CCGGTACTGACTTACATTAACCAACAAGGCTTGTATCGCTGATA  633712 
 
 
9.1.1.5 nadE 
>109352_pET28anadE2_T7 
TTTTTAAACGGTTATTCCCTCTAGAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATC
ATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCTAGCATGACTGGTGGACAGCAAATGG
GTCGCGGATCCATGACATTGCAACAACAAATAATAAAGGCGCTGGGCGCAAAACCGCAGATTAATGCTGAAGAGG
AAATTCGTCGTAGTGTCGATTTTCTGAAAAGCTACCTGCAAACTTATCCGTTCATTAAATCACTGGTGCTCGGGA
TCAGCGGCGGTCAGGACTCCACGCTTGCCGGAAAGCTGTGCCAGATGGCGATTAATGAGCTGCGCCTGGAAACCG
GCAACGAATCACTGCAATTTATTGCCGTACGCCTGCCCTATGGTGTTCAGGCCGACGAACAAGATTGCCAGGATG
CCATTGCCTTTATTCAACCGGATCGCGTATTAACCGTTAATATCAAGGGCGCGGTATTGGCCAGCGAACAGGCAT
TGCGGGAAGCAGGCATTGAACTGAGCGATTTTGTCCGTGGCAATGAAAAAGCGCGTGAGCGGATGAAAGCACAAT
ATAGCATTGCGGGTATGACCAGCGGTGTCGTGGTGGGCACCGATCATGCAGCAGAAGCCATTACCGGATTCTTCA
CTAAATATGGTGACGGCGGTACGGACATTAATCCGCTGTATCGTCTCAACAAACGTCAGGGTAAACAGTTACTGG
CGGCATTAGCTTGCCCGGAACACCTTTATAAGAAAGCGCCAACGGCCGATCTGGAAGATGATCGCCCTTCTCTGC
CAGATGAAGTGGCACTCGGCGTGACCTATGACAATATCGACGACTATCTGGAAAGGGAAAAACGTACCTCAACAG
GTCGCCAGAACAATAGAGAACTGGTATCTGAAAACCGAACATAAACGCCGTCCGCCAATTACCGTTTTCGATGAT
TTCTGGAAAAGTAATAATTTGCACATATTGGTTGTGTGAAAAGCTTGCGGCCGCACTCGAGCACCACCACCACCA
CCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAGCTGAGTTGGCTGCTGCCACCGCTGAGCATACTAGCATA
CCCCTGGGGCCTCTAACGGGTCTGGAGGGTTTTTGCTGAAGGAGACTTATATCGATGGCGATGGGACCGCGCCTG
TACGTCCATACCGCGAGTGTGTGTACGCGCAGCGGGACGCTACACATGTCCAAGCGCCCTA 
 
 
Query  162  MTLQQQIIKALGAKPQINAEEEIRRSVDFLKSYLQTYPFIKSLVLGISGGQDSTLAGKLC  341 
            MTLQQQIIKALGAKPQINAEEEIRRSVDFLKSYLQTYPFIKSLVLGISGGQDSTLAGKLC 
Sbjct  1    MTLQQQIIKALGAKPQINAEEEIRRSVDFLKSYLQTYPFIKSLVLGISGGQDSTLAGKLC  60 
 
Query  342  QMAINELRLETGNESLQFIAVRLPYGVQADEQDCQDAIAFIQPDRVLTVNIKGAVLASEQ  521 
            QMAINELRLETGNESLQFIAVRLPYGVQADEQDCQDAIAFIQPDRVLTVNIKGAVLASEQ 
Sbjct  61   QMAINELRLETGNESLQFIAVRLPYGVQADEQDCQDAIAFIQPDRVLTVNIKGAVLASEQ  120 
 
Query  522  ALREAGIELSDFVRGNEKARERMKAQYSIAGMTSGVVVGTDHAAEAITGFFTKYGDGGTD  701 
            ALREAGIELSDFVRGNEKARERMKAQYSIAGMTSGVVVGTDHAAEAITGFFTKYGDGGTD 
Sbjct  121  ALREAGIELSDFVRGNEKARERMKAQYSIAGMTSGVVVGTDHAAEAITGFFTKYGDGGTD  180 
 
Query  702  INPLYRLNKRQGKQLLAALACPEHLYKKAPTADLEDDRPSLPDEVALGVTYDNIDDYLE  878 
            INPLYRLNKRQGKQLLAALACPEHLYKKAPTADLEDDRPSLPDEVALGVTYDNIDDYLE 
Sbjct  181  INPLYRLNKRQGKQLLAALACPEHLYKKAPTADLEDDRPSLPDEVALGVTYDNIDDYLE  239 
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9.1.1.6 nadK 
>109964_pNCOnadK1 
AGGTAGCAAATCTTTCGCTGATCTCATGGTCATGTTTCACCAAAGAACACCACGATCACGACACCACCTTTGAAG
AAATTATTATTGGTTCCGCGGCATCTGGTCTGGTGCCACGCGGATCCATGAATAATCATTTCAAGTGTATTGGCA
TTGTGGGACACCCACGGCACCCCACTGCACTGACAACACATGAAATGCTCTACCGCTGGCTGTGCACAAAAGGTT
ACGAGGTCATCGTTGAGCAACAAATCGCTCACGAACTGCAACTGAAGAATGTGAAAACTGGCACGCTCGCGGAGA
TTGGGCAACTAGCTGATCTCGCGGTAGTCGTTGGTGGCGACGGTAATATGCTGGGCGCGGCACGCACACTCGCCC
GTTACGATATTAAAGTTATTGGAATCAACCGTGGCAACCTGGGTTTCCTGACTGACCTTGACCCCGATAACGCCC
AGCAACAGTTAGCCGATGTGCTGGAAGGCCACTACATCAGCGAGAAACGTTTTTTGCTGGAAGCGCAAGTCTGTC
AGCAAGATTGCCAGAAACGCATCAGCACCGCGATAAATGAAGTGGTGCTTCATCCAGGCAAAGTGGCGCATATGA
TTGAGTTCGAAGTGTATATCGACGAGATCTTTGCGTTTTCTCAGCGATCTGATGGACTAATTATTTCGACGCCAA
CAGGCTCCACCGCCTATTCCCTCTCTGCAGGCGGTCCTATTCTGACCCCCTCTCTGGATGCGATTACCCTGGTGC
CCATGTTCCCGCATACGTTGTCAGCACGACCACTGGTCATAAACAGCAGCAGCACGATCCGTCTGCGTTTTTCGC
ATCGCCGTAACGACCTGAAATCAGTTGCGACAGCCAGATAGCACTGCCGATTCAGGAAGGTGAAGATGTCCTGAT
TCGTCGCTGTGATTACCATCTGAATCTGATTCATCCGAAAGATTACAGTTATTTCAACACATTAAGCACCAAGCT
CGGCTGGTCAAAAAATTATTTCTAATAAGCTTAATTAGCTGAGCTTGGACTCTGTTGATAGATCCAGTAATGACC
TCAGAACTCCATCTGGATTTGTTCAGAACGCTCGGTTGCCGCCGGGCGTTTTTTATTGGTGGGG 
 
 
Query  123      ATGAATAATCATTTCAAGTGTATTGGCATTGTGGGACACCCACGGCACCCCACTGCACTG  182 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693359  ATGAATAATCATTTCAAGTGTATTGGCATTGTGGGACACCCACGGCACCCCACTGCACTG  2693418 
 
Query  183      ACAACACATGAAATGCTCTACCGCTGGCTGTGCACAAAAGGTTACGAGGTCATCGTTGAG  242 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693419  ACAACACATGAAATGCTCTACCGCTGGCTGTGCACAAAAGGTTACGAGGTCATCGTTGAG  2693478 
 
Query  243      CAACAAATCGCTCACGAACTGCAACTGAAGAATGTGAAAACTGGCACGCTCGCGGAGATT  302 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693479  CAACAAATCGCTCACGAACTGCAACTGAAGAATGTGAAAACTGGCACGCTCGCGGAGATT  2693538 
 
Query  303      GGGCAACTAGCTGATCTCGCGGTAGTCGTTGGTGGCGACGGTAATATGCTGGGCGCGGCA  362 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693539  GGGCAACTAGCTGATCTCGCGGTAGTCGTTGGTGGCGACGGTAATATGCTGGGCGCGGCA  2693598 
 
Query  363      CGCACACTCGCCCGTTACGATATTAAAGTTATTGGAATCAACCGTGGCAACCTGGGTTTC  422 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693599  CGCACACTCGCCCGTTACGATATTAAAGTTATTGGAATCAACCGTGGCAACCTGGGTTTC  2693658 
 
Query  423      CTGACTGACCTTGACCCCGATAACGCCCAGCAACAGTTAGCCGATGTGCTGGAAGGCCAC  482 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693659  CTGACTGACCTTGACCCCGATAACGCCCAGCAACAGTTAGCCGATGTGCTGGAAGGCCAC  2693718 
 
Query  483      TACATCAGCGAGAAACGTTTTTTGCTGGAAGCGCAAGTCTGTCAGCAAGATTGCCAGAAA  542 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693719  TACATCAGCGAGAAACGTTTTTTGCTGGAAGCGCAAGTCTGTCAGCAAGATTGCCAGAAA  2693778 
 
Query  543      CGCATCAGCACCGCGATAAATGAAGTGGTGCTTCATCCAGGCAAAGTGGCGCATATGATT  602 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693779  CGCATCAGCACCGCGATAAATGAAGTGGTGCTTCATCCAGGCAAAGTGGCGCATATGATT  2693838 
 
Query  603      GAGTTCGAAGTGTATATCGACGAGATCTTTGCGTTTTCTCAGCGATCTGATGGACTAATT  662 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693839  GAGTTCGAAGTGTATATCGACGAGATCTTTGCGTTTTCTCAGCGATCTGATGGACTAATT  2693898 
 
Query  663      ATTTCGACGCCAACAGGCTCCACCGCCTATTCCCTCTCTGCAGGCGGTCCTATTCTGACC  722 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693899  ATTTCGACGCCAACAGGCTCCACCGCCTATTCCCTCTCTGCAGGCGGTCCTATTCTGACC  2693958 
 
Query  723      CCCTCTCTGGATGCGATTACCCTGGTGCCCATGTTCCCGCATACGTTGTCAGCACGACCA  782 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2693959  CCCTCTCTGGATGCGATTACCCTGGTGCCCATGTTCCCGCATACGTTGTCAGCACGACCA  2694018 
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Query  783      CTGGTCATAAACAGCAGCAGCACGATCCGTCTGCGTTTTTCGCATCGCCGTAACGACCT-  841 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  2694019  CTGGTCATAAACAGCAGCAGCACGATCCGTCTGCGTTTTTCGCATCGCCGTAACGACCTG  2694078 
 
Query  842      GAAATCAGTTGCGACAGCCAGATAGCACTGCCGATTCAGGAAGGTGAAGATGTCCTGATT  901 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2694079  GAAATCAGTTGCGACAGCCAGATAGCACTGCCGATTCAGGAAGGTGAAGATGTCCTGATT  2694138 
 
Query  902      CGTCGCTGTGATTACCATCTGAATCTGATTCATCCGAAAGATTACAGTTATTTCAACACA  961 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2694139  CGTCGCTGTGATTACCATCTGAATCTGATTCATCCGAAAGATTACAGTTATTTCAACACA  2694198 
 
Query  962      TTAAGCACCAAGCTCGGCTGGTCAAAAAATTATTTCTAAT  1001 
                ||||||||||||||||||||||||||||| |  ||||||| 
Sbjct  2694199  TTAAGCACCAAGCTCGGCTGGTCAAAAAAATTATTCTAAT  2694238 
 
9.1.1.7 pncB 
>109345_pET28apncB1_T7 
ATGATTGCCGTCATTCCCTCTAGAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATCA
TCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCTAGCATGACTGGTGGACAGCAAATGGG
TCGCGGATCCATGACACAATTCGCTTCTCCTGTTCTGCACTCGTTGCTGGATACAGATGCTTATAAGTTGCATAT
GCAGCAAGCCGTGTTTCATCACTATTACGATGTGCATGTCGCGGCGGAGTTTCGTTGCCGAGGTGACGATCTGCT
GGGTATTTATGCCGATGCTATTCGTGAACAGGTTCAGGCGATGCAGCACCTGCGCCTGCAGGATGATGAATATCA
GTGGCTTTCTGCCCTGCCTTTCTTTAAGGCCGACTATCTTAACTGGTTACGCGAGTTCCGCTTTAACCCGGAACA
AGTCACCGTGTCCAACGATAATGGCAAGCTGGATATTCGTTTAAGCGGCCCGTGGCGTGAAGTCATCCTCTGGGA
AGTTCCTTTGCTGGCGGTTATCAGTGAAATGGTACATCGCTATCGCTCACCGCAGGCCGACGTTGCGCAAGCCCT
CGACACGCTGGAAAGCAAATTAGTCGACTTCTCGGCGTTAACCGCCGGTCTTGATATGTCGCGCTTCCATCTGAT
GGATTTTGGCACCCGTCGCCGTTTTTCTCGCGAAGTACAAGAAACCATCGTTAAGCGTCTGCAACAGGAATCCTG
GTTTGTGGGCACCAGCAACTACGATCTGGCGCGTCGGCTTTCCCTCACGCCGATGGGAACACAGGCACACGAATG
GTTCCAGGCACATCAGCAAATCAGCCCGGATCTAGCCAACAGCCAGCGAGCTGCACTTGCTGCCTGGCTGGAAGA
GTATCCCGACCAACTTGGCATTGCATTAACCGACTGCATCACTATGGATGCTTTCCTGCGTGATTTCGGTGTCGA
GTTCGCTAGTCGGTATCAGGCCTGCGTCATGACTCTGGCGACCCGGTTGAATGGGGTGAAAAGCCATTGCACATT
ATGAAAAGCTGGGAATGATCCACAGAGTAAAACGCTGGGTTTCTCCTGACATCTGGATTTACGCAAGCGGTTGAG
CTATACCGCCAACTTCTCTTCCCGCGTGCAATTAGGTTTGATTGGGAACTCGGCCTGAACTGGCGAATATCCCCA
GGTTAAGCCTGAATTTGCCATTAAGTGGTCAGGTTACGTTAATCGGGTGCGAACTTCTTGAACAGGCCTGTGCAA
AAACCTATCTCTGC 
 
 
Query  153     GCGGATCCATGACACAATTCGCTTCTCCTGTTCTGCACTCGTTGCTGGATACAGATGCTT  212 
               ||| | | |||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955483  GCGCACCTATGACACAATTCGCTTCTCCTGTTCTGCACTCGTTGCTGGATACAGATGCTT  955424 
 
Query  213     ATAAGTTGCATATGCAGCAAGCCGTGTTTCATCACTATTACGATGTGCATGTCGCGGCGG  272 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955423  ATAAGTTGCATATGCAGCAAGCCGTGTTTCATCACTATTACGATGTGCATGTCGCGGCGG  955364 
 
Query  273     AGTTTCGTTGCCGAGGTGACGATCTGCTGGGTATTTATGCCGATGCTATTCGTGAACAGG  332 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955363  AGTTTCGTTGCCGAGGTGACGATCTGCTGGGTATTTATGCCGATGCTATTCGTGAACAGG  955304 
 
Query  333     TTCAGGCGATGCAGCACCTGCGCCTGCAGGATGATGAATATCAGTGGCTTTCTGCCCTGC  392 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955303  TTCAGGCGATGCAGCACCTGCGCCTGCAGGATGATGAATATCAGTGGCTTTCTGCCCTGC  955244 
 
Query  393     CTTTCTTTAAGGCCGACTATCTTAACTGGTTACGCGAGTTCCGCTTTAACCCGGAACAAG  452 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
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Sbjct  955243  CTTTCTTTAAGGCCGACTATCTTAACTGGTTACGCGAGTTCCGCTTTAACCCGGAACAAG  955184 
 
Query  453     TCACCGTGTCCAACGATAATGGCAAGCTGGATATTCGTTTAAGCGGCCCGTGGCGTGAAG  512 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955183  TCACCGTGTCCAACGATAATGGCAAGCTGGATATTCGTTTAAGCGGCCCGTGGCGTGAAG  955124 
 
Query  513     TCATCCTCTGGGAAGTTCCTTTGCTGGCGGTTATCAGTGAAATGGTACATCGCTATCGCT  572 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955123  TCATCCTCTGGGAAGTTCCTTTGCTGGCGGTTATCAGTGAAATGGTACATCGCTATCGCT  955064 
 
Query  573     CACCGCAGGCCGACGTTGCGCAAGCCCTCGACACGCTGGAAAGCAAATTAGTCGACTTCT  632 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955063  CACCGCAGGCCGACGTTGCGCAAGCCCTCGACACGCTGGAAAGCAAATTAGTCGACTTCT  955004 
 
Query  633     CGGCGTTAACCGCCGGTCTTGATATGTCGCGCTTCCATCTGATGGATTTTGGCACCCGTC  692 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955003  CGGCGTTAACCGCCGGTCTTGATATGTCGCGCTTCCATCTGATGGATTTTGGCACCCGTC  954944 
 
Query  693     GCCGTTTTTCTCGCGAAGTACAAGAAACCATCGTTAAGCGTCTGCAACAGGAATCCTGGT  752 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954943  GCCGTTTTTCTCGCGAAGTACAAGAAACCATCGTTAAGCGTCTGCAACAGGAATCCTGGT  954884 
 
Query  753     TTGTGGGCACCAGCAACTACGATCTGGCGCGTCGGCTTTCCCTCACGCCGATGGGAACAC  812 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954883  TTGTGGGCACCAGCAACTACGATCTGGCGCGTCGGCTTTCCCTCACGCCGATGGGAACAC  954824 
 
Query  813     AGGCACACGAATGGTTCCAGGCACATCAGCAAATCAGCCCGGATCTAGCCAACAGCCAGC  872 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954823  AGGCACACGAATGGTTCCAGGCACATCAGCAAATCAGCCCGGATCTAGCCAACAGCCAGC  954764 
 
Query  873     GAGCTGCACTTGCTGCCTGGCTGGAAGAGTATCCCGACCAACTTGGCATTGCATTAACCG  932 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954763  GAGCTGCACTTGCTGCCTGGCTGGAAGAGTATCCCGACCAACTTGGCATTGCATTAACCG  954704 
 
Query  933     ACTGCATCACTATGGATGCTTTCCTGCGTGATTTCGGTGTCGAGTTCGCTAGTCGGTATC  992 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954703  ACTGCATCACTATGGATGCTTTCCTGCGTGATTTCGGTGTCGAGTTCGCTAGTCGGTATC  954644 
 
Query  993     A-GGCCTGCGTCATGACTCTGGCGACCCGGTTGAATGGGGTG-AAAAGCCATTGCACATT  1050 
               | |||||||||||||||||||||||||||||||||||||||| ||||||||||||||||| 
Sbjct  954643  AGGGCCTGCGTCATGACTCTGGCGACCCGGTTGAATGGGGTGAAAAAGCCATTGCACATT  954584 
 
Query  1051    ATGAAAAGCTGGGAA-TGATCCACAGAGTAAAACGCTGGGTTTCTCCTGAC-ATCTGGAT  1108 
               ||||||||||||||| ||||||||||||||||||||||| ||||| ||||| |||||||| 
Sbjct  954583  ATGAAAAGCTGGGAATTGATCCACAGAGTAAAACGCTGGTTTTCT-CTGACAATCTGGAT  954525 
 
Query  1109    TTACGC-AAGCGGTTGAGCTATACCGCCAACTTCTCTTCCCGCGTGCAATTAGGTTT---  1164 
               |||||| ||||||||||||||||||||| ||||||||||||||||||||||| ||||    
Sbjct  954524  TTACGCAAAGCGGTTGAGCTATACCGCC-ACTTCTCTTCCCGCGTGCAATTAAGTTTTGG  954466 
 
Query  1165    GATTGGGAACTCGGCCTGAACTGGCGAATAT-CCCCAGGTTAA--GCCTGAAT-TTGCCA  1220 
                |||||| |||| |||||| || ||| |||| |||||||| ||   ||||||| ||| || 
Sbjct  954465  TATTGGG-ACTC-GCCTGACCT-GCG-ATATCCCCCAGGTAAAACCCCTGAATATTGTCA  954410 
 
Query  1221    TTAAGTGGTCAG---GTTACGTTAATCGGGT-GCG-AACTTCTTGAACAGGCCTGTGCAA  1275 
               |||||| |  ||   || ||| ||| | ||| ||| |||||  || |||| |||| |||| 
Sbjct  954409  TTAAGTTGGTAGAGTGTAACGGTAAACCGGTGGCGAAACTTTCTG-ACAGCCCTG-GCAA  954352 
 
Query  1276    AAACCTATCT  1285 
               ||  |||||| 
Sbjct  954351  AA--CTATCT  954344 
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>200911_109431_pET28apncB1_T7-TERM 
TTGGTGCTCGTTCGGGCTTTGTTAGCAGCCGGATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTGCGGCCGCAAGC
TTTCGGAATTAAAGGTAAAAAAAGGGAGCCGATTAGCTCCCTGATGATATTAACTGGCTTTTTTAATATGCGGAA
GGTCGAACGCTTTGCGCAGCGCCCGAACAAACGCTTTATCATGGCAGATAGTTTTGCCAGGGCTGTCAGAAAGTT
TCGCCACCGGTTTACCGTTACACTCTACCAACTTAATGACAATATTCAGGGGTTTTACCTGGGGGATATCGCAGG
TCAGGCGAGTCCCAATACCAAAACTTAATTGCACGCGGGAAGAGAAGTGGCGGTATAGCTCAACCGCTTTGCGTA
AATCCAGATTGTCAGAGAAAACCAGCGTTTTACTCTGTGGATCAATTCCCAGCTTTTCATAATGTGCAATGGCTT
TTTCACCCCATTCAACCGGGTCGCCAGAGTCATGACGCAGGCCCTGATACCGACTAGCGAACTCGACACCGAAAT
CACGCAGGAAAGCATCCATAGTGATGCAGTCGGTTAATGCAATGCCAAGTTGGTCGGGATACTCTTCCAGCCAGG
CAGCAAGTGCAGCTCGCTGGCTGTTGGCTAGATCCGGGCTGATTTGCTGATGTGCCTGGAACCATTCGTGTGCCT
GTGTTCCCATCGGCGTGAGGGAAAGCCGACGCGCCAGATCGTAGTTGCTGGTGCCCACAAACCAGGATTCCTGTT
GCAGACGCTTAACGATGGTTTCTTGTACTTCGCGAGAAAAACGGCGACGGGTGCCAAAATCCATCAGATGGAAGC
GCGACATATCAAGACCGGCGGTTAACGCCGAGAAGTCGACTAATTTGCTTTCCAGCGTGTCGAGGGCTTGCGCAA
CGTCGGCCTGCGGTGAGCGATAGCGATGTACCATTTCACTGATAACCGCCAGCAAAGGAACTTCCCAGAGGATGA
CTTCACGCCACGGGCCGCTTAAACGATATCCAGCTTGCCATTATCGTTGGGACACGGTGACTTGTTCCGGGTTAA
AGCGGACTCGCGTAGCAGTTAGATAGTCGCTTAAAGAAACGCAGGCAGAAGCCACTGATATTCATCATCTGCAGC
GCAGGTGCTGCATCGCCCTGACTGATCACGATAGCATCGGCATAAATACCCAGCGAATCGTCACCTCGCACGAAC
TTCGGCTCGCGCGAACAATTCCACACTCGCGTG 
 
 
Query  69      CGCAAGCTTTCGGAATTAAAGGTaaaaaaaGGGAGCCGATTAGCTCCCTGATGATATTAA  128 
               || ||| ||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954217  CGAAAGATTTCGGAATTAAAGGTAAAAAAAGGGAGCCGATTAGCTCCCTGATGATATTAA  954276 
 
Query  129     CTGGCTTTTTTAATATGCGGAAGGTCGAACGCTTTGCGCAGCGCCCGAACAAACGCTTTA  188 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954277  CTGGCTTTTTTAATATGCGGAAGGTCGAACGCTTTGCGCAGCGCCCGAACAAACGCTTTA  954336 
 
Query  189     TCATGGCAGATAGTTTTGCCAGGGCTGTCAGAAAGTTTCGCCACCGGTTTACCGTTACAC  248 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954337  TCATGGCAGATAGTTTTGCCAGGGCTGTCAGAAAGTTTCGCCACCGGTTTACCGTTACAC  954396 
 
Query  249     TCTACCAACTTAATGACAATATTCAGGGGTTTTACCTGGGGGATATCGCAGGTCAGGCGA  308 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954397  TCTACCAACTTAATGACAATATTCAGGGGTTTTACCTGGGGGATATCGCAGGTCAGGCGA  954456 
 
Query  309     GTCCCAATACCAAAACTTAATTGCACGCGGGAAGAGAAGTGGCGGTATAGCTCAACCGCT  368 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954457  GTCCCAATACCAAAACTTAATTGCACGCGGGAAGAGAAGTGGCGGTATAGCTCAACCGCT  954516 
 
Query  369     TTGCGTAAATCCAGATTGTCAGAGAAAACCAGCGTTTTACTCTGTGGATCAATTCCCAGC  428 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954517  TTGCGTAAATCCAGATTGTCAGAGAAAACCAGCGTTTTACTCTGTGGATCAATTCCCAGC  954576 
 
Query  429     TTTTCATAATGTGCAATGGCTTTTTCACCCCATTCAACCGGGTCGCCAGAGTCATGACGC  488 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954577  TTTTCATAATGTGCAATGGCTTTTTCACCCCATTCAACCGGGTCGCCAGAGTCATGACGC  954636 
 
Query  489     AGGCCCTGATACCGACTAGCGAACTCGACACCGAAATCACGCAGGAAAGCATCCATAGTG  548 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954637  AGGCCCTGATACCGACTAGCGAACTCGACACCGAAATCACGCAGGAAAGCATCCATAGTG  954696 
 
Query  549     ATGCAGTCGGTTAATGCAATGCCAAGTTGGTCGGGATACTCTTCCAGCCAGGCAGCAAGT  608 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954697  ATGCAGTCGGTTAATGCAATGCCAAGTTGGTCGGGATACTCTTCCAGCCAGGCAGCAAGT  954756 
 
Query  609     GCAGCTCGCTGGCTGTTGGCTAGATCCGGGCTGATTTGCTGATGTGCCTGGAACCATTCG  668 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954757  GCAGCTCGCTGGCTGTTGGCTAGATCCGGGCTGATTTGCTGATGTGCCTGGAACCATTCG  954816 
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Query  669     TGTGCCTGTGTTCCCATCGGCGTGAGGGAAAGCCGACGCGCCAGATCGTAGTTGCTGGTG  728 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954817  TGTGCCTGTGTTCCCATCGGCGTGAGGGAAAGCCGACGCGCCAGATCGTAGTTGCTGGTG  954876 
 
Query  729     CCCACAAACCAGGATTCCTGTTGCAGACGCTTAACGATGGTTTCTTGTACTTCGCGAGAA  788 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954877  CCCACAAACCAGGATTCCTGTTGCAGACGCTTAACGATGGTTTCTTGTACTTCGCGAGAA  954936 
 
Query  789     AAACGGCGACGGGTGCCAAAATCCATCAGATGGAAGCGCGACATATCAAGACCGGCGGTT  848 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954937  AAACGGCGACGGGTGCCAAAATCCATCAGATGGAAGCGCGACATATCAAGACCGGCGGTT  954996 
 
Query  849     AACGCCGAGAAGTCGACTAATTTGCTTTCCAGCGTGTCGAGGGCTTGCGCAACGTCGGCC  908 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  954997  AACGCCGAGAAGTCGACTAATTTGCTTTCCAGCGTGTCGAGGGCTTGCGCAACGTCGGCC  955056 
 
Query  909     TGCGGTGAGCGATAGCGATGTACCATTTCACTGATAACCGCCAGCAAAGGAACTTCCCAG  968 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  955057  TGCGGTGAGCGATAGCGATGTACCATTTCACTGATAACCGCCAGCAAAGGAACTTCCCAG  955116 
 
Query  969     AGGATGACTTCACGCCACGGGCCGCTTAAACG-ATATCCAGCTTGCCATTATCGTTGGGA  1027 
               |||||||||||||||||||||||||||||||| ||||||||||||||||||||||| ||| 
Sbjct  955117  AGGATGACTTCACGCCACGGGCCGCTTAAACGAATATCCAGCTTGCCATTATCGTT-GGA  955175 
 
Query  1028    CACGGTGACTTGTTCCGGGTTAAAGCGG-ACTCGCGT-AGCAGTT-AGATAGTCG--CTT  1082 
               |||||||||||||||||||||||||||| |||||||| | ||||| |||||||||  ||| 
Sbjct  955176  CACGGTGACTTGTTCCGGGTTAAAGCGGAACTCGCGTAACCAGTTAAGATAGTCGGCCTT  955235 
 
Query  1083    AAAGAAACGCA-GGCAG-AAGCCACTGATATTCATCAT-CTGCA-GCGCAGGTGCTGCAT  1138 
               ||||||| ||| ||||| |||||||||||||||||||| ||||| ||||||||||||||| 
Sbjct  955236  AAAGAAAGGCAGGGCAGAAAGCCACTGATATTCATCATCCTGCAGGCGCAGGTGCTGCAT  955295 
 
Query  1139    CGCCCTGA--CTGATCACG-ATAGCATCGGCATAAATACCCAGCGAATCGTCACCTCG  1193 
               || |||||  ||| ||||| ||||||||||||||||||||||||  |||||||||||| 
Sbjct  955296  CG-CCTGAACCTGTTCACGAATAGCATCGGCATAAATACCCAGCAGATCGTCACCTCG  955352 
 
9.1.2 fol gene family sequencing data 
folP and folC were synthesised by Epoch gene synthesis service rather than being 
cloned from E. coli directly. 
9.1.2.1 folE 
>110315_pET21dfolE21_T7 
CCGTAGAAAGTACATTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGATGCCATCACTC
AGTAAAGAAGCGGCCCTGGTTCATGAAGCGTTAGTTGCGCGAGGACTGGAAACACCGCTGCGCCCGCCCGTGCAT
GAAATGGATAACGAAACGCGCAAAAGCCTTATTGCTGGTCATATGACCGAAATCATGCAGCTGCTGAATCTCGAC
CTGGCTGATGACAGTTTGATGGAAACGCCGCATCGCATCGCTAAAATGTATGTCGATGAAATTTTCTCCGGTCTG
GATTACGCCAATTTCCCGAAAATCACCCTCATTGAAAACAAAATGAAGGTCGATGAAATGGTCACCGTGCGCGAT
ATCACTCTGACCAGCACCTGTGAACACCATTTTGTTACCATCGATGGCAAAGCGACGGTGGCCTATATCCCGAAA
GATTCGGTGATCGGTCTGTCAAAAATTAACCGCATTGTGCAGTTCTTTGCCCAGCGTCCGCAGGTGCAGGAACGT
CTGACGCAGCAAATTCTTATTGCGCTACAAACGCTGCTGGGCACCAATAACGTGGCTGTCTCGATCGACGCAGTG
CATTACTGCGTGAAGGCGCGTGGCATCCGCGATGCAACCAGTGCCACGACAACGACCTCTCTTGGTGGATTGTTC
AAATCCAGTCAGAATACGCGCCACGAGTTTCTGCGCGCTGTGCGTCATCACAACTGATAAAAGCTTGCGGCCGCA
CTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCC
ACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGA
ACTATATCCGGATTGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCA
GCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCGCTCCTTTCGCTTTCTTCCCTTCTTTCTCGCCACGTTCGCC
GGCTTTCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGG 
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Query  64       ATGCCATCACTCAGTAAAGAAGCGGCCCTGGTTCATGAAGCGTTAGTTGCGCGAGGACTG  123 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191709  ATGCCATCACTCAGTAAAGAAGCGGCCCTGGTTCATGAAGCGTTAGTTGCGCGAGGACTG  2191650 
 
Query  124      GAAACACCGCTGCGCCCGCCCGTGCATGAAATGGATAACGAAACGCGCAAAAGCCTTATT  183 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191649  GAAACACCGCTGCGCCCGCCCGTGCATGAAATGGATAACGAAACGCGCAAAAGCCTTATT  2191590 
 
Query  184      GCTGGTCATATGACCGAAATCATGCAGCTGCTGAATCTCGACCTGGCTGATGACAGTTTG  243 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191589  GCTGGTCATATGACCGAAATCATGCAGCTGCTGAATCTCGACCTGGCTGATGACAGTTTG  2191530 
 
Query  244      ATGGAAACGCCGCATCGCATCGCTAAAATGTATGTCGATGAAATTTTCTCCGGTCTGGAT  303 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191529  ATGGAAACGCCGCATCGCATCGCTAAAATGTATGTCGATGAAATTTTCTCCGGTCTGGAT  2191470 
 
Query  304      TACGCCAATTTCCCGAAAATCACCCTCATTGAAAACAAAATGAAGGTCGATGAAATGGTC  363 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191469  TACGCCAATTTCCCGAAAATCACCCTCATTGAAAACAAAATGAAGGTCGATGAAATGGTC  2191410 
 
Query  364      ACCGTGCGCGATATCACTCTGACCAGCACCTGTGAACACCATTTTGTTACCATCGATGGC  423 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191409  ACCGTGCGCGATATCACTCTGACCAGCACCTGTGAACACCATTTTGTTACCATCGATGGC  2191350 
 
Query  424      AAAGCGACGGTGGCCTATATCCCGAAAGATTCGGTGATCGGTCTGTCAAAAATTAACCGC  483 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191349  AAAGCGACGGTGGCCTATATCCCGAAAGATTCGGTGATCGGTCTGTCAAAAATTAACCGC  2191290 
 
Query  484      ATTGTGCAGTTCTTTGCCCAGCGTCCGCAGGTGCAGGAACGTCTGACGCAGCAAATTCTT  543 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191289  ATTGTGCAGTTCTTTGCCCAGCGTCCGCAGGTGCAGGAACGTCTGACGCAGCAAATTCTT  2191230 
 
Query  544      ATTGCGCTACAAACGCTGCTGGGCACCAATAACGTGGCTGTCTCGATCGACGCAGTGCAT  603 
                ||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||| 
Sbjct  2191229  ATTGCGCTACAAACGCTGCTGGGCACCAATAACGTGGCTGTCTCGATCGACGCGGTGCAT  2191170 
 
Query  604      TACTGCGTGAAGGCGCGTGGCATCCGCGATGCAACCAGTGCCACGACAACGACCTCTCTT  663 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191169  TACTGCGTGAAGGCGCGTGGCATCCGCGATGCAACCAGTGCCACGACAACGACCTCTCTT  2191110 
 
Query  664      GGTGGATTGTTCAAATCCAGTCAGAATACGCGCCACGAGTTTCTGCGCGCTGTGCGTCAT  723 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2191109  GGTGGATTGTTCAAATCCAGTCAGAATACGCGCCACGAGTTTCTGCGCGCTGTGCGTCAT  2191050 
 
Query  724      CACAACTGATAAAA  737 
                |||||||||| ||| 
Sbjct  2191049  CACAACTGATTAAA  2191036 
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9.1.2.2 folB 
Final sequences after three rounds of SDM, as original BLAST search did not align with any 
known sequences in the database. 
>115165_pET28afolBWT2_T7 
TATGGAATTCCCGTACATTTCCCCTTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGC
AGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGATATTGTATTTATAGAGCAA
CTTTCGGTAATCACCACTATTGGTGTTTACGACTGGGAACAGACCATCGAACAGAAGTTAGTGTTCGATATCGAA
ATGGCGTGGGATAACCGTAAAGCGGCGAAAAGTGATGATGTGGCGGATTGCCTCAGTTACGCTGACATTGCAGAA
ACGGTGGTCAACCACGTCGAGGGGGCGCGTTTTGCGCTGGTGGAACGCGTGGCTGAAGAGGTGGCGGAGCTGCTG
TTAGCACGCTTCAACTCGCCGTGGGTGCGTATCAAACTCAGCAAGCCAGGCGCAGTGGCGCGGGCGGCGAATGTT
GGCGTAATCATTGAGCGTGGCAATAATCTGAAAGAAAATAATTAATAAGGATCCGAATTCGAGCTCCGTCGACAA
GCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGA
GTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTT
GCTGAAAGGAGGAACTATATCCGGATTGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTG
GTGGTTACGCGCAGCGT 
 
 
Query  127  MDIVFIEQLSVITTIGVYDWEQTIEQKLVFDIEMAWDNRKAAKSDDVADCLSYADIAETV  306 
            MDIVFIEQLSVITTIGVYDWEQTIEQKLVFDIEMAWDNRKAAKSDDVADCLSYADIAETV 
Sbjct  1    MDIVFIEQLSVITTIGVYDWEQTIEQKLVFDIEMAWDNRKAAKSDDVADCLSYADIAETV  60 
 
Query  307  VNHVEGarfalvervaeevaelllarfNSPWVRIKLSKPGAVARAANVGVIIERGNNLKE  486 
            VNHVEGARFALVERVAEEVAELLLARFNSPWVRIKLSKPGAVARAANVGVIIERGNNLKE 
Sbjct  61   VNHVEGARFALVERVAEEVAELLLARFNSPWVRIKLSKPGAVARAANVGVIIERGNNLKE  120 
 
Query  487  NN  492 
            NN 
Sbjct  121  NN  122 
 
 
9.1.2.3 folK 
>110587_pET28afolK12_T7 
GTATATCCGGAAACATTTCCCCTTCTTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCA
GCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCTAGCATGACTGGTGGACAGC
AAATGGGTCGCGGATCCTTATTACCATTTGTTTAATTTGTCAAATGCTCTTGTATGTAAGATTTGACGCAACATC
TCCCCATCAGGAAACACCAACTCCGGCGCGATTTCAAACAGCGGCCACAGCATAAATCCACGATTCTTCATATCG
TAGTGCGGAACGGTCAGGCGTTCAGTATTTATCACTTCATTACCAAACAGCATGATGTCGAGATCCAGCGTGCGT
GGTCCCCAGCGTTCAGCTTTGCGGACGCGACCTTGCTGCAATTCAATACGCTGTGTGTGATTGAGTAGCTCTTCA
GGTGCAAGAGAGGTTTCCAGCGCCACGGCTGCGTTTAAGTAATCGGGTTGATTTTGCGGCCCCAGCGGTGGGGTG
CGGTAAAACGAAGAAACGGTAAGAATGTGGCTTTCAGGGATATCGCCTAATGCTTTCAGGGCAGCATTGACCTGC
TCCAGCGGAGAGGCCAGATTGCTGCCTATGGCAATATACGCCACTGTCATATGGTACCCAAGGGCGAATTCCACA
TTGGTCGCTGCAGCCCGGGGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCCCCACC
ACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAAC
TAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGGTTTTTTGCTGAAAGGAGGAACTATATCCCGGATT
GGCGAATGGGGACGCGCCCCTGTACCGCCCCTTAAGCGCGGCGGGAGTGGGTGGGTTACGCGCACCGTGACCGCT
ACACTTGCCAGCGCCCTACGCCCGCTTCCTTTTGCTTTTCTTTCCTTCCTTTCTCGGCCCCTTTCGCCCGGGCTT
TCCCCGTCAAGCTCTATAATCCGGG 
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Query  650  MTVAYIAIGSNLASPLEQVNAALKALGDIPESHILTVSSFYRTPPLGPQNQPDYLNAAVA  471 
            MTVAYIAIGSNLASPLEQVNAALKALGDIPESHILTVSSFYRTPPLGPQNQPDYLNAAVA 
Sbjct  1    MTVAYIAIGSNLASPLEQVNAALKALGDIPESHILTVSSFYRTPPLGPQNQPDYLNAAVA  60 
 
Query  470  LETSLAPEELLNHTQRIELQQGRVRKAERWGPRTLDLDIMLFGNEVINTERLTVPHYDMK  291 
            LETSLAPEELLNHTQRIELQQGRVRKAERWGPRTLDLDIMLFGNEVINTERLTVPHYDMK 
Sbjct  61   LETSLAPEELLNHTQRIELQQGRVRKAERWGPRTLDLDIMLFGNEVINTERLTVPHYDMK  120 
 
Query  290  NRGFMLWPLFEIAPELVFPDGEMLRQILHTRAFDKLNKW  174 
            NRGFMLWPLFEIAPELVFPDGEMLRQILHTRAFDKLNKW 
Sbjct  121  NRGFMLWPLFEIAPELVFPDGEMLRQILHTRAFDKLNKW  159 
 
9.1.2.4 folP 
>folP 
CATATGAAACTGTTCGCACAAGGTACTTCTCTGGATCTGTCTCACCCACATGTGATGGGTATCCTGAATGTAACT
CCGGATAGCTTCAGCGATGGCGGCACCCACAACAGCCTGATCGACGCCGTTAAACATGCGAACCTGATGATTAAT
GCCGGCGCGACCATCATCGACGTTGGCGGCGAGTCCACCCGTCCGGGTGCCGCTGAAGTTAGCGTTGAAGAAGAA
CTGCAGCGTGTTATTCCGGTTGTAGAAGCAATCGCGCAGCGCTTTGAAGTTTGGATTTCCGTTGACACTTCTAAA
CCGGAAGTTATTCGTGAATCCGCTAAAGTTGGCGCTCACATTATTAACGATATCCGCTCCCTGAGCGAACCGGGT
GCCCTGGAAGCTGCAGCAGAAACCGGTCTGCCAGTGTGCCTGATGCACATGCAGGGTAACCCGAAAACTATGCAG
GAAGCCCCGAAATACGATGACGTGTTCGCCGAAGTAAACCGCTACTTTATTGAACAGATCGCTCGCTGCGAACAG
GCAGGTATCGCGAAAGAGAAACTGCTGCTGGACCCGGGCTTCGGTTTCGGCAAGAACCTGTCCCACAACTACAGC
CTGCTGGCCCGTCTGGCTGAATTCCACCACTTCAACCTGCCGCTGCTGGTGGGTATGAGCCGCAAATCCATGATT
GGCCAGCTGCTGAATGTGGGTCCGTCTGAACGTCTGAGCGGTAGCCTGGCTTGTGCTGTGATTGCAGCGATGCAG
GGCGCACATATCATCCGTGTACACGATGTTAAAGAAACCGTTGAAGCGATGCGCGTTGTGGAAGCTACCCTGTCC
GCAAAAGAGAACAAACGCTACGAATAAAAGCTT 
 
 
Query  62   MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGE  241 
            MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGE 
Sbjct  1    MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGE  60 
 
Query  242  STRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRESAKVGAHIINDIRSL  421 
            STRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRESAKVGAHIINDIRSL 
Sbjct  61   STRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRESAKVGAHIINDIRSL  120 
 
Query  422  SEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEQAGIAKE  601 
            SEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEQAGIAKE 
Sbjct  121  SEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEQAGIAKE  180 
 
Query  602  KLLLDPGFGF  631 
            KLLLDPGFGF 
Sbjct  181  KLLLDPGFGF  190 
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9.1.2.5 folC 
>folC 
CATATGATCATTAAACGTACTCCGCAAGCTGCATCTCCACTGGCATCTTGGCTGAGCTACCTGGAAAACCTGCAC
AGCAAAACTATCGACCTGGGCCTGGAACGTGTTTCCCTGGTAGCGGCTCGTCTGGGTGTTCTGAAACCGGCGCCA
TTCGTGTTCACCGTTGCAGGCACTAACGGCAAGGGTACCACTTGTCGCACCCTGGAGTCTATCCTGATGGCGGCA
GGCTACAAAGTAGGTGTTTACTCTTCTCCACACCTGGTTCGCTACACTGAACGTGTTCGTGTGCAGGGTCAGGAG
CTGCCGGAAAGCGCTCACACCGCTTCTTTTGCTGAAATCGAATCTGCGCGTGGTGATATCTCCCTGACTTACTTT
GAATACGGTACCCTGAGCGCACTGTGGCTGTTCAAACAGGCCCAACTGGATGTTGTGATCCTGGAAGTAGGCCTG
GGCGGTCGCCTGGACGCTACCAACATCGTGGATGCCGATGTGGCCGTAGTTACCTCTATCGCACTGGACCACACC
GACTGGCTGGGCCCGGACCGTGAATCTATTGGCCGCGAAAAGGCCGGCATCTTCCGCTCCGAAAAGCCGGCGATT
GTGGGCGAGCCGGAAATGCCGTCCACCATCGCGGACGTTGCGCAGGAGAAAGGTGCTCTGCTGCAGCGTCGCGGT
GTTGAGTGGAACTACTCCGTTACTGACCACGACTGGGCTTTCAGCGACGCTCACGGTACTCTGGAGAACCTGCCA
CTGCCACTGGTTCCGCAGCCGAACGCTGCAACCGCGCTGGCAGCACTGCGTGCATCTGGCCTGGAAGTATCTGAA
AACGCCATTCGCGATGGCATCGCCAGCGCCATTCTGCCGGGTCGTTTCCAGATCGTGTCCGAGAGCCCGCGTGTA
ATCTTCGATGTGGCACACAATCCGCACGCAGCGGAATACCTGACTGGTCGTATGAAAGCTCTGCCGAAGAATGGT
CGTGTTCTGGCTGTGATCGGCATGCTGCATGACAAGGATATCGCAGGTACCCTGGCGTGGCTGAAATCTGTGGTT
GACGATTGGTACTGTGCTCCACTGGAAGGCCCACGTGGTGCGACTGCGGAGCAGCTGCTGGAACACCTGGGTAAC
GGCAAATCTTTTGACTCCGTGGCTCAAGCATGGGACGCTGCTATGGCAGATGCTAAGGCGGAAGACACCGTTCTG
GTTTGCGGTTCTTTTCACACTGTTGCCCACGTTATGGAAGTAATCGATGCTCGTCGCAGCGGTGGTAAATAAAAG
CTT 
 
 
Query  66   MIIKRTPQAASPLASWLSYLENLHSKTIDLGLERVSLVAARLGVLKPAPFVFTVAGTNGK  245 
            MIIKRTPQAASPLASWLSYLENLHSKTIDLGLERVSLVAARLGVLKPAPFVFTVAGTNGK 
Sbjct  1    MIIKRTPQAASPLASWLSYLENLHSKTIDLGLERVSLVAARLGVLKPAPFVFTVAGTNGK  60 
 
Query  246  GTTCRTLESILMAAGYKVGVYSSPHLVRYTERVRVQGQELPESAHTASFAEIESARGDIS  425 
            GTTCRTLESILMAAGYKVGVYSSPHLVRYTERVRVQGQELPESAHTASFAEIESARGDIS 
Sbjct  61   GTTCRTLESILMAAGYKVGVYSSPHLVRYTERVRVQGQELPESAHTASFAEIESARGDIS  120 
 
Query  426  LTYFEYGTLSALWLFKQAQLDVVILEVGLGGRLDATNIVDADVAVVTSIALDHTDWLGPD  605 
            LTYFEYGTLSALWLFKQAQLDVVILEVGLGGRLDATNIVDADVAVVTSIALDHTDWLGPD 
Sbjct  121  LTYFEYGTLSALWLFKQAQLDVVILEVGLGGRLDATNIVDADVAVVTSIALDHTDWLGPD  180 
 
Query  606  RESIGREKAGIFRSEKPAIVGEPEMPSTIADVA  704 
            RESIGREKAGIFRSEKPAIVGEPEMPSTIADVA 
Sbjct  181  RESIGREKAGIFRSEKPAIVGEPEMPSTIADVA  213 
 
9.1.3 gpt sequencing data 
>113666_pET28agpt2_T7 
TTTTGAAAACCAAAACATTTTTCCCTTCTAGAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGC
AGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGAGCGAAAAATACATCGTCACC
TGGGACATGTTGCAGATCCATGCACGTAAACTCGCAAGCCGACTGATGCCTTCTGAACAATGGAAAGGCATTATT
GCCGTAAGCCGTGGCGGTCTGGTACCGGGTGCGTTACTGGCGCGTGAACTGGGTATTCGTCATGTCGATACCGTT
TGTATTTCCAGCTACGATCACGACAACCAGCGCGAGCTTAAAGTGCTGAAACGCGCAGAAGGCGATGGCGAAGGC
TTCATCGTTATTGATGACCTGGTGGATACCGGTGGTACTGCGGTTGCGATTCGTGAAATGTATCCAAAAGCGCAC
TTTGTCACCATCTTCGCAAAACCGGCTGGTCGTCCGCTGGTTGATGACTATGTTGTTGATATCCCGCAAGATACC
TGGATCGAACAGCCGTGGGATATGGGCGTCGTATTCGTCCCGCCAATCTCCGGTCGCTAATAAGCTTGCGGCCGC
ACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGC
CACCGCTGAGCAATAAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAG
GAACTATATCCGGATTGGCGAATGAGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGGCAGGTGTGGTGGTTACG
CGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACG
TTCGCCGGCTTTCCCCGTCAAGCCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACCGGCACC
TCGACCCCAAAAAACTTGATTTAGGGTGAATGGTTCACCGTAGTGGCCATCGCCCTGATTAAACGGTTTTCGCCC
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TTGACGTTGGAGTCCACGTTCTTTATAGTGGACTTCTGTTCCATACTTGAACAACCCTCAAACCTATCTCGTCTA
TTCCTTTGAATTAATAACGAATTGGGCCGATTTCCGGCCTATTGTTTAAAAAATGGACCTGAATT 
 
Query  124      CATATGAGCGAAAAATACATCGTCACCTGGGACATGTTGCAGATCCATGCACGTAAACTC  183 
                || ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3705738  CACATGAGCGAAAAATACATCGTCACCTGGGACATGTTGCAGATCCATGCACGTAAACTC  3705679 
 
Query  184      GCAAGCCGACTGATGCCTTCTGAACAATGGAAAGGCATTATTGCCGTAAGCCGTGGCGGT  243 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3705678  GCAAGCCGACTGATGCCTTCTGAACAATGGAAAGGCATTATTGCCGTAAGCCGTGGCGGT  3705619 
 
Query  244      CTGGTACCGGGTGCGTTACTGGCGCGTGAACTGGGTATTCGTCATGTCGATACCGTTTGT  303 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3705618  CTGGTACCGGGTGCGTTACTGGCGCGTGAACTGGGTATTCGTCATGTCGATACCGTTTGT  3705559 
 
Query  304      ATTTCCAGCTACGATCACGACAACCAGCGCGAGCTTAAAGTGCTGAAACGCGCAGAAGGC  363 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3705558  ATTTCCAGCTACGATCACGACAACCAGCGCGAGCTTAAAGTGCTGAAACGCGCAGAAGGC  3705499 
 
Query  364      GATGGCGAAGGCTTCATCGTTATTGATGACCTGGTGGATACCGGTGGTACTGCGGTTGCG  423 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3705498  GATGGCGAAGGCTTCATCGTTATTGATGACCTGGTGGATACCGGTGGTACTGCGGTTGCG  3705439 
 
Query  424      ATTCGTGAAATGTATCCAAAAGCGCACTTTGTCACCATCTTCGCAAAACCGGCTGGTCGT  483 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3705438  ATTCGTGAAATGTATCCAAAAGCGCACTTTGTCACCATCTTCGCAAAACCGGCTGGTCGT  3705379 
 
Query  484      CCGCTGGTTGATGACTATGTTGTTGATATCCCGCAAGATACCTGGATCGAACAGCCGTGG  543 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3705378  CCGCTGGTTGATGACTATGTTGTTGATATCCCGCAAGATACCTGGATCGAACAGCCGTGG  3705319 
 
Query  544      GATATGGGCGTCGTATTCGTCCCGCCAATCTCCGGTCGCTAAT  586 
                ||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3705318  GATATGGGCGTCGTATTCGTCCCGCCAATCTCCGGTCGCTAAT  3705276 
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9.2 Appendix 2 - SDS-PAGE analysis 
The purified protein involved in NADP+ and dyhdrofolate biosynthesis were analysed by 
SDS-PAGE to assess purity, and confirm the correct monomeric weight.  
 
Figure 9.1 SDS-PAGE analysis of aspartate oxidase following Ni2+-affinity purication. M = 
marker, S = supernatant, FT = flow through, W1-3 = washes and E = elution. 
 
Figure 9.2 SDS-PAGE analysis of QAPRT following purification via Ni2+-affinity 
chromatography. E = elution, W2 - wash 2, W1 = wash 1, FT = flow through, S = 
supernatant and M = marker. 
      E      W2      W1       FT        S        M  
60 kDa  
 
45 kDa    
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Appendix 
 
245 
 
 
Figure 9.3 SDS-PAGE analysis of NADS, NAMNT, NADK and NAPRT following Ni2+-affinity 
purification. M = marker, NS = NADS and NK = NADK 
 
Figure 9.4 SDS-PAGE analysis of HPPK  purifiaction via Ni2+-affinity chromatography. FT = 
flow through, W = wash, M = marker, E1 = elution 1 and E2 = elution 2. 
    FT            W        M         E1        E2 
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Figure 9.5 SDS-PAGE of DHPS fractions from ion-exchange and size-exclusion 
chromatography. M = marker, IEC = ion-exchange column, SEC = size-exclusion column. 
 
 
Figure 9.6 SDS-PAGE of DHFS containing fractions from ion-exchange chromatography. M 
= marker, 1-9 = fractions. 
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9.3 Appendix 3 - Stopped-flow spectroscopy data analysis 
Double exponential fits were applied to the decrease in signal observed for each 
reaction trace, using the software provided on the stopped flow instrument 
(Applied Photophysics Workstation). This provided a rate constant for the reaction 
at each temperature. Each rate constant was an average of at least 3 individual 
traces, and this was repeated at least 3 independent times for each temperature. 
Thus, reported rate constants are an average of at least 9 individual traces, with 
standard deviation of the 3 independent runs used to calculate the error for each 
reported rate constant. Examples of individual traces (red) and the corresponding 
double exponential fits (black) for light and heavy BsDHFR and 13C-labelled NADPH 
and NADPD are shown below. 
 
 
Figure 9.7 Reaction trace from the pre-steady state reaction of EcDHFR with [4-13C]-
NADPD at 5 °C. 
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Figure 9.8 Reaction trace from the pre-steady state reaction of EcDHFR with [4-13C]-
NADPD at 10 °C. 
 
Figure 9.9 Reaction trace from the pre-steady state reaction of EcDHFR with [4-13C]-
NADPH at 5 °C. 
 
Figure 9.10 Reaction trace from the pre-steady state reaction of EcDHFR with [4-13C]-
NADPH at 5 °C. 
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Figure 9.11 Reaction trace from the pre-steady state reaction of 13C15N2H-labelled BsDHFR 
with NADPH at 25 °C. 
 
Figure 9.12 Reaction trace from the pre-steady state reaction of BsDHFR with NADPH at 
25 °C. 
